ADVANCES IN
Immunology EDITED BY FRANK J. DIXON Research Institute of Scripps Clinic La Jolla, California ASSOCIATE EDI...
16 downloads
1638 Views
27MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
ADVANCES IN
Immunology EDITED BY FRANK J. DIXON Research Institute of Scripps Clinic La Jolla, California ASSOCIATE EDITORS
FREDERICK ALT K. FRANK AUSTEN TADAMITSU KISHIMOTO FRITZMELCHERS JONATHAN
w. U H R
VOLUME 5a
ACADEMIC PRESS San Diego New York Boston
London
Sydney Tokyo Toronto
This book is printed on acid-free paper.
63
Copyright 0 1995 by ACADEMIC PRESS, INC All Rights Reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher.
Academic Press, Inc.
A Division of Harcourt Brace & Company 525 B Street, Suite 1900, San Diego, California 92101-4495
h i r e d Kingdom Edition published by Academic Press Limited 24-28 Oval Road, London NW 1 7DX International Standard Serial Number: 0065-2776 International Standard Book Number: 0- 12-022458-5 PRINTED INTHE UNITED STATES OF AMERICA 95 96 9 7 9 8 99 0 0 B B 9 8 7 6
5
4
3 2 1
CONTRIBUTORS
Numbers in parentheses indicute the puges on which the uuthors’ contributions begin.
Harald von Boehmer (87), Basel Institute for Immunology, CH-4005 Basel, Switzerland Glenn Dranoff (417),Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115 Dominique Dunon (345), CNRS-URA 1135, Universitk Pierre et Marie Curie, F-75006 Paris, France Sankar Ghosh (l),Department of Molecular Biophysics and Biochemistry, Section of Immunobiology, Howard Hughes Medical Institute, Yale University, New Haven, Connecticut 06520 Beat A. Imhof (345), Basel Institute for Immunology, CH-4005 Basel, Switzerland Pawel Kisielow (87),Basel lnstitute for Immunology, CH-4005 Basel, Switzerland Elizabeth B. Kopp (l),Department of Cell Biology, Yale University, New Haven, Connecticut 06520 Guido Kroemer (21I), CNRS-UPR 420, F-94801 Villejuif, France Richard C. Mulligan (417), Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142 Gek-Kee Sim (297), Basel Institute for Immunology, CH-4005 Basel, Switzerland David T. Weaver (29), Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115
ix
ADVANCES I N IMIIUNOLOCY. VOL. 58
NF-KB and Re1 Proteins in Innate Immunity ELIZABETH B. KOPP* AND SANKAR G H O S H t
t
Department of Cell Biology and Department of Moleculor Biophysics and Biochemistry and Section of Immunobiology, Howard Hughes Medical Institute, role University, New Haven, Connecticut 06520
I. 11. 111. I\’. V. VI. VII.
Introduction Description of NF-KBand IKB The Activation of NF-KB Physiologic Inducers of NF-KB NF-KBand the Inflammatory Responses Inappropriate NF-KBActivation T Cell Activation VIII. Inhibition of NF-KB:Potential for Therapy IX. Conclusion References
1 2
4 6 9
14 18 19
20 21
I. Introduction Vertebrates respond to infection through a combination of adaptive or acquired immunity and innate or natural immunity. The principal feature of acquired immunity is the generation of receptors on B and T cells that can distinguish between selfand nonself, and hence protect the organism from infectious agents such as bacteria or viruses. By contrast, the hallmarks of innate immunity consist of physical barriers and the ability to generate a battery of cytokines upon nonspecific recognition of conserved structures on infectious agents such as bacterial lipopolysaccharides (LPS) (Colten and Ravetch, 1992). The cytokines help to mount an inflammatory response and to recruit specialized cells, such as natural killer cells, to the site of infection (Abbas et al., 1991). A particularly interesting question is whether the rapid induction in the synthesis of these cytokines is coordinated by some common element. Work carried out over the past several years has identified such an element in a transcription factor known commonly as NF-KB.NF-KBis critical for the inducible expression of many genes involved in the immune and inflammatory responses including IL-1, IL-2, IL-2Ra, IL-6, IL-8, TNF-a, TNF-P, P-IFN, GM-CSF, and serum amyloid A protein. In addition, NF-KB has been conserved through 1 Copyright 0 1995 by Academic P r e w lnc All rights of reproduction in any form reserved
2
ELIZABETH B. KOPP AND SANKAR GHOSH
evolution. A number of recent reviews have described various aspects of NF-KB function in great detail (Grilli et al., 1993; Baeuerle and Henkel, 1994); therefore, this report will instead focus primarily on the role of NF-KB as a unifying element in the body’s response to infection and injury and thus as an important mediator of natural immunity in vertebrates. II. Description of NF-KB and IKB
NF-KB was first characterized in mature B and plasma cells as a nuclear protein that binds specifically to a 10-bp sequence in the K intronic enhancer (Sen and Baltimore, 1986a,b). The correlation between the activity of this transcription factor and the expression of the K gene suggested that it might be a critical regulator for the tissue and developmental stage-specific expression of this gene (Sen and Baltimore, 1986b; Atchison and Perry, 1987; Lenardo et al., 1987). However, the finding that NF-KBexisted in virtually all cells and could be induced b y treatment with agents, such as LPS or PMA, indicated that it had a significantly broader role. Subsequent studies revealed that a wide variety of inducible genes contained NF-KB-responsive sites in their promoters and enhancers, thus indicating a general role for NF-KB as a rapid response transcription factor in different cells (reviewed in detail recently in Grilli et al., 1993; Baeuerle and Henkel, 1994).In most cells, with the exception of mature B cells, macrophages, and some neurons (Kaltschmidt et al., 1994), NF-KB remains in the cytoplasm by being bound to an inhibitory protein called IKB(Baeuerle and Baltimore, 1988a,b; Baeuerle et al., 1988; Gilmore and Morin, 1993).Treatment of cells with various inducers leads to the dissociation of the cytoplasmic complex and the translocation of free NF-KBto the nucleus (Baeuerle et al., 1988). Therefore, NF-KB serves as a signal transducer by carrying information from external agents directly to the nucleus. NF-KB is classically described as a heterodimer of p50 and p65 subunits; however, the cloning of the genes encoding these subunits revealed that they were members of a much larger family of proteins known as the re1 family of transcription factors (Bours et al., 1990; Ghosh et al., 1990; Kieran et al., 1990; Meyer et al., 1991; Nolan et al., 1991; Ruben et al.,1991; Blank et al., 1992). Now, NF-KBis often more loosely described as a homo- or heterodimer of re1 subunits. In addition to p50 and p65, the re1 family currently includes p52, rel-B, the oncogene v-rel, the corresponding protooncogene c-rel,and the Drosophila morphogen dorsal (Stephens et al., 1983; Wilhelmsen et
NF-KB AND HEL PROTEINS IN INNATE IMMUNITY
3
al., 1984; Steward, 1987; Brownell et al., 1989; Neri et ul., 1991; Schinid et al., 1991; Bours et ul., 1992; Mercurio et al., 1992; Ruben et al., 1991; Ryseck et nl., 1992). A conserved, N-terminal, 300-amino-acid segment termed the re1
homology (RH) domain is responsible for the DNA binding, dimerization, activation, and IKBinteractions of the re1 proteins. It is currently believed that the selection of re1 partners in an NF-KBdimer imparts transcriptional activity (or inactivity) on the complex. Thus, the combination of p50 with p65 or c-rel is transcriptionally active as are p65 homodinier and p65/c-rel, whereas p52 and p50 homodimers are transcriptionally inactive and can repress KB-dependent transcription (Bal1992; Lernbecher et al., 1993; Brown et d., 1994; Hansen et lard et d., al., 1994).A PCR-assisted selection of binding sites using recombinant proteins demonstrated that the combination of subunits confers distinct specificities for DNA sequence (Kunsch et al., 1992). The 10bp consensus binding sequence is GGGGYNNCCY, where each re1 protein subunit contacts one-half of the binding site (Urban and Baeuerle, 1990; Urban et al., 1991; see also Baeuerle and Henkel, 1994). The three-dimensional crystal structure of the NF-KBp50 dimer bound to a symmetric binding sequence confirms the basic principles previously established from inutagenesis studies (G. Ghosh et al., unpublished observations). The crystal structure has also revealed a novel DNA binding motif (G. Ghosh et al., unpublished observations). The p50 and p52 proteins are unique in that both of these molecules are derived from larger precursor proteins which are probably cleaved via a novel proteolytic processing mechanism (Fan et al., 1991). The mRNAs for p50 and p52 code for proteins of 105 and 100 kDa, respectively (Bours et al.,1990; Ghosh et nl., 1990; Kieran et al.,1990; Meyer et al., 1991; Neri et nl., 1991; Schniid et ul., 1991; Bours et al., 1992; Mercurio et al., 1992). The N-terminal region of p105 and plOO yields the p50 and p52 molecules. The C-terminal region resembles the NFKB inhibitory molecule, IKB,in that it contains repeats of a sequence motif known as ankyrin repeats. Indeed, intact p105 and plOO do not bind DNA and do not enter the nucleus because the C-terminal region folds back and masks the nuclear localization signal and the DNAbinding domain present in the N-terminus (Beg et al., 1992; Blank et al., 1992; Hatada et al., 1992; Henkel et al., 1992; Liou et al., 1992). As previously mentioned, NF-KB is retained in the cytoplasm of most cells in an inactive form by binding to an inhibitor protein known as IKB(Baeuerle and Baltimore, 1988a,b). Like NF-KB,IKBis a member of a much larger group of proteins. The distinguishing feature of these proteins is the presence of multiple conserved ankyrin repeats
4
ELIZABETH B. KOPP A N D SANKAR GHOSH
which are thought to interact with the re1 domain of NF-KB (Davis et al., 1991; Haskill et al., 1991; Inoue et al., 1992b; Franzoso et al., 1992; Gilmore and Morin, 1993; Naumann et al., 1993). The various members of the IKBfamily have preferences for specific combinations of re1 proteins, and the number and spacing of ankyrin repeats appears to determine this specificity (Beg and Baldwin, 1993; Hatada et al., 1993; Naumann et al., 1993). Currently, the IKB family consists of IKB-a,IKB-P, 1 ~ B - 7and , Bcl-3 (Ohno et al., 1990; Davis et al., 1991; Haskill et al., 1991; Tewari et al., 1992; Inoue et al., 1992a; Liou et al., 1992; Bhatia et al., 1991; Hatada et al., 1992; Wulczyn et aE., 1992; Franzoso et al., 1992). With the exception of Bcl-3, the IKBSclearly inhibit NF-KBactivity (Baeuerle and Baltimore, 1988a,b; Inoue et al., 1992b; Zabel and Baeuerle, 1990; Zabel et al., 1993; Beg et al., 1992; Gilmore and Morin, 1993). The putative oncogene bcl-3 (Bhatia et al., 1991) appears to interact specifically with only p50 and p52 homodimers through a rel-ankyrin repeat interaction and can form a nuclear complex. Ironically, bcl-3 has been reported to both inhibit these homodimers and cause transcriptional activation (Franzosoet al., 1992, 1993; Inoue et al., 1993; Fujita et al., 1993; Bours et al., 1993; Kerr et al., 1992; Wulczyn et al., 1992; Nolan et al., 1993; Gilmore and Morin, 1993; Zhang et al., 1994). It may be that bcl-3 prevents the transcriptionally inactive p50 homodimer from binding to DNA thus allowing the binding of a transcriptionally active NF-KB complex to the same site (Franzosoet al., 1993).The Drosophila morphogen dorsal is also inhibited by a protein (cactus) (Geisler et al., 1992; Kidd, 1992) containing multiple ankyrin repeats and therefore reinforces the view that the Re1 homology domain and the ankyrin repeats have remained specific protein-protein interaction motifs throughout evolution. The specific combination of proteins involved determines whether the interaction has a negative or positive regulatory role. 111. The Activation of NF-KB
The mechanism by which NF-KBactivity is induced remains a novel and fascinating process whose molecular details are yet to be fully elucidated. In uitro studies indicated that phosphorylation of NF-KB:IKB complexes causes their dissociation suggesting a direct role for phosphorylation in the signaling pathway (Ghosh and Baltimore, 1990; Shirakawa and Mizel, 1989). It was recently reported that the activation of NF-KB results in the rapid degradation of the IKB protein, thus ensuring a complete release of NF-KBfrom its cytosolic inhibitor (Sun et al., 1993; Scott et al., 1993; Brown et al., 1993; Henkel
NF-KB A N D REL PROTEINS IN INNATE IMMUNITY
5
et aE., 1993; Beg and Baldwin, 1993; Beg et aE., 1993). Interestingly, I K B - ~which , is the most thoroughly characterized IKB member, is transcriptionally regulated by nuclear NF-KB (de Martin et al., 1993; Beg et al., 1993; Le Bail et al., 1993; Brown et al., 1993; Sun et al., 1993). The release to the nucleus of NF-KBthus causes the upregulation of IKB-a synthesis which then helps to shut down the NF-KB response. This type of feedback loop is uniquely suited for the role of NF-KB as a transient inducer of responsive genes (Fig 1). A characteristic feature of NF-KB activation is the rapidity with which this protein can be induced. Inducers, such as TNF-a, can cause significant activation NF-KB within minutes (Hohmann et al., 1990b; Henkel et at., 1993; Beg et a!., 1993). This rapid response allows NFKB to function as an effective signal transducer, connecting events occurring in the cytoplasm to responses in the nucleus. This property is therefore similar in principle to some other transcription factors such as the interferon stimulated transcription factor and the steroid receptors. But, as will be discussed, the unique feature of signaling through NF-KBis the diversity of signaling molecules and situations that result in the activation of NF-KBand the types of genes responsive to active NF-KB. Although the nature of NF-KB inducers can be diverse, their common feature is that they all signal situations of stress, infection, or injury to the organism. Therefore, it appears that the Viruses
Reactive Oxygen Intermediates Cytokines
Mitogens
/
FIG.1. NF-KB activation. NF-KB is activated by a variety of agents as shown. The identity and pathway of second messengers is currently unknown. Ultimately, however, 1 ~ B - ais presumed to be phosphorylated and rapidly degraded, leading to the release and translocation of NF-KBto the nucleus. NF-KBthen influences the transcription of selected genes, including that of IKB-a.
6
ELIZABETH B. KOPP AND SANKAR GHOSH
primary role of NF-KB is to help coordinate the body’s response to situations of insult by upregulating the synthesis of a wide variety of response genes such as cytokines, adhesion molecules, and acute phase response proteins. IV. Physiologic Inducers of NF-KB
There are many known inducers of NF-KB complexes. NF-KB can be artificially induced in tissue culture by phorbol esters, calcium ionophores, uv light, and various mitogens (Grilli et al., 1993; Baeuerle
and Henkel, 1994).Ofthe physiologic inducing agents, TNFa, sphingomyelin, or other membrane products, LPS, IL-1, viral products including double-stranded RNA, and reactive oxygen intermediates are the most likely to be relevant to NF-KB activation in vivo. These physiologic inducers will be discussed below with regard to their specific roles in innate immunity. OF NF-KB BY BACTERIAL AND VIRAL INFECTION A. INDUCTION The activation of NF-KBupon bacterial or viral infection is a particu-
larly effective way of initiating an immune response to the infection. Since NF-KBpreexists in the cell and can be stimulated without new protein synthesis, its activation can occur quickly. Likewise, the swift activation of this protein promotes the synthesis of many important immune system regulators. It is not surprising then that bacterial and viral products, such as LPS and double-stranded RNA (Visvanathan and Goodbourne, 1989; Lenardo and Baltimore, 1989a; Lenardo et al., 1989), stimulate NF-KB. LPS is known to bind cell surface receptors on important cell types, such as monocytes and macrophages, which can engulf bacteria by phagocytosis. Double-stranded RNA activation of NF-KB has been shown to lead to the production of the important antiviral cytokine, interferon+. The effect of interferon+ is discussed in another section. Other viral products, such as the transactivating proteins of herpes simplex virus, human T cell leukemia virus (HTLVl),(HIV-1), and hepatitis B, can also activate NF-KB (see NF-KB and viral Infection). OF NF-KB BY REACTIVE OXYGEN INTERMEDIATES B. INDUCTION
NF-KB can also be activated through reactive oxygen intermediates (ROIs) (Schreck et al,, 1991). ROIs are produced by macrophages and granulocytes as part of the oxidative burst to destroy bacteria and are also elevated in some pathological situations. The finding that N-acetyl-L-cysteine, an ROI scavenger and glutathione precursor, and
NF-KB A N D REL PROTEINS IN INNATE IMMUNITY
7
dithiocarbamates reduce the activation of NF-KB by many agents (Schreck et al., 1991,1992; Staal et al., 1990; Ivanov et al., 1993; Ziegler-Heitbrock et al., 1993) supports the idea that the redox state of the cell may play a general role in the activity of NF-KB. Although H,O, is reported to activate NF-KB in Jurkat T cells, it is likely that this state (namely, an oxidizing state) merely facilitates the activation of NF-KBb y other physiologic inducers since H,Oz does not activate transcription from &-reporter constructs in all cells without the addition of PMA or TNF (Israel et al., 1992; Ziegler-Heitbrook et al., 1993). OF NF-KB BY CYTOKINES C. INDUCTION
Cytokines are soluble signaling messengers which have a short half-
life and must be induced, which are two properties rendering them
effective for signaling rapid change in homeostasis. NF-KBis critically positioned in a network of cytokines involved in immune system function. Several cytokines induce NF-KBand many cytokines are induced by NF-KBthus establishing an autoregulatory feedback loop. The cytokines known to induce NF-KB are TNFa and IL-I (Grilli et al., 1993; Baeuerle and Henkel, 1994; Beg et al., 1993). IL-1 and T N F a are also transcriptionally regulated by NF-KB (Hiscott et al., 1993).The signalingpathwayof IL-1 has not yet been well characterized. A discussion of the better understood T N F pathway follows (Fig 2). Tumor necrosis factor is a cytokine produced mainly by macrophages which acts on a variety of cell types possessing TNF receptors. T N F induces macrophages in an autoregulatory manner to stimulate the continued production of TNF and of IL-1 and to promote cytotoxic functions of the macrophage. It also stimulates degranulation in neutrophils and the expression of several adhesion molecules in endothelial cells which permits migration and invasion of damaged vessels by immune cells. TNFa activates NF-KB to bind TNF-responsive elements in promoters of a number of genes including its own (Anisowicz et al., 1991; Beget al., 1993; Israel et al., 1989; Hohmann et al., 1990a; Pessara and Koch, 1990; Hohmann et al., 1990b; Yasumoto et al., 1992; also see Section V). The signal transduction pathway leading to the activation of NF-KB by TNFa is currently under investigation. Unlike induction by PMA, the activation of NF-KBby TNFa may function independently of protein kinase C since NF-KB can still be induced by T N F a in cells treated with PKC inhibitors (Meichle et al., 1990). One interesting potential activation pathway of NF-KBinvolves ceramide, the sphingomyelin component. In the T N F a signaling pathway, phospholipase C (PLC) is activated generating diacylglycerol (DAG) and IP3 from PIP2.
8
ELIZABETH B. KOPP A N D SANKAR CHOSH
IL-1, TNF-a
FIG.2. NF-KBand the cytokine network. NF-KBparticipates in a cytokine network in which IL-1 and TNFa can activate NF-KBwhich leads to the production of more IL-1 and TNFa as well as other cytokines.
Since DAG is known to activate PKC and PKC can activate NF-KB, it is likely that T N F a stimulates NF-KB through PKC, possibly by phosphorylating IKB. This outcome has been demonstrated in vitro where PKC treatment of NF-KB/IKBcomplexes causes the dissociation of these complexes (Ghosh and Baltimore, 1990). Ceramide, however, is another potential by-product of this cascade since DAG also activates the enzyme sphingomyelinase (Dressler et al., 1992). Indeed, T N F a treatment stimulates sphingomyelinase activity and elevates ceramide levels in Jurkat T cells, HL-60 leukemia cells, and U937 monocytes (Schiitze et al., 1992; Dbaibo et al., 1993; Yang et al., 1993) and the sphingomyelin degradation is effected through the TNF receptor (Weigmann et at., 1992; Yanaga and Watson, 1992). Several groups have now demonstrated that sphingomyelinase and cell-permeable ceramide can independently activate NF-KB in cells suggesting that TNFa could affect NF-KB activation in more than one way (Schutze et al., 1992; Dbaibo et al., 1993; Yang et al., 1993). The mechanism for the ceramide activation of NF-KBmay involve a ceramide-activated protein kinase which, perhaps through Raf (Finco and Baldwin, 1993), may ultimately influence the phosphorylation of I K B(Kolesnick ~ and Golde, 1994).
NF-KB A N D REL PROTEINS I N INNATE IMMUNITY
9
It is possible that other membrane products also activate NF-KB through their breakdown. In one recent study, phosphatidylcholine-PLC was shown to activate NF-KB in Jurkat and U937 cells (Arenzana-Seisdedos et al., 1993). This enzyme, added exogenously or overexpressed internally, hydrolyzed phosphatidylcholine specifically without affecting sphingomyelin breakdown or the breakdown of other membrane components. Much more research is still needed to determine the relevance of lipid second messengers to NF-KB signaling and activation. V. NF-KB and the Inflammatory Responses
When faced with insult, inflammatory defense mechanisms quickly respond to repair tissue and destroy invasive organisms in order to reattain homeostasis. The localized response is termed inflammation and is critical for the immediate defense at the site of injury. The systemic reaction to injury or infection is referred to as the acute phase response and is characterized by fever, increased gluconeogenesis, alterations in lipid metabolism, and increased synthesis of several endocrine hormones. Of particular importance for the innate immune response is the production of acute phase proteins, cytokines, and cell adhesion molecules. Interestingly, NF-KB is intricately involved in the promotion of these inflammatory mediators.
A. NF-KB-DEPENDENT INFLAMMATORY MEDIATORS 1 , Acute Phase Response Proteins During the acute phase response, the liver is responsible for the enhanced production of a number of marker plasma proteins referred to as the acute phase proteins (APPs) (Baumann and Gauldie, 1994; Steel and Whitehead, 1994). These proteins provide host protection by scavenging reactive oxygen intermediates, controlling serine proteases, activating complement, and aiding in tissue repair. Several of the acute phase proteins depend on NF-KBfor their efficient transcription including serum amyloid A protein (SAA) (Edbrooke et al., 1989), the C3 component of complement (Darlington et al., 1993), a1 acid glycoprotein (Baumann and Gauldie, 1994), and angiotensinogen (Ron et nl., 1990). The KB binding site renders these genes responsive to mitogen and cytokine stimulation (Edbrooke et al., 1989).The function of many of the acute phase proteins, including SAA and a1 acid glycoprotein, is unknown. The C3 component of complement is important in both the classical and the alternative pathways of complement activa-
10
ELIZABETH B. KOPP A N D SANKAR GHOSH
tion (Darlington et al., 1993), and angiotensinogen is the substrate for renin in the renin-angiotensin system for vasoconstriction and sodium retention. Although cell adhesion molecules are not acute phase response proteins, their production during inflammation is critical for the optimum response of migrating immune cells. The promoters of VCAM-1, ELAM-1, and ICAM-1 all contain NF-KB sites (Shu et al., 1993; Degitz et al., 1991; Whelan et at., 1991; Neish et aE., 1992). The activation of NF-KB then can enhance the surface expression of these molecules on a variety of cells thus allowing a specific adherence of immune cells to sites of injury and infection (Table 1).
2. Cytokines Znduced by NF-KB The signals of stress or infection activate NF-KBto allow the upregulation of immediate-response genes. Among the cytokine genes upregulated by NF-KB are IL-1, IL-2, IL-6, IL-8, GM-CSF, G-CSF, TNFa, TNFP, and p-interferon (Grilli et al., 1993; Hiscott et al., 1993). The activation of IL-2 and IL-2 receptor will be discussed with regard to T cell activation. The other cytokines are addressed below with regard to their effect on the inflammatory responses.
TABLE I NF-KB-INDUCED INFLAMMATORY MEDIATORS Cytokines @-Interferon Interleukin-1 Interleukin-2 Interleukin-6 Interleukin-8 CM-CSF (granulocyte/macrophage colony-stimulating factor) C-CSF (granulocyte colony-stimulating factor) T N F a (tumor necrosis factor) LT (lymphotoxin) Acute phase response proteins a1 acid glycoprotein Angiotensinogen Complement factor B (Bf) C 3 component of complement Serum amyloid A protein Cell adhesion molecules ICAM-1 (intercellular cell adhesion molecule 1) ELAM-1 (E selectin) VCAM-1 (vascular cell adhesion molecule 1)
NF-KB A N D REL PROTEINS IN INNATE IMMUNITY
11
The hepatic and extrahepatic acute phase response results from exposure of these tissues to cytokines. The so-called inflammatory cytokines consist of IL-1, IL-6, IL-8, and TNFa. The production ofeach of these cytokines results from the activation of NF-KB;as previously mentioned, IL-1 and TNFa also activate NF-KBthemselves (Hohmann et al., 1990a,b; Israel et al., 1989; Collart et al., 1990; Lacoste et al., 1990; Osborn et al., 1989; Nonaka and Huang, 1990; Hiscott et al., 1993) to initiate an autoregulatory pathway. The “early cytokines,” IL-1 and TNFa, are those produced in the first stages of the response. These in turn upregulate the production of the important “late” cytokine, IL-6, and the IL-6 receptor. This upregulation is at least partly mediated by NF-KB proteins binding to regulatory sites in the IL-6 and IL-6 receptor promoter and is discussed further below. NF-KB promotes the production of TNFa by binding to the four KB sites in the TNFa promoter in macrophages and it also activates transcription ofthe TNF-related lymphotoxin gene (Paul et al., 1990).The initiating factors in this inflammatory cytokine cascade are unknown but probable candidates include prostaglandins, free radicals, LPS, and viruses (Koj et al., 1993). As previously mentioned, free radicals, LPS, and viruses have all been shown capable of activating NF-KB. f3-Interferon, GM-CSF, and G-CSF are not strictly defined as inflammatory cytokines. They do, however, participate in the immune and inflammatory responses and thus deserve mention. G-CSF and GM-CSF each are cytokines which stimulate the proliferation and differentiation of macrophages and granulocytes, cells which are critical to the immediate response to infection. Both of these genes contain NF-KB sites which confer inducibility to them. f3-Interferon is a cytokine produced by macrophages and fibroblasts as a result of viral infection. It has an antiviral protective effect on neighboring uninfected cells, stimulates NK activity, and promotes class I MHC expression (Abbas et al., 1991) Double-stranded RNA will induce the production of this cytokine. As previously mentioned, double-stranded RNA will also induce NF-KB activation. This induction may be caused by phosphorylation of I K Bby ~ double-stranded RNA-dependent Ser/Thr protein kinase which has recently been shown capable of phosphorylating and inactivating I K B in ~ vitra (Kumar et al., 1994). These two events are linked in that NF-KB binds a regulatory element known as the PRDII element in the @-interferon promoter. The binding of NF-KB to this site requires the binding of an accessory factor, the high mobility group protein HMG I(Y), which may bend the DNA to allow appropriate binding of NF-KB (Thanos and Maniatis, 1992). The NF-KBbinding site is critical for the inducibility of this gene by
12
ELIZABETH B. KOPP A N D SANKAR GHOSH
double-stranded RNA (Visvanathan and Goodbourne, 1989; Hiscott et al., 1989; Lenardo et at., 1989; Fujita et al., 1989).Binding of NFKB to this site then activates production of IFNP RNA. IL-1 is an important inflammatory cytokine involved in the activation and proliferation of lymphocytes and other cell types and in the induction of acute phase response proteins by the liver (see Section 3). IL-1 is also considered to be an endogenous pyrogen, causing fever perhaps by increasing prostaglandins which act directly on the thermoregulatory center of the hypothalamus. IL-1 treatment of cells results in the activation of NF-KBand subsequent enhancement of transcription of a variety of genes including several acute phase proteins such as complement factor B (Bf) (shown for mouse Bf), serum amyloid A2 (SAA2) (Betts et al., 1993), and angiotensinogen (Brasier et al., 1990). The IL-1 induction of these proteins has been shown to depend on an intact KB-like binding site (Nonaka and Huang, 1990; Betts et al., 1993; Brasier et al., 1990) and may require additional factors for maximum expression (Bf, Nonaka and Huang, 1990). The cytokines IL-1 and IL-6 also combine to produce a synergistic activation of SAA2 transcription mediated by NF-KB and NF-IL6 (Betts et al., 1993). IL-8 is another important inflammatory cytokine. It is a chemotactic molecule which activates luekocytes and attracts them to areas of tissue damage and influences the release of histamine by granulocytes. Like T N F a and IL-1, IL-8 is at least partially regulated by NF-KB (Stein and Baldwin, 1993;Yasumoto et al., 1992).Although another important transcription factor, NF-IL6 (see also below) is also necessary for IL8 transcription, it is the NF-KB site that imparts the inducibility to the IL-8 enhancer (Mukaida et al., 1990). NF-IL6 or another C/EBP transcription factor member is able to cooperate with NF-KBto modulate transcription from the IL-8 enhancer (Stein and Baldwin, 1993). Interestingly, in vitro DNA-binding studies and transient transfection assays implicate p65 homodimer as the transcriptional activator binding to the &-like site in this enhancer (Kunsch and Rosen, 1993). p50ip65 did not bind the IL-8 site in vitro and did not transactivate transcription from this enhancer despite its ability to do so in cells transfected with Igrc or HIV KB site reporters (Kunsch and Rosen,
1993).
3. Important Role of ZL-6 IL-6 is an inflammatory cytokine released by a variety of cell types, most notably, activated monocytes, T cells, B cells, endothelial cells, fibroblasts, and glial cells (reviewed in Kishimoto et al., 1994; Wong and Clark, 1988; Van Snick, 1990). The importance of IL-6 in the
NF-KH AND REL PROTEINS IN INNATE IMMUNITY
13
acute phase response cannot be underestimated. IL-6 induces the transcription of virtually all of the APPs either alone or in combination with other cytokines. Indeed, IL-6-deficient mice respond poorly to bacterial and viral infections and tissue injuries, and mRNA levels of haptoglobin, serum amyloid A protein, and a1 acid glycoprotein do not increase in these mice after insult (Kopf et al., 1994). Furthermore, because IL-6 levels are raised in body fluids during many disease states, measurements of IL-6 have prognostic and diagnostic value for various neoplasias, graft versus host disease, trauma, autoimmune diseases, and preterm labor. a. The Production of IL-6 Is Itself Regulated by N F - K B . The IL6 promoter contains single binding sites for the transcription factors NF-IL6 and NF-KB.NF-IL6 is a member ofthe broader class of leucine zipper DNA binding proteins known as the C/EBP family (Akira et al., 1990). In transfection assays, the NF-KBbinding site is necessary for transcription of CAT reporters containing the IL-6 promoter. This transcription is activated when cells are exposed to mitogens or other cytokines including PMA, LPS, IL-1, TNFa, dsRNA, and PHA (Shimizu et al., 1990; Libermann and Baltimore, 1990; Zhang et al., 1990; Dendorfer et al., 1994).Thus, the initial inflammatory event may cause the production of IL-1 and TNFa which in turn can activate NF-KB leading to the production of more IL-1 and of IL-6 (Brouckaert and Libert, 1993).IL-6 induces production of the APPs and may downregulate production of IL-1 and TNFa.
b. Synergy between NF-IL6 and N F - K B . In addition to enhancing the transcription of IL-6, NF-IL6 and NF-KB work cooperatively to increase transcription for a number of other cytokines and acute phase response proteins. There is a synergistic enhancement of transcription from IL-6 pronioter-reporter constructs in the presence of cotransfected NF-KB and NF-IL6 (Betts et al., 1993). This synergism is not limited to pSO/p65 alone as p65 homodimer yields the greatest activation of transcription in the presence of NF-IL6 (Matsusaka et al., 1993).The SAA2 gene was similarly found to respond synergistically to the combination of NF-KB p65 subunit and NF-IL6. The interaction of NF-KB with NF-IL6, although enhancing transcription and DNA-binding from C/EBP promoters and promoters containing both NF-KB and C/EBP sites, can also inhibit transcription from the HIV-1 enhancer containing only KB sites (Stein et al., 1993).Evidence supporting the direct physical contact between NF-KB and NF-IL6 or other C/EBP members demonstrates the ability to crosslink these proteins in vitro in the absence of DNA. Crosslinking using mutant and
14
ELIZABETH B. KOPP AND SANKAR GHOSH
wild-type constructs revealed that the putative proteidprotein interaction occurs via the conserved bZIP domain of the C/EBP protein with the re1 homology domain of NF-KB (Matsusaka et al., 1993; Stein et al., 1993; LeClair et ul., 1992). B. EVOLUTIONARY SIGNIFICANCE OF NF-KB AS
AN
INFLAMMATORY MEDIATOR The importance of NF-KB in the innate response to infection and inflammation has been further substantiated by an exciting recent discovery. This discovery involves the characterization of Dif, an insect transcription factor of the re1 family which binds KB-like motifs in the promoters of insect immunity genes ( I p et al., 1993; Sun and Faye, 1992). Dif becomes activated in the fat body of insects as a result of infection. Since the fat body is considered to be the evolutionary ancestor of the liver, it has been suggested that the activation of Dif is analogous to the acute phase response of inflammation in vertebrates ( I p et al., 1993; Hultmark, 1994). This suggests that the NF-KBdependent aspect of innate immunity arose from a primitive form of the same and that this efficient system survived evolution. VI. Inappropriate NF-KB Activation
A. NF-KB AND VIRALINFECTION It is now known that several viruses, including CMV, SV40, and HIV-1, use NF-KB for efficient transcription of their own genes (Grilli et al., 1993). The promoters of these viral genomes contain NF-KB binding sites which influence viral transcription upon activation of NF-KB. Since NF-KB activation is virtually ensured in infected cells, the use of this host transcription factor conveniently enhances viral infectivity. In other situations, the transactivation proteins of other viruses inadvertently activate NF-KBproducing aberrant levels of NFKB-dependent proteins and promoting inappropriate inflammatory responses (Gutsch e t al., 1994; Hammarskjold and Simurda, 1992; Waldmann et ul., 1984; Ballard et al., 1988; Lindholm et al., 1990; Hirai et ul., 1994; Depper et aE., 1984; Ruben et al., 1988). In either case, the innate immune response is exploited to the detriment of the cell. Both types of viral response are discussed below.
1. NF-KB and HIV-1
The HIV-1 LTR contains several cis-acting regulatory sequences (Rosen et al., 1985; Garcia et al., 1987) including two tandem NF-KB sites (Nabel and Baltimore, 1987).Numerous studies have determined
NF-KB AND REL PROTEINS IN INNATE IMMUNITY
15
that these NF-KBsites are effective in transcriptional activation of viral genes (Muesing et al., 1987). Indeed, chronically infected cell lines can be induced to produce virus when treated with activators of re1 proteins such as TNFa (Folks et al., 1989; Matsuyama et al., 1989; Duh et al., 1989; LaCoste et al., 1990; Griffin et al., 1989), PMA (LaCoste et al., 1990; Siekevitz et al., 1987), or IL-1. Similarly, transfected cell lines can be stimulated to activate transcription from HIV reporter constructs when treated with the same agents (Kaufman et al., 1987; Osborn et al., 1989; Duh et al., 1989; LaCoste et al., 1990; Nabel and Baltimore, 1987; Siekevitz et al., 1987).It is now becoming clear that effective transcription from the HIV enhancer like many of its cellular counterparts requires several transcription factors of which NF-KB (or the re1 protein family) is one, albeit important, element (Perkins et al., 1993; Muchardt et al., 1992). The relative significance of the multiple transcription factor binding sites depends on the cell type infected with the virus and may rely on the amount of a particular active transcription factor present (Parrott et al., 1991; Ross et al., 1991; Franza et al., 1987; Osborn et al., 1989; Hazan et al., 1990; LaCoste et al., 1990). In addition to the NF-KB sites in the HIV LTR, there are three SP-1 sites and the TAR element, which is responsive to the HIV transactivating product, tat. Recent studies confirm that all of these sites are important (Berkhout and Jeang, 1992) but they may be functionally redundant; that is, the deletion of one or more sites slows transcription but does not halt it (Ross et al., 1991). Cell types that have copious amounts of activated NF-KB (by virtue of infection or stimulation by mitogen or cytokine) are insensitive to deletion of SP1 sites (Parrott et aZ., 1991)or mutation to the TAR element (Harrich et al., 1990). Similarly, deletion of the NF-KB sites but retention of the three SP1 sites and the TAR element will sustain viral production (Leonard et uZ., 1989). Moreover, it appears that NF-KBand SP-1 also physically interact to produce a synergistic response when bound to their respective sites (Perkins et al., 1993).The specific re1 subunits activated during infection may also play a role in the promotion of HIV-1 transcription. For example, the re1 complex, p50B/p65, appears to be particularly effective at stimulating transcription from the HIV1 LTR especially when expressed with the HIV tat protein, whereas c-re1 appears to repress p65-mediated transcription from this promoter (Doerre et al., 1993). This interaction is most likely functional, not physical (Liu et al., 1992; Schmid et al., 1991). Notably, a negative strand RNA transcript has also been detected by R T PCR in acutely and chronically HIV-infected cell lines (Michael et al., 1994), the transcription of which also depends on the NF-KB
16
ELIZABETH B. KOPP A N D SANKAR GHOSH
sites. A protein corresponding to this transcript has not yet been described, and the relevance of this RNA to HIV infection remains to be demonstrated.
2 . NF-KB Activation and HZV-1 Infectivity The activation of NF-KBhas been associated with a switch from viral latency to viral productivity (Nabel and Baltimore, 1987; Bachelerie et al., 1991; Griffin et al., 1989).This activation may be caused by cellular signals involved in HIV infection itself, by secondary infection, or by differentiation in HIV-infected cells (Griffin et al., 1989; Bachelerie et al., 1991; Nabel, 1991; Bohnlein et al., 1989; Roulston et al., 1993; Hazan et al., 1990; Tong-Starksen et al., 1987; Paya et al., 1992; Suzan et al., 1991; Hamrnarskjold and Simurda, 1992) positioning NF-KB in a prominent role in maintaining viral production. Human herpes virus8 (HHV6) predominantly infects T cells and other cells involved in HIV-1 infection. Although a common virus for which most humans are seropositive, it exacerbates disease progression for patients suffering from AIDS. Coinfection of T cells with HHVG and HIV-1 accelerates cytopathic degeneration (Lusso et al., 1989).This effect has been investigated transcriptionally in coinfected or cotransfected cells. HHVG isolated from AIDS patients is able to activate transcription from the HIV LTR. This transcription is dependent on NF-KBsites in the HIV enhancer (Ensoli et d.,1989; Gimble et al., 1988; Horvat et al., 1991). Consistent with those observations, HHVG infection has been shown to activate NF-KB. The herpesvirus proteins involved in stimulation of NF-KB have not yet been well defined. An uncharacterized HHVG gene, B701, has been identified which is able to transactivate the HIV-1 promoter contingent on intact NF-KB sites (Geng et al., 1992; Horvat et al., 1991). An HHVG immediate-early protein, ICP4, is also able to stimulate HIV-1 replication although it is unclear whether this stimulation is mediated through the HIV-1 NF-KB sites (Albrecht et at., 1989). Herpes Simplex Virus 1 (HSV-l), HTLV-1, and Epstein-Barr Virus also produce proteins that transactivate NF-KB(Vlach and Pitha, 1992; Albrecht et al., 1992; Hammarskjold and Simurda, 1992). Although the HSV-1 proteins responsible for this transactivation are also not yet adequately characterized, it is known that the HSV-1 immediate-early protein, ICPO, enhances transcription from the HIV-1 LTR in transfected cells. This activity is further increased when NF-KBlevels are high (Vlach and Pitha, 1993). Taken together, all of these results suggest that the HIV-1 LTR is organized for optimal transcription; a complex physical and functional
NF-KH AND REL PROTEINS I N INNATE IMMUNITY
17
interplay between SP1, NF-KB, and tat regulates the effectiveness of this transcription (Jeang e t al., 1988; Ross et al., 1991; Parrott et al., 1991).This transcription can be induced by mitogenic stimulation, by secondary viral infection, or by cellular differentiation. Finally, the tandem NF-KB sites in the HIV-1 LTR confer inducibility of this promoter to cellular signals.
B. INAPPROPRIATE EXPRESSION OF KB-DEPENDENT PROTEINS The HTLV-1 tax protein is a nuclear transcriptional transactivator that induces the production of its own RNAs. Tax does not bind DNA alone; it presumably interacts with other cellular proteins involved in transcription. Tax has been shown to activate NF-KB(re1 proteins) and DNA binding activity in transfected Jurkat T cells and other cells (Li e t al., 1993; Li and Siekevitz, 1993; Bohnlein e t al., 1989; Leung and Nabel, 1988; Ruben et al., 1988; Ballard et al., 1988; Watanabe et al., 1993; Arima e t ul., 1991) although NF-KBdoes not enhance transcription of HTLV-1 genes. In appropriate cells, however, it does inadvertently lead to transcription of some cellular genes responsive to NFKB including the IL-2 receptor gene (Ruben e t al., 1988; Ballard et al., 1988; Leung and Nabel, 1988; Wano e t al., 1988), the IL-2 gene (Wano et ul., 1988), the TNFa gene (Albrecht e t al., 1992),the TNFP gene (Lindholm et ul., 1992), the IgK gene (Lindholm et al., 1992), and the human vimentin gene (Lilienbaum and Paulin, 1993). In fact, T cells infected with HTLV-1 characteristically display unusually high levels of surface IL-2 receptor (Gootenberg et ul., 1981; Waldmann et ul., 1984; Depper et al., 1984). The mechanism of tax activation of NFKB is still unclear. Since tax is predominantly a nuclear protein, it is unlikely that it activates NF-KB by acting directly on the cytosolic NFKB inhibitor, IKB. Notably, soluble tax protein applied extracellularly can also induce NF-KB activity (Lindholm et al., 1990,1992). The role of tax in HIV-1 infection parallels that of the putative HHV-6 transactivator proteins. Since tax is able to activate NF-KB, a secondary infection with HTLV-1 in HIV-infected cells would presumably enhance HIV production. Indeed, the NF-KB sites of the HIV-1 LTR are tax responsive and can convey tax inducibility to a heterologous promoter (Bohnlein et al., 1989). Remarkably, tax appears to interact with the pl00 product of the N F K B gene. ~ This interaction was recently shown to inhibit taxinduced expression from HTLV-1 and HIV-1-CAT reporter constructs cotransfected with plOO and tax in Jurkat T cells. Furthermore, the overexpressed plOO sequestered tax in the cytoplasm where it presum-
18
ELIZABETH B. KOPP A N D SANKAR GHOSH
ably has no activity (Bkraud et al., 1994). This inhibition may be an important factor contributing to the extreme viral latency associated with HTLV-1 infection in uiuo (Bkraud et al., 1994). In another system, overexpressed IKBY,which is an alternatively spliced C-terminal variant of p105, has also been shown to bind and sequester coexpressed tax in the cytoplasm (Hirai et al., 1994). It remains to be seen whether this binding ability is relevant to NF-KBactivation in uivo. VII. T Cell Activation
T cell activation involves engagement of the T cell receptor at the cell surface and transmission of a Ca2+-dependentsignal to the nucleus. This signal activates transcription of a number of genes initiating differentiation, proliferation, and secretion from the cell. Although classical T cell activation requires antigen and thus participates in acquired rather than innate immunity, this process also requires and generates cytokines which depend on NF-KBfor their production. In particular, the production of IL-2 and IL-2 receptor is enormously important in T cell activation and will thus be discussed with regard to NF-KBregulation. A. IL-2 PRODUCTION IL-2 is produced by activated T cells and acts back on these cells to produce more IL-2 and to produce IL-2 receptor. The production of IL-2 is regulated transcriptionally and is associated with differentiation and proliferation of these cells (Brorson et al., 1991). The IL-2 promoter contains binding sites for a number of transcription factors including NF-KB(Lenardo et al., 1988). No one of these transcription factors plays a dominant role; rather, each contributes to the activation of transcription of IL-2 (Serfling et al., 1989; Hoyos et al., 1989). It is now known that activation of IL-2 production by T cells requires calcineurin, a Ca2+-dependent phosphatase. The immunosuppressive activity of the drugs FK506 and cyclosporin A is attributed to these drugs’ ability to bind and inhibit calcineurin. It is notable that in some studies this inhibition does not appear to affect DNA binding and only partially affects transactivation of NF-KB in transformed T cell lines but does affect these properties of other transcription factors suggesting that the induction of NF-KB in T cell activation is independent of calcineurin (Banerji et al., 1991). A more recent study in Jurkat T cells contradicts this conclusion however. Frantz et al. (1994) found that in Jurkat cells transfected with a constitutively active mutant of calcineurin, NF-KB was activated resulting in transcription from the
NF-KB AND REL PROTEINS IN INNATE IMMUNITY
19
I L - ~ K promoter. B This affect was enhanced synergistically in the presence of PMA and was sensitive to treatment with FK506. Overexpressed I K B in ~ these cells appears to be phosphorylated, possibly suggesting that calcineurin acts upstream of the release of NF-KBfrom IKB (Frantz et al., 1994). Studies in nontransformed T cells concur indicating that stimulation of transcription from the I L - ~ K B site requires antigen and antigen-presenting cells and is inhibited by cyclosporin A (Kang et al., 1992). Interestingly, this activation appears to be repressed by p50 homodimers and activated by p50/p65 (Kang et al., 1992).
B. IL-2 RECEPTORPRODUCTION The expression of the IL-2 receptor is induced during T cell activation and by binding IL-2 contributes to the further production of this important cytokine. IL-2R is made up of two subunits, a! and p, of which the a subunit is inducible concomitant with T cell activation. The IL-2Ra subunit gene contains a KB-like regulatory sequence that is responsive to mitogens, TNFa (Lowenthal et al., 1989), and the HTLV-1 transactivator protein, tax (Pomerantz et al., 1989). This sequence is necessary but not sufficient for efficient transcription of IL2Ra (Pomeratitz et al., 1989; Cross et al., 1989; Freimuth et al., 1989; Hkniar et al,, 1991). Interestingly, it appears that cell-type-specific proteins and/or other sequence elements are also important in the T cell specificity of expression of this gene since the KB site alone does not confer transcriptional activity to heterologous promoters, and nuclear NF-KB which can bind to this site (as in mature B cells) does not necessarily induce transcription (Freimuth et al., 1989; Cross et al., 1989; Pomerantz et al., 1989). VIII. Inhibition of NF-KB: Potential for Therapy
Because the inappropriate activation of NF-KBcan theoretically lead to undesired inflammatory or immune responses, the inhibition of NFKB is now being investigated. As previously mentioned, N-acetylcysteine can block the activation of NF-KBpresumably through interfering with signaling via reactive oxygen intermediates or by altering the redox state of the cell. The protease inhibitor, TPCK, can also inhibit activation of NF-KB (Henkel et al., 1993). Neither of these drugs, however, specifically inhibit NF-KB and therefore would probably not be good candidates for therapy. Interestingly, the common antiinflammatory drugs sodium salicylate and aspirin can inhibit the activation of NF-KBat high doses (Kopp and Ghosh, 1994). Historically, the
20
ELIZABETH B. KOPP A N D SANKAR GHOSH
clinical effectivenss of these drugs has been attributed to their ability to inhibit prostaglandin production; however, the prostaglandin hypothesis as the sole explanation for the activity of the salicylates has come into question (Weissmann, 1991). In particular, there appears to be a discrepancy between the high doses necessary to treat chronic inflammatory diseases and the low doses sufficient to inhibit prostaglandin production. Therefore, the inhibition of NF-KBby these drugs may account for their anti-inflammatory activity at high doses. Although the salicylates clearly inhibit other processes beside NF-KB, they are viable drugs as they have been used clinically for hundreds of years (Weissmann, 1991). However, a search for more specific and effective NF-KB inhibitors will surely b e pursued in the future. IX. Conclusion
Although NF-KBwas first discovered as a key regulator for the developmental stage and tissue-specific expression of the immunoglobulin K light-chain gene, subsequent studies as described in this review demonstrate that this inducible transcription factor plays an important role in the expression of many other genes. The remarkable aspects of NF-KB function are its involvement in the expression of so many different target genes and the diversity of signals that activate this transcription factor from its cryptic inactive state. Although such prolific use of one transcription factor for regulating so many genes appears at a first glance bewildering, an examin,ation of these genes suggests that NF-KB is recruited for situations requiring a rapid response to stress, infection, and injury. As many of the gene products regulated by NF-KB(cytokines, acute phase response proteins, and cell adhesion molecules) are integral components of innate immunity, it is not intuitively difficult to regard NF-KBas a crucial element in this protective system. NF-KBplays an evolutionarily conserved role in helping to protect the organism from infection as evidenced by the recent characterization of Dif, an insect transcription factor that regulates innate immunity in Drosophila. The properties of mutant mice that lack the p105 (p50) gene also support the concept of NF-KB as a key player in this system (W. Sha and D. Baltimore, personal communication). These mice, generated by gene targeting, developed normally indicating that NF-KB p50 function is redundant for specifyingoverall development. However, careful examination ofthese mutant mice revealed that their B cells were deficient in their ability to interact with T cells and to respond to LPS. Remarkably, despite containing normal numbers of functional B and T cells, they are far more susceptible to infection than normal littermates.
NF-KB AND REL PROTEINS IN INNATE IMMUNITY
21
The importance of NF-KB in modulating the expression of so many cytokines and lymphokines makes it an attractive target for possible therapeutic intervention. This is particularly true in the case of viruses, such as HIV, which have taken advantage of the obligatory activation of NF-KB in sites of infection or inflammation. Further work will be necessary to determine if specific NF-KB inhibitors can be developed to slow the progression of diseases such as AIDS. REFERENCES Abbas, A., Lichtman, A. H., and Pober, J. S. (1991).Cytokines. In “Cellular and Molecular Immunology,” pp. 226-242. Saunders, Philadelphia. Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nichio, Y., Nakajima, T., Hirano, T., and Kishimoto, T. (1990). EMBOJ. 9, 1897-1906. Albrecht, H., Shakhov, A., and Jongeneel, V. (1992).J . Virol. 66,6191-6193. Albrecht, M., DeLuca, M., Bym, R., Schaffer, P., and Hammer, S. (1989).J . Virol. 63, 1861-1868. Anisowicz, A., Messineo, M., Lee, S., and Sager, R. (1991).J. lmmunol. 147, 520-527. Arenzana-Seisdedos, F., Fernandez, B., Dominguez, I., Jacque, J., Thomas, D., DiazMeco, M. T., Moscat, J., and Virelizier, J. L. (1993)./. Virol. 67, 6596-6604. Arima, N., Molitor, J., Smith, M., Kim, J., Daitoku, Y., and Greene, W. (1991).J. Virol. 65,6892-6899. Atchison, M., and Perry, R. (1987). Cell 48, 121-128. Bachelerie, F., Alcami, J., Arenzana-Seisdedos, F., and Virelizier, J-L. (1991).Nature 350, 709-712. Baeuerle, P., and Baltimore, D. (1988a). Cell 53,211-217. Baeuerle, P., and Baltimore, D. (1988b). Science 242, 540-546. Baeuerle, P., and Henkel, T. (1994). Annu. Reo. Inimunol. 12, 141-179. Baeuerle, P., Lenardo, M., Pierce, J., and Baltimore, D. (1988). Cold Spring Harbor Syni. Qrrant. Biol. 53, 789-798. Ballard, D., Bohnlein, E., Lowenthal, J., Wano, Y., Franza, R., and Greene, W. (1988). Science 241, 1652-1655. Ballard, D., Dixon, R., Peffer, N., Bogerd, H., Doerre, S., Stein, B., and Greene, W. (1992).Proc. Natl. Acad. Sci. USA 89, 1875-1879. Banerji, S., Parsons, J., and Tocci, M. (1991). M o l . Cell. Biol. 11, 4074-4087. Baumann, H., and Caddie, J. (1994). Immunol. Today, 74, 74-80. Beg, A,, and Baldwin, A. (1993). Genes Del;. 7,2064-2070. Beg, A,, Finco, T.,.Nantermet, P., and Baldwin, A. (1993).M o l . Cell. Biol. 13,3301-3310. Beg, A,, Ruben, S., Scheinman, R., Haskill, S., Rosen, C., and Baldwin, A. (1992).Genes Deo. 6, 1899-1913. BCraud, C., Sun, S.-C., Ganchi, P., Ballard, D., and Greene, W. C. (1993).M o l . Cell. Biol. 14, 1374-1382. Berkhout, B., and Jeang, K-T. (1992).J . Virol. 66, 139-149. Betts, J. C., Cheshire, J. K., Akira, S., Kishimoto, T., and Woo, P. (1993).J . B i d . Chem. 268,25624-25631. Bhatia, K., Huppi, K., McKeithan, T., Siwarski, D., Mushinski, J., and Magrath, I. (1991). Oncogetie 6, 1569-1573. Blank, V., Kourilsky, P., and Israel, A. (1992). TIBS 17, 135-140. Bohnlein, E., Siekevitz, M., Ballard, D., Lowenthal, J., Rimsky, L., Bogerd, H., Hoffman, J.. Wano, Y., Franza, B., and Greene, W. (1989).J . V i r d . 63, 1578-1586.
22
ELIZABETH B. KOPP A N D SANKAR GHOSH
Bours, V., Burd, P., Brown, K., Villalobos, J., Park, S., Ryseck, R., Bravo, R., Kelly, K., and Siebenlist, U. (1992). Mol. Cell. Biol. 12, 685-695. Bours, V., Franzoso, G., Azarenko, V., Park, S., Kanno, T., Brown, K., and Siebenlist, U. (1993). Cell 72, 729-739. Bours, V., Villalobos, J., Burd, P., Kelly, K., and Siebenlist, U. (1990).Nature 348,76-80. Brasier, A. R., Ron, D., Tate, J. E., and Habener, J. F. (1990). EMBOJ. 9, 3933-3944. Brorson, K., Beverly, B., Kang, S-M., Lenardo, M., and Schwartz, R. (1991).J.Zmmunol. 147,3601-3609. Brouckaert, P., and Libert, C. (1993). In “Acute Phase Proteins Molecular Biology, Biochemistry, and Clinical Applications” (I. Kushner, A. Mackiewicz, and H. Baumann, Eds.), pp. 329-342. CRC Press, Boca Raton, FL. Brown, A., Linhoff, M., Stein, B., Wright, K., Baldwin, A., Basta, P., and Ting, J. (1994). Mol. Cell. Biol. 14, 2926-2935. Brown, K., Park, S., Kanno, T., Franzoso, G., and Siebenlist, U. (1993).Proc. Natl. Acad. Sci. USA 90,2532-2536. Brownell, E., Mittereder, N., and Rice, N. (1989). Oncogene 4,935-942. Collart, M., Baeuerle, P., and Vassalli, P. (1990). Mol. Cell. Biol. 10, 1498-1506. Colten, H., and Ravetch, J. (1992). Curr. Opinion Zmmunol. 4, 1-2. Cross, S., Halden, N., Lenardo, M., and Leonard, W. (1989). Science 244,466-469. Darlington, G., Wilson, D., and Juan, T. (1993). In “Acute Phase Proteins Molecular Biology, Biochemistry, and Clinical Applications” (I. Kushner, A. Mackiewicz, and H. Baumann, Eds.), pp. 425-442. CRC Press, Boca Raton, FL. Davis, N., Ghosh, S., Simmons, D., Tempst, P., Liou, H.-C., Baltimore, D., and Bose, H. (1991). Science 253, 1268-1271. Dbaibo, G., Obeid, L., and Hannun, Y. (1993).J. Biol. Chem. 268, 17762-17766. Degitz, K., Lian-Jie, L., and Caughman, S. (1991).J. Biol. Chem. 266, 14024-14030. de Martin, R., Vanhove, B., Cheng, Q., Hofer, E., Csizmadia, V., Winkler, H., and Bach, F. (1993).EMBO J. 12,2773-2779. Dendorfer, U., Oettgen, P., and Libermann, T. (1994). Mol. Cell. Biol. 14,4443-4454. Depper, J., Leonard, W., Kronke, M., Waldmann, T., and Greene, W. (1984).J.Zmmunol. 133, 1691-1695. Doerre, S., Sista, P., Sun, S-C., Ballard, D., and Greene, W. (1993). Proc. Natl. Acad. Sci. USA 90, 1023-1027. Dressler, K., Mathias, S., and Kolesnick, R. (1992). Science 255, 1715-1718. Duh, E., Maury, W., Folks, T., Fauci, A., and Rabson, A. (1989). Proc. Natl. Acad. Sci. USA 86,5974-5978. Edbrooke, M., Burt, D., Cheshire, J., and Woo, P. (1989). Mol. Cell. Biol. 9, 1908-1916. Ensoli, B., Lusso, P., Schachter, F., Josephs, S., Rappaport, J., Negro, F., Gallo, R., and Wong-Staal, F. (1989).EMBO J. 8, 3019-3027. Finco, T., and Baldwin, A. (1993).J. Biol. Chenz. 268, 17676-17679. Folks, T., Clause, K., Justement, J., Rabson, A., Duh, E., Kehrl, J., and Fauci, A. (1989). Proc. Natl. Acad. Sci. USA 89, 23265-2368. Frantz, B., Nordby, E., Bren, G., Steffan, N., Paya, C., Kincaid, R., Tocci, M., O’Keefe, S., and O’Neill, E. (1994).EMBO J. 13, 861-870. Franza B., Josephs, S., Gilman, M., Ryan, W., and Clarkson, B. (1987). Nature 330, 391-395. Franzoso, G., Bours, V., Azarenko, V., Park, S., Tomita-Yamaguichi, M., Kanno, T., Brown, K., and Siebenlist, U. (1993). EMBOJ. 12, 3893-3901. Franzoso, G., Bours, V., Park, S., Tomita-Yarnaguchi, M., Kelly, K., and Siebenlist, U. (1992). Nature 359,339-342.
NF-KB AND REL PROTEINS IN INNATE IMMUNITY
23
Freimuth, W., Depper, J., and Nabel, G. (1989).J. Zrnrnunol. 143,3064-3068. Fujita, T., Miyamoto, M., Kiniura, Y., Hammer, J., and Taniguchi, T. (1989).Nucl. Acids Res. 17,3335-3346. Fujita, T., Nolan, G., Liou, H., Scott, M., and Baltimore, D. (1993). Genes D e v . 7, 1354-1363. Garcia, J., Wu, F., Mitsuyasu, R., and Gaynor, R. (1987).EMBOJ. 6, 3761-3770. Geisler, R., Bergmann, A., Hiromi, Y., and Niisslein-Volhard, C. (1992).Cell 71,613-621. Geng, Y., Chandran, B., Josephs, S., and Wood, C. (1992).J. Virol. 66, 1564-1570. Ghosh, S., and Baltimore, D. (1990). Nature 344, 678-682. Ghosh, S., Gifford, A., Riviere, L., Tempst, P., Nolan, G., and Baltimore, D. (1990).Cell 62, 1019-1029. Gilmore, T., and Morin, P. (1993).Trends Genet. 9,427-433. Gimhle, J., Duh, E., Ostrove, J., Gendelman, H., Max, E., and Rabson, A. (1988). J . Virol. 62, 4104-4112. Gootenberg, J., Ruscetti, F., Mier, J., Gazdar, A., and Gallo, R. (1981).]. E x p . Med. 154, 1403-14 18. Griffin, C . . Leung, K., Folks, T., Kunkel, S., and Nabel, G. (1989). Nature 339, 70-73. Grilli, M., Chiu, J J.-S., and Lenardo, M. (1993). Znt. Rev. Cytol. 143, 1-62. Gutsch, D., Holley-Guthrie, E., Zhang, Q., Stein, B., Blanar, M., Baldwin, A., and Kenney, S. (1994).Mol. Cell. B i d . 14, 1939-1948. Hammarskjold, M-L, and Simurda, M. (1992).J. Virol. 66, 6496-6501. Hansen, S . , Baeuerle, P., and Blasi, F. (1994). Mol. Cell. Biol. 14, 2593-2603. Harrich, D., Garcia, J., Mitsuyasu, R., and Gaynor, R. (1990).EMBOJ. 9, 4417-4423. Haskill, S., Beg, A,, Tompkins, S., Morris, J., Yurochko, A., Sampson-Johannes, A,, Mondal, K., Ralph, P., and Baldwin, A. (1992). Cell 65, 1281-1289. Hatada, E., Nauniann, M., and Scheidereit, C. (1993). EMBO J. 12, 2781-2788. Hatada, E., Nieters, A,, Wulczyn, F., Nauniann, M., Meyer, R., Nucifora, G., McKeithan, T., and Scheidereit, C. (1992). Proc. Natl. Acad. Sci. USA 89, 2489-2493. Hazan, U., Thomas, D., Alcami, J., Bachelerie, F., Israel, N., Yssel, H., Virelizier, J-L., and Arenzana-Seisdedos, F. (1990).Proc. Natl. Acad. Sci. USA 87, 7861-7865. Hemar, A,, Cereghini, S., Cornet, V., Blank, V., Israel, A., Greene, W., and DautryVarsat, A. (1991).J. Inmunol. 146, 2409-2416. Henkel, T., Machleidt, T., Alkalay, I., Kronke, M., Ben-Neriah, Y., and Baeuerle, P. (1993).Nature 365, 182-185 Henkel, T., Zabel, U., van Zee, K., Miiller, J., Fanning, E., and Baeuerle, P. (1992). Cell 68, 1121-1133. Hirai, €I.,Suzuki, T., Fujisawa, J.-I., Inoue, J.-I., and Yoshida, M. (1994). Proc. Natl. Acad. S c i . USA 91,3584-3588. Hiscott, J., Alper, D., Cohen, L., LeBlanc, J.-F., Sportza, L., Wong, A,, and Xanthoudakis, S. (1989).J . Virol. 63, 2557-2566. Hiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., LaCoste, J.. Nguyen, H., Bensi, C., and Fenton, M. (1993). Mol. Cell. Biol. 13 6231-6240. Hohniann, H-P., Brockhaus, M., Baeuerle, P. A., Reniy, R., Kolbeck, R., and van Loon, A. (1990a).J. B i d . Cheni. 265, 22409-22417. Hohniann, H-P., Remy, R., Pbschl, B., and van Loon, A. (1990b).J . Biol. Chein. 265, 15183- 15188. Horvat, R., Wood, C., Josephs, S., and Balachandran, N. (1991).J. Virol. 65,2895-2902. Hoyos, B., Ballad, D., Bohnlein, E., Siekevitz, M., and Greene, W. (1989).Science 244, 457-460.
24
ELIZABETH R. KOPP AND SANKAR GHOSH
Hultmark, D. (1994). Nature 367, 116-117. Inoue, J., Kerr, L., Kakizuka, A,, and Verma, I. (1992a). Cell 68, 1109-1120. Inoue, J.-I., Ken, L., Rashid, D., Davis, N., Bose, H., and Verma, I. (1992b). Proc. Natl. Acad. Sci. USA 88,3715-3719. Inoue, J., Takahara, T., Akizawa, T., and Hino, 0. (1993).Oncogene 8, 2067-2073. Ip, Y., Reach, M., Engstrom, Y., Kadalayil, L., Cai, H., GonzAlez-Crespo, S., Tatei, K., and Levine, M. (1993).Cell 75, 753-763. Israel, A,, Le Bail, O., Hatat, D., Piette, J,, Kieran, M., Logeat, F., Wallach, D., Fellous, M., and Kourilsky, P. (1989). E M B O J . 8,3793-3800. Israel, N., Gougerot-Pocidalo, M-A., Aillet, F., and Virelizier, J-L. (1992).J. Immunol. 149,3386-3393. Ivanov, V., Merkenschlager, M., and Ceredig, R. (1993).J. Immunol. 151,4694-4704. Jeang, K-T., Shank, P., and Kumar, A. (1988).Proc. Natl. Acad. Sci. USA 85,8291-8295. Kaltschmidt, C., Kaltschmidt, B., Neumannn, H., Wekerle, H., and Baeuerle, P. (1994). M o l . Cell. Biol. 14, 3981-3992. Kang, S-M., Tran, A-C., Grilli, M., and Lenardo, M. (1992).Science 256, 1452-1456. Kaufman, J., Valandra, G., Roderiquez, F., Bushar, G, Giri, C., and Norcross, M. (1987). M o l . Cell. Biol. 7, 3759-3766. Kerr, L., Duckett, C., Wamsley, P, Zhang, Q., Chiao, P., Nabel, G., McKeithan, T., Baeuerle, P., and Verma, I. (1992). Genes Deu. 6, 2352-2363. Kidd, S. (1992). Cell 71, 623-635. Kieran, M., Blank, V., Logeat, F., Vandekerckhove, J., Lottspeich, F., LeBail, O., Urban, M., Kourilsky, P., Baeuerle, P., and Israel, A. (1990). Cell 62, 1007-1018. Kishimoto, T., Taga, T., and Akira, S. (1994). Cytokine signal transduction. Cell 76, 253-262. Koj, A., Gauldie, J., and Baumann, H. (1993). In “Acute Phase Proteins Molecular Biology, Biochemistry, and Clinical Applications” (I. Kushner, A. Mackiewicz, and H. Baumann, Eds.), pp. 277-278. CRC Press, Boca Raton, FL. Kolesnick, R., and Golde, D. (1994). Cell 77, 325-328. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., and Kohler, G. (1994). Nature 368,339-342. Kopp, E., and Ghosh, S. (1994). Science, 258,956-959. Kumar, A., Haque, J., Lacoste, J., Hiscott, J., and Williams, B. (1994). Proc. Nutl. Acad. Sci. USA 91,6288-6292. Kunsch, C., and Rosen, C . (1993). M o l . Cell. Biol. 13, 6137-6146. Kunsch, C., Ruben, S., and Rosen, C. (1992). M o l . Cell. Biol. 12,4412-4421. Kushner, I., and Mackiewicz, A. (1993). In “Acute Phase Proteins: Molecular Biology, Biochemistry, and Clinical Applications” (I. Kushner, A. Mackiewicz, and H. Baumann, Eds.), pp. 3-19. CRC Press, Boca Raton, FL. LaCoste, J.. D’Addario, M., Roulston, A,, Wainberg, M., and Hiscott, J. (199O).J.Virol. 64,4726-4734. Le Bail, O., Schmidt-Ullrich, R., and Israel, A. (1993). EMBOJ. 12, 5043-5049. LeClair, K., Blanar, M., and Sharp, P. (1992). Proc. Natl. Acad. Sci. USA 89,8145-8149. Lenardo, M., and Baltimore, D. (1989). Cell 58, 227-229. Lenardo, M., Fan, C., Maniatis, T., and Baltimore, D. (1988).Proc. Natl. Acad. Sci. USA 85,8825-8829. Lenardo, M., Pierce, J., and Baltimore, D. (1987). Science 236, 1573-1577. Leonard, J., Parrott, C., Buckler-White, A., Turner, W., Ross, E., Martin, M., and Rabson, A. (1989).J . Virol. 63,4919-4924. Lernbecher, T., Muller, U., and Wirth, T. (1993). Nature 365, 767-770.
NF-KB AND REL PROTEINS IN INNATE IMMUNITY
25
Leung, K., and Nahel, G. (1988). Nature 333, 776-778. Li, C-C., Ruscetti, F., Rice, N., Chen, E., Yang, N-S., Mikovits, J., and Longo, D. (1993). J . Virol. 67,4205-4213. Li, M., and Siekevitz (1993).Mol. Cell. Biol. 13, 6490-6500. Libermann, T., and Baltimore, D. (1990). Mol. Cell. Biol. 10, 2327-2334. Lilienbaum, A., And Paulin, D. (1993).J . Biol. Chem. 268, 2180-2188. Lindholm, P., Marriott, S., Gitlin, S.,Bohan, C., and Brady, J. (1990).New Biologist 2, 1034- 1043. Lindholm, P., Reid, R., and Brady, J. (1992).J . Virol. 66, 1294-1302. Liou, H.-C., Nolan, G., Ghosh, S., Fujita, T., and Balitmore, D. (1992). E M B O J . 11, 3003-3009. Liu, J . , Perkins, N., Schmid, R., and Nahel, G. (1992).J . Virol. 66, 3883-3887. Lowenthal, J., Ballard, D., Bogerd, H., Bohnlein, E., and Greene, W. (1989a).J.Zmrnunol. 142,3121-3128. Lowenthal, J., Ballard, D., Bohnlein, E., and Greene, W. (1989b).Proc. N n t l . Acad. Sci. USA 86,2331-2335. LUSSO,P., Ensoli, B., Markham, P., Ablashi, D., Salahuddin, S.,Tschachler, E., WongStaal, F., and Gallo. R. (1989). Nature 337, 370-373. Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., and Akira, S. (1993).Proc. Natl. Acud. Sci. USA 90, 10193-10197. Matsuyama, T., Hamamoto, Y., Soma, G-I., Mizuno, D., Yamanioto, N., and Kohayashi, N. (1989).J . Virol. 63, 2504-2509. Meichle, A., Schiitze, S . , Hensel, G., Brunsing, D., and Kronke, M. (199O).J.Biol. Chem. 265,8339-8343. Mercurio, F., Didonato, J., Rosette, C., and Karin, M . (1992).DNA Cell. B i d . 11, 523537. Meyer, R., Hatada, E., Hohmann, H.-P., Haiker, M., Bartsch, C., Rothlisherger, U., Lahm, H.-W., Schlaeger, E., van Loon, A., and Scheidereit, C. (1991). Proc. Natl. Acud. Sci. USA 88,966-970. Michael, N., Vahey, M., D'Arcy, L., Ehrenberg, P., Mosca, J., Rappaport, J., and Redfield, R. (1994).J . Virol. 68, 979-987. Muchardt, C., Seeler, J-S.,Nirula, A , , Shurland, D-L., and Gaynor, R. (1992).J . Virol. 66,244-250. Muesing, M., Smith, D., and Capon, D. (1987).Cell 48, 691-701. Mukaida, N., Mahe, Y., and Matsushima, K. (1990).J . B i d . Chern. 265, 21182-21133. Nabel, G. (1991). Nature 350, 658. Nabel, G., and Baltimore, D. (1987). Nature 326, 711-713. Naumann, M., Wulczyn, C . , and Scheidereit. (1993).E M B O J . 12,213-222. Neish, A,, Williams, A , , Palmer, H., Whitley, M., and Collins, T. (1992).J . E x p . Med. 176, 1583-1593. Neri, A,, Chang, C.-C., Lombardi, L., Salina, M., Corradini, P., Maiolo, A., Chaganti, R., and Dalla-Favera, R. (1991).Cell 67, 1075-1087. Nolan, G., Fujita, T., Bhatia, K., Huppi, K., Liou, H.-C., Scott, M., and Baltimore, D. (1993).21101. Cell. B i d . 13, 3557-3566. Nolan, G., Ghosh, S., Liou, H.-C.,Tempst, P., and Baltimore, D. (1991).Ce1/64,961-969. Nonaka, M., and Huang, Z.-M. (1990).Mol. Cell. B i d . 10, 628343289. Ohno, H., Takimoto, G., and McKeithan, T. (1990).Cell 60, 991-997. Oshorn, L., Kunkel, S., and Nabel, C. J. (1989).Proc. Nut/.Acad. Sci. USA 86,2336-2340. Parrott, C., Seidner, T., Duh, E., Leonard, J., Theordore, T., Buckler-White, A., Martin, M., and Hahson, A. (1991).J.Virol. 65, 1414-1419.
26
ELIZABETH B. KOPP AND SANKAR GHOSH
Paul, N., Lenardo, M., Novak, K., Sam, T., Tang, W-L., and Ruddle, N. (199O).J.Virol. 64,5412-5419. Paya, C., Ten, R., Bessia, C., Alcami, J., Hay, R., and Virelizier, J-L. (1992). Proc. Natl. Acad. Sci. USA 389, 7826-7830. Perkins, N., Edwards, N., Duckett, C., Agranoff, A., Schmid, R., and Nabel, G. (1993). EMBO J. 12,3551-3558. Pessara, U., and Koch, N. (1990). Mol. Cell. Biol. 10,4146-4154. Pomerantz, J., Mauxion, F., Yoshida, M., Greene, W., and Sen, R. (1989).J. Zmmunol. 143,4275-4281. Ron, D., Brasier, A., Wright, K., and Hebener, J. (1990). Mol. Cell. Biol. 10,4389-4395. Rosen, C . , Sodroski, J., and Haseltine, W. (1985). Cell 41,813-823. Ross, E., Buckler-White, A., Rabson, R., Englund, G., and Martin, M. (1991).J. Virol. 65,4350-4358. Roulston, A,, Beauparlant, P. Rice, N., and Hiscott, J. (1993).J. Virol. 67, 5235-5246. Ruben, S., Dillon, P., Schreck, R., Henkel, T., Chen, C., Maher, M., Baeuerle, P., and Rosen, C. (1991). Science 251, 1490-1493. Ruben, S., Poteat, H., Tan, T.-H., Kawakami, K., Roeder, R., Haseltine, W., and Rosen, C . (1988).Science 241,89-92. Ryseck, R.-P., Bull, P., Takamiya, M., Bours, V., Siebenlist, U., Dobrzanski, P., and Bravo, R. (1992). M o l . Cell. B i d . 12, 674-684. Schmid, R., Perkins, N., Duckett, C., Andrews, P., and Nabel, G. (1991). Noture 352, 733-736. Schreck, R., Meier, B. Mammel, D., Drage, W., and Bauerle, P. (1992). J. E x p . Med. 175, 1181-1194. Schreck, R., Rieber, P., and Baeuerle, P. (1991). EMBOJ. 10, 2247-2258. Schiitze, S., Potthoff, K., Machleidt, T., Berkovic, D., Wiegmann, K., and Kronke, M. (1992). Cell 71,765. Scott, M., Fujita, T., Liou, H.-C., Nolan, G., and Baltimore, D. (1993). Genes Deo. 7, 1266-1276, Sen, R., and Baltimore, D. (1986a). Cell 46, 705-716. Sen, R., and Baltimore, D. (1986b). Cell 47, 921-928. Serfling, E, Balthelmas, R., Peuffler, I., Schenk, B., Zarius, S., Swoboda, R. Mercurio, F., and Karin, M. (1989).EMBO J. 8,465-473. Shimizu, H., Mitomo, K., Watanabe, T., Okanioto, S., and Yamamoto, K-I. (1990). Mol. Cell. Biol. 10, 561-568. Shirakawa, F., and Mizel, S. (1989). Mol. Cell. Biol. 9, 2424-2430. Shu, H., Agranoff, A., Nabel, E., Leung, K., Duckett, C., Neish, A., Collins, T., and Nabel, G. (1993). Mol. Cell. B i d . 13, 6283-6289. Siekevitz, M., Josephs, S., Dukovich, M., Peffer, N., Wong-Staal, F., and Greene, W. C. (1987). Science 238, 1575-1578. Staal, F., Roederer, M., and Herzenberg, L. (1990).Proc. Natl. Acad. Sci. USA 87,99349947. Steel, D., and Whitehead, A. (1994). Zmmunol. Today 15, 81-88. Stein, B., and Baldwin, A. (1993). Mol. Cell. Biol. 13, 7191-7198. Stein, B., Cogswell, P., and Baldwin, A. (1993). Mol. Cell. Biol. 13, 3964-3974. Stephens, R., Rice, N., Hiebsch, R., Bose, H., and Gelden, R. (1983). Proc. Natl. Acad. Sci. USA 80,6229-6232. Steward, R. (1987). Science 238, 692-694. Sun, S-C., Ganchi, P., Ballard, D., and Greene, W. (1993). Science 259, 1912-1915. Sun, S-C., And Faye, I. (1992). Comp. Biochem. Physiol. B103,225-233.
NF-KB AND REL PROTEINS IN INNATE IMMUNITY
27
Suzan, M., Salaun, D., Neuveut, C., Spire, B., Hirsch, I., Le Bouteiller, P., Querat, G., and Sire, J. (1991).J. Zmmunol. 146, 377-383. Tewari, M., Dobrzanski, P., Mohn, K., Cressman, D., Hsu, J.-C., Bravo, R., and Taub, R. (1992).M o l . Cell. Biol. 12, 2898-2908. Thanos, D., and Maniatis, T. (1992). Cell 71, 777-789. Tong-Starksen, S . , Luciw, P., and Peterlin, M. (1987).Proc. N u t / . Acad. Sci. USA 84, 6845-6849. Urban, M., and Baeuerle, P. (1990).Genes Det;. 4, 1975-1984. Urban, M., Schreck, R., and Baeuerle, P. (1991).E M B O J . 10, 1817-1825. Van Snick, J . (1990).Annu. Reo. Zniti~unol.8, 253-278. Visvanathan, K., and Goodbourn, S. (1989). EMBO J . 8, 1129-1 138. Vlach, J., and Pitha, P. (1993).J. Virol. 67, 4427-4431. Vlach, J., and Pitha, P. (1992).J . Virol. 66, 3616-3623. Waldmann, T., Greene, W., Sarin, P., Saxinger, C., Blayney, D., Blather, W., Goldman, C. Bongiovanni, K., Sharrow, S., Depper, J . , Leonard, W., Uchiyania, T., and Gallo, R. (1984).J.Clin. Znoest. 73, 1711-1718. Wano, Y., Feinberg, M., Hosking, J., Bogerd, H., and Greene, W. (1988). Proc. N u t / . Acad. Sci. USA 85,9733-9737. Watanabe, M., hlurarnatsu, M., Hirai, H., Suzuki, T., Fujisawa, J., Yoshida, M., Arai, K., and Arai, N . (1993). Oncogene 8, 2949-2958. Weigniann, K., Schiitze, S., Kampen, E., Hininiler, E., hlachleidt, T., and Kriinke, M . (1992).J . B i d . Chem. 267, 17997-18001. Weissrnann, G. (1991). Sci. Am., January, 84-90. Whelan, J., Ghersa, P., van Huijsduijnen, R., Gray, J., Chandra, G.. Talabot, F., and DeLainarter, J. (1991).Nucl. Acids Res. 19, 2645-2653. Wilhelmsen, K., Eggleton, K., and Ternin, H. (1984).J. Virol. 52, 172-182. Wong, G. G., and Clark, S. C. (1988). I m m u d . Toduy 9, 137-139. Yanaga, F., and Watson, S. (1992). F E E S Lett. 314, 297-300. Yang, Z., Costanzo, M., Golde, D., and Kolesnick, R. (1993).J. Biol. Chem. 268, 20520-20523. Yasumoto, K., Okamoto, S-i., Mukaida, N., Murakanii, S., hlai, M., and Matsushima, K. (1992).J . B i d . Chem. 267, 22506-22511. Zabel, U., and Baeuerle, P. (1990).Cell 61, 255-265. Zabel, U., Henkel, T., dos Santos Silva, M., and Baeuerle, P. (1993). EMBO J . 12, 20 1-21 1 . Zhang, Y., Didonato, J., Karin, M., and McKeithan, T. (1994). Mol. Cell. B i d . 14, 3915-3926. Zhang, Y., Lin, J-X., and Vilcek, J. (1990). Mol. Cell. B i d . 10, 3818-3823. Ziegler-Heitbrock, H., Sternsdorf, T., Liese, J . , Belohradsky, B., Weber, C., Wedel, A., Schreck, R., Bguerle, P., and Strobel, M. (1993).J . l m n ~ u n o l151, . 6986-6993.
ADVANCES IN lMMUNOLOGY, VOL 58
V(D)J Recombination and Double-Strand Break Repair David T. Weaver Division of Tumor Immunology, Dana-Farber Cancer Institute, and Department of Microbiology and Molecular Genetics, Harvord Medical School, Boston, Massachusetts 021 15
I.
Introduction
11. The V(D)J Recombination Mechanism 111. Joining Mechanisms
Genes Involved in DSB Repair and V(D)J Recombination The Ku Autoantigen Human Immunodeficiency and DNA Repair Syndromes ImmunodeficiencylDNA Repair Syndromes Affecting Cell Cycle Checkpoint Mechanisms VIII. Cell Cycle Regulation of V(D)J Recombination and DSB Repair References IV. V. VI. VII.
29 30 39 45
55 62 66 70 74
1. Introduction
The immune system relies on site-specific recombination (V(D)J recombination) for the formation of Ig and TCR genes, the primary antigen-recognition molecules. This complex rearrangement pathway has been investigated on the level of its DNA requirements and the identification of necessary proteins. Mutations in several genes and/ or activation of the mechanism in nonlymphoid cells have identified key players in V(D)J recombination. Some of these factors are lymphoid restricted, but others are ubiquitous and also utilized in DNA repair pathways. Mutations in four complementation groups have the combined defects of V(D)J recombination deficiency, sensitivity to ionizing radiation (IR), and double-strand break repair (DSB repair) deficiency. A subset of human DNA repair syndromes may be relevant to the connection between DNA repair and V(D)J recombination via a DNA damage signal transduction pathway. DNA damage-induced cell cycle arrest is a likely mechanism to monitor V(D)J recombination completion and accuracy. Mutations in cell cycle checkpoints are associated with increased cancer susceptibility, especially in lymphoid tissues . 29 Copyright 0 1995 by Academic Prrs*, Inr. A11 rights 111 reproduction in any form rrsrrvrd.
30
DAVID T. WEAVER
II. The V(D)J Recombination Mechanism
The notion that genes rearrange somatically to facilitate immune cell function originated with Tonegawa (Tonegawa, 1983). Since this seminal observation, an extensive investigation of this recombination pathway has ensued. Previous excellent reviews have documented the developmental regulation of V(D)J recombination, the pathway with regard to putative DNA intermediates, and the protein components (Gellert, 1992a,b; Lieber, 1991; Lewis and Gellert, 1989; Schatz et al., 1992; Oettinger, 1992; Alt et al., 1992). Here, I will concentrate on the reaction pathway as it compares with DSB repair. In the ranks of recombination mechanisms V( D)J rearrangement is an illegitimate pathway because the rearranging DNA is not conserved between the substrates and the products of the reaction. This key observation makes the pathway mechanistically intriguing. The principle of junctional variation generated by rearrangement also forms an essential component for antibody and TCR diversity. For simplicity, the discussion of the rearrangement pathway has been divided into two phases: cleavage and joining. Recent advances have offered potential intermediates for the reaction and better described the processes between cleavages and recombination products. Following cleavages, the joining steps bear striking similarities to DNA repair processes. These similarities may include common features of synapsis, processing, and ligation with chromosomal damage or DSB repair.
A. INITIATING V(D)J RECOMBINATION V(D)J recombination is a site-specific process normally restricted to
B and T cell progenitors. Significant progress has occurred toward
proving that the onset of chromosomal gene rearrangements in lymphoid development is regulated by transcription factor assembly and methylation status in cis. The strategy has been to examine several cis-acting sites for enhancer element binding and/or recombinase interaction. Several recent studies with transgenic mice containing knockout mutations of regions of the Ig heavy-chain enhancer, Ig JH, or downstream Ig enhancer elements have illustrated that these cis-acting elements are necessary for gene rearrangement (Kitamura et al., 1991; Chen et al., 1993; Takeda et al., 1993; Oltz et al., 1993).Homozygous mutations of any of these cis-acting elements lead to mice without gene rearrangement and an absence of B cells and Ig. Currently, no human immunodeficiency syndromes correlate with an absence of these elements by mutation. Because a lack of transcription factor binding sites or enhancer assembly elements in the Ig locus can create
V(D)J RECOMBINATION A N D DOUBLE-STRAND BREAK REPAIR
31
immunodeficiency in mouse models, it may also be expected that immunodeficiency diseases may arise where transcription factors are missing. Murine models with transcription factor deficiencies are forthcoming, but a characterization of the syndromes is likely to be complicated by the utilization of these proteins in other tissues and transcription units. The DNA requirements of the reaction have been easiest to examine because of the vast number of independent gene rearrangement events available (see GenBank entries for most complete and up-to-date listing). Also, the advent o f a transient transfection system for monitoring V(D)J rearrangement has made the manipulation of substrate molecules extremely useful. These two experimental strategies provide a means to document the products and substrate parameters for efficient rearrangement. Two cassettes of recombination signal sequences (RSS) are required for V(D)J recombination. Each Ig or TCR gene segment that has been observed to undergo rearrangement i n vivo contains one RSS at its 3' or 5' border. Each RSS is composed of a highly conserved heptamer and a less-conserved nonamer (Fig. 1). The consensus heptamer (CACAGTC) is palindromic and separated from the nonamer by a spacer region in one of two ways. RSS-12 contain a 12-bp spacer and RSS-23 contain a 23-bp spacer. One each of RSS-12 and RSS-23 is needed to signal V(D)J rearrangement, and these are the only essential elements for the reaction (Gellert, 1992a; Akira et al., 1987).Variations in spacer length reduce or eliminate recombination frequency in transient transfection assays in pre-B cell lines (Hesse et al., 1989). Although the spacer sequences are not random, there is also not any strict nucleotide position requirements for this intervening region (Ramsden et al., 1994). In contrast, the heptamer is relatively invariant with close to 100%conservation of the first three residues (CAC----) between all vertebrates examined. The other four residues (---AGTG)
V
5
/
CACAGTG-12-
ACAAAAACC
J
\
GGTTTTTGT-23-CACTGTG 3
FIG.1. Recornhination signal sequence (RSS). Each V, D, and J gene element is flanked by an RSS consisting of a highly conserved palindromic heptamer separated by a spacer from a conserved nonamer. Spacers of either 12 or 23 b p are used together. Triangles of different stippling represent RSS-12 and RSS-23, respectively.
32
D A V I D T. WEAVER
are conserved at the level of 76437% (see Gellert, 1992a for more details). The molecular features of the recombination products are instructive in delineating mechanism steps. Because the two DNA products are so distinctly different, the joining pathway must diverge at some point following cleavages that initiate rearrangement. Chromosomal signal joints are formed by the precise fusion of the two RSS. Signal joints have been observed from in vivo rearrangements in which the orientation of the gene segments dictates an inversional recombination path rather than deletion. Similarly, recombination templates, such as integrating retroviruses or plasmid transient transfection assays, have also demonstrated that the primary RSS product of gene rearrangements is a fusion without loss or addition of nucleotides. Insertion or deletion of nucleotides is detectable at these junctions, but only considerably less frequently (Lieber et at., 1988b; Boubnov et al., 1994a). The protein requirements for the initiation mechanism are only partly defined. The RAGl and RAG2 genes were cloned based on a functional complementation screen for induction of DNA rearrangement in nonlymphoid fibroblasts (Schatz and Baltimore, 1988; Schatz et al., 1989; Oettinger et al., 1990). Introduction of RAGl and RAG2 into any normal cell type is sufficient to drive V(D)J recombination of cotransfected plasmid substrates (Oettinger et al., 1990). RAG1 and RAG2 are primarily expressed in lymphoid progenitor cells, consistent with the timing of V(D)J recombination (reviewed by Oettinger et al., 1990).Homozygous knockout mutations of either RAGl or RAG2 eliminate all V(D)J recombination, creating immunodeficient mice (Shinkai et al., 1992; Mombaerts et al., 1992). RAG1 and RAG2 may be sufficient to initiate V(D)J recombination, but the biochemistry of how these proteins function is still developing. It has not yet been demonstrated that either RAGl andlor RAG2 are associated with any strand cleavage or strand transfer reactions. Additional proteins may be required to initiate V(D)J recombination to facilitate the action of RAGl and RAG2. RAGl and RAG2 could also potentially be involved in joining steps, but this is becoming increasingly unlikely. Several activities identified by binding to RSS have been discovered and recently reviewed (Gellert, 1992a). Proteins of this type may be used to recognize RSS and assemble recombinase complexes. B. DSB INTERMEDIATES IN V(D)J RECOMBINATION?
A number of observations implicate double-stranded broken ends of DNA as intermediate structures for V(D)J recombination. The cut sites for V(D)J recombination are likely to occur at the borders of RSS
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
33
heptamers where coding sequence from V, D, or J elements is found. This conclusion has been substantiated by extensive DNA sequencing of gene rearrangements. The RSS junctions themselves are consistent with strand breaks immediately next to the heptamers. Although cleavages at RSS borders may be DSBs, staggered breaks could also be the primary cleavages, where one of the two strand scissions occurs at the heptamer border. Coding sequence junctions, although variable between independent events, are similarly consistent with a sitespecific double-strand break model. New findings suggest that both RSS ends and coding ends pass through double-strand break intermediates in the pathway. RSS ends of TCR 6 rearrangements accumulate in thymocytes sufficiently so that recombination-associated broken DNA of particular configuration can be characterized by Southern blot analysis (Roth et al., 1992a). RSS ends, and not corresponding coding ends, are preferentially seen. More sensitive assays involving the ligation of double-strand broken genomic DNA to oligonucleotide primers for PCR (ligation-mediated PCR, LMPCR) have been recently used (Schlissel et al., 1993; Roth et al., 1993). Free RSS ends can be observed from primary thymocytes, bone marrow, or fetal liver, the most abundant tissue sources of lymphoid gene rearrangement events. RSS ends of J or D elements from the less complex gene rearrangement families were scored. Also, RSS ends from Abelson murine leukemia virus-transformed pre-B cell lines have also been identified for Ig V-JKrearrangements (Schlissel et al., 1993). Thus, RSS ends are a consistent feature of many, and possibly all, of the gene rearrangement families. RSS ends are associated with gene rearrangement because they are not detected in RAG1 -I- knockout mouse lymphoid tissues (Schlissel et al., 1993). It is not yet clear why the RSS ends are preferentially detectable. Perhaps the rate of joining of the “nonessential” RSS junctions discarded from the chromosome is slower than that for coding junctions. Using LMPCR, a more detailed picture of the structure of the RSS ends has also been uncovered (Schlissel et al., 1993; Roth et al., 1993; Fig. 2A). The 5’ RSS strands retain a 5’-phosphate group (5‘-P-CACAGTG-3’) which was demonstrated by blocking of the utilization of oligonucleotides in ligation reactions by pretreatment of the genomic DNA with calf intestine phosphatase. A uniformity of end structures was shown using pairs of oligonucleotides differing by the extent of overlap at the ends. These experiments indicated that RSS ends are blunt ended immediately flanking the RSS heptamers. Considering the consistency with which blunt RSS ends form from primary tissues, it was concluded that RSS ends could well be the immediate products
34
DAVID T. WEAVER
A. Cleavage 5’ 3‘
I hairpin
p
e
OH
p
1 hairpin
FIG.2. Pathway of V(D)J recombination. (A) Initiation and cleavage steps of the mechanism. Recombination signal sequences (RSS) are shown as shaded triangles. One RSS containing a 12-bp spacer and one RSS containing a 23-bp spacer is used in the reaction. Protein-DNA intermediates are shown bridged by a phosphate (P) bond. (B) Resolution and joining steps of V(D)J recombination. Resolution of putative coding end hairpins is shown by positions of arrows. Two cases of “resolved’ hairpin ends are shown. Dark lines represent regions of same DNA sequence (DNA homology) between coding ends. Two examples of coding junction formation are illustrated: top, junction occurs in DNA homology; bottom, junction is formed outside of DNA homology. RSS end formation triangles represent RSS.
of cleavage reactions. It stands to reason that RSS ends may be the immediate precursors to RSS joints because they can b e directly ligated. However, it is not yet clear whether RSS ends are normal intermediates in the pathway or are by-products or dead-end products. The latter would not necessarily be informative concerning the mechanism.
V(D)J RECOMBINATION A N D DOUBLE-STRAND BREAK REPAIR
8.
35
Joining RSS ends:
Coding ends:
1 1
1
Deletion
N sddltlon Llgatlon
+
Fill-In
or
FIG.2. Continued
However, because these molecules have some of the anticipated features of V(D)J intermediates, it is tantalizing to speculate that they are involved in the pathway. Broken molecules from coding ends in the reaction have not been detectable by the above methodology (Schlissel et al., 1993).This may be due to a greater degree of heterogeneity amongst the ends, thus reducing the ability to detect any products. Heterogeneity of doublestrand broken coding ends is predicted in models for gene rearrangement. Alternatively, coding ends may be blocked, sequestered, and/or unligatable without processing. To address this issue, the same genomic DNA was pretreated with modifying enzymes prior to LMPCR with coding DNA. The combination of nuclease and DNA polymerase prior to LMPCR did not enhance the recovery and identification of coding ends. An additional explanation would be that coding ends are rapidly repaired in the recombination mechanism such that the short-lived cleavage products from these ends are difficult to detect.
36
DAVID T. WEAVER
In reality, both may be true: coding ends are unligatable without processing and not a stable form compared to RSS ends (see following sections). C. THE HAIRPINRESOLUTION MODELFOR P NUCLEOTIDE FORMATION
V( D)J recombination coding junction products are highly variable in nucleotide content, a consequence of the rearrangement mechanism. Both nucleotide addition and loss were frequently displayed in the products (Tonegawa, 1983). It has been estimated that greater than 95% of all coding junction products contain deletion (Lieber, 1991). Deletion is limited to an average of zero to six residues per coding segment. Therefore, the combined junctional loss of nucleotide is usually 10 b p or less. Coding ends that are not deleted have proved to be informative concerning the reaction. Undeleted coding ends are often associated with the retention of specific nucleotides that appear to be templated by the nucleotide composition of the coding ends. These residues, termed P ( palindrornic) nucleotides, are complementary to the terminal coding segment residues flanking the RSS prior to rearrangement. P nucleotides have been demonstrated from either or both of the RSS in individual reactions (Lafaille et al., 1989; McCormack et al., 1989). P nucleotide formation or retention is more abundant in early stage rearrangements than in developmentally late rearrangements. Tissuespecific and stage-specific variations may be dictated by processing activities rather than by whether or not P nucleotides serve as reaction intermediates. The size of P nucleotides is frequently one or two residues with longer P residues appearing in some TCR rearrangements; exceptionally long P nucleotides have been found for gene rearrangements from scid, V-3, and XR-I mutant cells in culture (see below). Also, sequence analysis of scid TCR rearrangements has revealed extended P nucleotides (Kienker, 1991; Schuler et al., 1991). Nearly all rearranging gene families and plasmid substrates for transient transfection have substantiated the general appearance of P nucleotides as part of the V(D)J mechanism. However, the average occurrence of these residues is on the order of 5% of coding joints (Meier and Lewis, 1993). Thus, the presence or absence of processing, or the level of processing, likely influences the detection of P nucleotides in coding joints. Regarding models for initiation of V(D)J recombination, cleavage events of the reaction may synthesize an intermediate that would be the precursor of P nucleotide formation. As such, hairpin-ended DNA
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
37
has been proposed as such an intermediate structure (Gellert, 1992b; Lieber, 1991) (Fig. 2B). With a hairpin as a DNA intermediate, coding ends with P nucleotides could be synthesized by the asymmetric cleavage of the hairpin. This process would generate a heterogeneous population of DNA ends at an intermediate stage prior to joining and may thus explain some of the heterogeneity of coding products. Several features of this model are consistent with DNA sequencing data of numerous coding joints. First, most P nucleotide-containing junctions have one or two nucleotides accounted for by a single coding end, indicating that cleavage of putative hairpins would occur near the ends. Thus, overhanging coding ends would usually be only 1 or 2 bp. The terminal residues of hairpins are not base paired due to their thermodynamic instability and may be structurally distinct and recognized by a specific factor(s). Second, measurement of rearrangement of the same sequences numerous independent times shows that the coding joint can include P nucleotides in only a fraction of the junctions. This property is consistent with an unselective resolution of a hairpin. A significant advance was made when hairpins associated with coding DNA sequences were observed in vivo for endogenous gene rearrangements. Roth et al. examined neonatal thymocyte genomic DNA for the appearance of chromosomal breaks associated with TCRG D-J rearrangements (Roth et al., 1992a,b). Scid mouse thymocytes showed an accumulation of broken DNA coding ends that were demonstrated to be hairpin terminated based on two dimensional native-alkaline gel electrophoresis (Roth et nl., 1992b). Hairpin forms do not accumulate in wild-type mouse thymocytes, but linear coding ends from the same genomic region are detectable at low levels. Hairpins associated with Ig, or TCRa or -p rearrangements were not observed. Also, hairpin DNA from rearrangement plasmid substrates following transient transfection into tissue culture cells has not been found (N. Boubnov and D. Weaver, unpublished data). Thus, the generality of hairpins as intermediates in V( D)J recombination is still not proven. Nevertheless, coding end hairpin intermediates of the reaction are thus far consistent with all experimental observations of the recombination reaction and its products. The hairpin model of P nucleotide formation has also gained recent experimental support from plasmid-based recombination assays. The composition of the coding DNA sequences immediately flanking the RSS influences the frequency of P nucleotide formation (Meier and Lewis, 1993; Boubnov et al., 1993). In these studies the composition of the terminal coding DNA sequences (10 bp or less) was the only
38
DAVID T. WEAVER
change in plasmid substrates. An explanation for this effect is that hairpins are processed in alternate ways depending on DNA sequence composition. Exclusively G/C coding ends, or coding ends with a high G/C content, show reduced processing and higher P nucleotide frequencies (Boubnov et al., 1993). Other nonrandom coding ends also show elevated P nucleotide frequencies but the rules for how these frequency levels are determined are unclear (Meier and Lewis, 1993). P nucleotides did not appear in signal junction products, suggesting that hairpin intermediates are not associated with RSS ends in the midst of the reaction. P nucleotides of longer lengths also form in response to the structure of the coding DNA (Meier and Lewis, 1993).
D. A V(D)J RECOMBINATIONCLEAVAGE MODEL V(D)J recombination cleavages are likely to occur in a two-step mechanism that generates an asymmetry between the newly formed coding end and RSS end intermediates. This model has been previously discussed (Lieber, 1991; Gellert, 1992b; Roth et al., 1993). From experimental observations, the RSS ends appear to be blunt ended with 5’ phosphoryl groups. Also, evidence has been generated that coding ends can accumulate as hairpins in scid thymocytes. Furthermore, DNA sequencing of gene rearrangement events shows the presence of P nucleotides in junctions, also consistent with a hairpin mechanism. With the caveat that neither of these structures has been proved as a reaction intermediate for V(D)J recombination biochemically, a compelling model for the cleavage mechanism can be outlined (Fig. 2A). Two cleavage mechanisms are currently consistent with the available data. In one model, DNA-protein intermediates form in a mechanism that is similar to A integration or resolvase site-specific recombination mechanisms [(Stark et al., 1992) and referenced in Roth et al., 1993; Fig. 2AI. This mechanism has been termed “asymmetric cleavage” by Roth et al. (1993). The initial RAGl/RAGe-induced strand breaks are probably single-strand breaks forming a DNA-protein intermediate on the coding end and a 3’-hydroxyl on the RSS end for the two RSS elements in the reaction. The break would occur immediately flanking the RSS on the 3’ strand. Either RAG1 or RAG2 would be the best candidates for the protein covalently bound to DNA at this stage. Hydrolysis of the phosphodiester bond opposite the DNAprotein intermediate would then be promoted, presumably by specific protein contacts in a synaptic complex. Coding end hairpins could then form by an interstrand nucleophylic attack on the DNA-protein phosphodiester bond. Following this cleavage, the two intermediates,
V(D)J RECOMBINATION A N D DOUBLE-STRAND BREAK REPAIR
39
hairpins and 5’-P-RSS ends, would form. An alternate possibility is that protein(s) may also be bound to RSS ends from the initial cleavages, but this was discounted by quantitation of the level of RSS ends (Roth et al., 1993).Thus, binding of protein to only two of the ends as shown may be found. An added benefit of this approach would be that hairpin formation may be favored in the next step, rather than precise sitespecific recombination. Covalently bound protein to all four phosphates would be more consistent with resolvase-type mechanisms, instead of A integrase pathways. If a protein-DNA covalent linkage is used in V(D)J recombination, then it is likely that this bond is via a serine residue in the protein. Tn3 resolvase-type protein-DNA bonds are all through serine residues as 5’ phosphodiester from the DNA; X integrase-type linkages are tyrosine linked to 3’ phosphodiester bonds from the DNA (Stark et al., 1992). Therefore, 5’-P-RSS ends are most consistent with resolvase-type linkages. In sum, potential DNA-protein linkages of V(D)J recombination appear to have some of the features of A integrase and resolvase strategies, possibly indicating that the mechanism wilI be unique. Further tests and refinements of this model will be necessary pending more experiments. In an alternative pathway, no DNA-protein intermediates would be required, and the cleavages would be formed by direct one-step esterification as for Mu transposition (Mizuuchi and Adzuma, 1991; Mizuuchi, 1992). There are no experimental data that are yet to distinguish among these mechanisms. 111. Joining Mechanisms
The mechanism by which joining occurs is dictated by the structures of cleavage products and/or other intermediates. Also, joining steps share extensive similarities to pathways for repairing DSBs in chromosomal DNA either arising spontaneously or induced by DNA damage. A. MICROHETEROGENEITY IN
FORMATION OF CODING JOINTS A striking property of all Ig and TCR gene rearrangements is the imprecision of coding junctions. This heterogeneity has been amply illustrated with the characterization of chromosomal gene rearrangements from lymphoid cells and recombination substrates in lymphoid and nonlymphoid cell culture. For any given V, D, or J element or any RSS, independent joining reactions yield variable deletion and addition of nucleotides in the joint. Thus, the extensive heterogeneity that occurs in the joining mechanism is largely independent of DNA sequence. The processing of these V(D)J coding ends prior THE
40
DAVID T. WEAVER
to joining combines both the addition of nucleotides and the loss of nucleotides. N-type nucleotide addition, attributable to the enzyme TdT, is observed in either the presence or the absence of P nucleotides in the junction. Also, N regions are found regardless of the extent of deletion, including abnormally large deleletions from rearrangements signaled in the presence of the scid mutation (Hendrickson et al., 1988; Malyn et aZ., 1988). Thus, N regions are probably added at a last step prior to ligation in the reaction. Because TdT is largely restricted in expression to specific lymphoid cell stages, it is unlikely to have general significance for the comparable mechanisms of nonhomologous recombination (see below). There are no DNA sequence requirements for codingjunction formation. Unlike strictly site-specific recombination mechanisms, any two DNA sequences can be joined together in V(D)J recombination. These observations would tend to suggest that the enzymology of this process is unique and potentially distinct from the protein requirements for initiation and cleavage. There is no information yet as to preferential use of processed ends in joinings steps in the reaction. Hairpins resolved on either strand by a single-stranded scission near the ends would generate P nucleotides of opposite strand polarity. No experiments have yet addressed whether 5' extended, 3' extended, or blunt ends are more likely to be repaired into coding junctions by the V(D)J recombination machinery. Highly G/C-rich coding ends may be either resilient to processing or have a tendency to cleave at their immediate termini creating blunt coding ends. For example, coding ends ofGloor Clohave a significantly reduced level of deletion (Boubnov et al., 1993). Because deletion is ordinarily observed for each coding end, a tentative conclusion would be that the rate of deletion is faster than the ability of DNA repair polymerases to fill-in gaps. Alternatively, protein contacts holding the recombination synapse together prior to ligation may actually exclude repair enzymes from doing their job. This may mean that repair events continue after the dissolution of the recombination synapse. B. MICROHOMOLOGY IN CODING JOINTS Several laboratories have found a restricted heterogeneity in junctional diversity between certain Ig or TCR V, D, and J gene elements. Characterization of the joints indicated that microhomology between the coding ends may be used in the joining reaction (Gu et al., 1990; Feeney, 1990,1992; Ichara et al., 1989; Feeney, 1991; Asarnow et al., 1989; Aguilar and Belmont, 1991).Small redundant homologies of 15 bp have been found more frequently at the breakpoint in coding
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
41
joints than would randomly occur. An issue left unresolved by these initial studies was whether immune cell-selection mechanisms may override the distribution or rearrangement products of the basal rearrangement machinery so that recombination products found in mature lymphoid tissues would be skewed by the selection. An indication that selective pressures were not in force was shown with V61-D62 and Vy6-Jy 1 nonproductive rearrangement junctions that showed a preponderance of invariant junctions, consistent with DNA homology sites from the two coding ends (Chien, 1987; Lafaille et al., 1989; Allison and Havran, 1991). Additional evidence for the use of microhomology has also come from recent studies with transgenic mice in which rearrangement of the transgene is scored. In each case the transgene does not produce a protein product so that there is no issue of selection following the rearrangement, but the same rearrangement events can be scored (Asarnow et al., 1993; Itohara et al., 1993). TCR CS-/- mice have a high degree of TCRy and S rearrangements that recruit short homologies in the coding junctions (Itohara et al., 1993). These animals cannot produce TCR y8 on the surface influencing cell-selection mechanisms. Likewise, introduction of frameshift mutations in Vy2,Vy4, and Vy3 obviated the protein production of their rearrangement products which showed an increased utilization of homology stretches (Asarnow et al., 1993). The most compelling examples of microhomology in junctions come from in uiuo gene rearrangements with genetically altered mice. TdT-/- knockout mice use D N A homology once TdT activity is not present. This experiment was done in two ways. TdT-/- somatic chimera mice were generated from RAG2-/- embryos (Komori et al., 1993). In this regimen all of the cells that populate the postrearrangement immune system come from embryonic stem cells with the TdT-/- genetic background (Chen et al., 1993). Alternatively, homozygous mutant TdT- / - mice were generated by breeding (Gilfillan et al., 1993). Gene rearrangements from both studies showed that untemplated N regions are not added in the absence of TdT. Second, the V(D)J coding ends frequently form at regions of microhomology, as illustrated by overlap residues that could have arisen from either coding end partner in the rearrangement (Komori et al., 1993; Gilfillan et al., 1993). These overlaps varied between one and five residues. These experiments are valuable as well because they allow the analysis of V(D)J recombination events in uiuo and at the lymphoid cell stages normally acting for each gene family. Transient transfection assays with recombination substrates have
42
DAVID T. WEAVER
not been so clear cut. In one study, a plasmid substrate with a 4-bp microhomology region located at coding ends gave coding joints in the 4-bp repeat 55% of the time in pre-B cells (Gerstein and Lieber, 1993). However, many of the recombination products observed did not utilize short stretches of D N A homology in the joint. Chinese hamster ovary fibroblasts from this study showed the use of DNA homology at a slightly lower frequency (33%). Alternatively, plasmid substrates with only two nucleotides of overlap between the coding ends are not apparently recruited to any greater extent than random (Boubnov et al., 1993; Gerstein and Lieber, 1993). Interestingly, each of these substrates has the two-nucleotide overlap internal to the coding end. Therefore, it is not clear whether the homology is recruited primarily because it is at the coding termini or because of its size. Because most of the in uivo gene rearrangements that have been implicated to utilize short terminal homology frequently only have 2 bp of overlap, there is a paradoxical difference between these findings. Also, extensive homology of 5-10 b p does not increase the recombination frequency (Boubnov et al., 1993). Perhaps the level of recombination activity is high enough in cell-based assays that there is less dependence on a stage of the reaction at which joining occurs. Because use of DNA homology at coding ends is not universally applied, even in chromosomal rearrangements in viuo, it cannot be considered as an essential part of the mechanism. However, DNA overlaps may be significant for rearranging gene families where a restricted recognition property serves an immunological strategy.
C. A V(D)J RECOMBINATION JOINING MODEL The joining steps of the reaction path allow the formulation of a likely model (Fig. 2B). Coding and RSS junctions differ b y the extent of normal processing. Precise RSS junctions are a logical product of 5’-phosphoryl and blunt RSS ends recently shown (Schlissel et al., 1993; Roth et al., 1993). Therefore, RSS ends may not be processed at all, but are directly ligated. RSS ends could be protected from processing by protein binding. None of the joining steps have any requirement for covalently associated proteins. Cleavage of hairpins by single-strand breaks near the ends would generate fragmented coding ends differing by the position of cleavage. In addition to coding ends of different-overhangs, a varying extent of processing does occur in independent events. DNA homology between the ends may be used to direct joining. The restriction on the extent of deletion is probably limited by the ability to hold the two coding ends in a synaptic complex by protein associations. N region addition is very likely to
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
43
occur after terminal deletion. The enzymology of coding end processing will require more experiments through the examination of mutants that effect these steps (see below).
D. NONHOMOLOGOUS RECOMBINATION AND ENDJOINING The joining of ends of DNA without regard to DNA sequence is an abundant property of most eukaryotic cells, but the significance of this process for cell metabolism and DNA repair is little understood. Molecular properties of end-joining have been defined for mammalian cells (reviewed in Roth and Wilson, 1988; Roth et al., 1985; Roth and Wilson, 1986; Roth et al., 1989) and Xenopus Zaevis or human cellfree extracts (Pfeiffer and Veilmetter, 1988;Thode et al., 1990; Fairman et al., 1992). Key features of this process bear a striking resemblance to V( D)J recombination coding junction formation, suggesting an overlap in the mechanisms, and a possible recruitment of aspects of nonhomologous end-joining in lymphoid-restricted gene rearrangement. Furthermore, characterization of chromosomal translocation breakpoint junctions associated with a variety of tumor types often has similar molecular features to end-joining. Efficient end-joining can be measured with transfected linearized plasmid DNA in cell culture although similar properties are observed with end-joining from cell-free extracts. Analysis of recovered junctions shows that end deletion/insertion occurs in concert with the joining so that recombinant outcomes of several types may occur. Models that accomodate the formation of all of these observed junctions have been proposed in which there is a combination of nuclease and polymerase functions that leads to the heterogeneity of joints with or without deletion of nucleotides. A sizeable fraction of observed junctions have no loss of DNA, but appear to result from filling-in steps prior to ligation, even if the ends are not cohesive and/or contain 3’ overhanging strands or blunt ends instead of 5’ overhanging strands (Roth et al., 1989; Thode et al., 1990; Pfeiffer et al., 1994b). In addition, “filler” DNA also appears in these junctions (Roth et al., 1989) as is found for V(D)J recombination. To explain the interesting properties of the fill-in reaction, it was proposed that a factor would hold DNA ends together such that repair synthesis could occur from one DNA end to the other. These factor(s), alignment proteins, are proposed to work without ligation between the ends. Evidence for alignment factors in nonhomologous end-joining was reported (Thode et al., 1990).Alignment protein(s) have been suggested to prepare the template so that a DNA polymerase may be
44
DAVID T. WEAVER
primed for repair synthesis across a double-strand gap (Thode et al., 1990). It is interesting that this repair synthesis is itself error prone because mismatched nucleotides between the two ends can be incorporated into the recombinant product rather than excised. Therefore, repair synthesis may occur either before or after ligation so that strands can be ligated in the presence of mismatches or following mismatched nucleotides being repaired (Pfeiffer et al., 1994a). Some rules already apply in this process. Completely nonhomologous ends can be ligated such that the polarity of mismatches relative to flanking matches determines whether or not the mismatches are retained in ligated strands or excised (Pfeiffer et al., 1994a). These parameters offer insight into the processing of DNA ends by matches and mismatches. Similarities between nonhomologous recombination and the sitespecific V(D)J recombination coding joint formation have previously been noted (Roth and Wilson, 1988). One feature of nonhomologous recombination reactions was the finding that short tracks of DNA homology are recruited in the joint a sizeable percentage of the time (approx 50%; Roth and Wilson, 1986; Roth et al., 1989). V(D)J recombination coding joints may share related properties as evidenced by the findings of several laboratories that coding end microhomology frequently dictates the exact nucleotide structure of coding joints. Furthermore, it may be expected that there is a similar use for alignment factors in V(D)J recombination. Because completely nonhomologous ends can be joined in V(D)J recombination (Boubnov et al., 1993), the recruitment of mismatches in the joined ends would be a means to increase junctional heterogeneity. The biochemistry of V(D)J recombination joining has also been explored recently as several aspects of the joining reaction are related to nonhomologous end-joining discussed above. Joining of linear D N A containing RSS elements was observed (Halligan, 1993; Halligan et al., 1994). DNA joining was achieved with a purified protein, VDJP, or crude nuclear extracts from pre-B cells containing VDJP. D N A joining facilitated by VDJP required RSS on both partners of the joining substrates; other DNA homology is nonessential for the reaction. VDJP was cloned from screening a cDNA expression library for binding to the nonamer region of an RSS, and this protein has been demonstrated to bind to the nonamer in uitro. VDJP is identical to a portion of replication factor C (RF-C) but has unique 5’ and 3’ ends. In addition, RNA analysis showed that a 1.7-kb mRNA corresponding to VDJP was expressed in immature lymphoid cells, but not in nonlymphoid cells. In contrast, RF-C has a 4.5-kb mRNA in all cells (Lu et al., 1993; Luckow et al., 1994). Thus, VDJP is possibly a distinct gene from
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
45
RF-C or a unique gene product that arises by differential splicing or altered RNA processing. The VDJP region of RF-C has homology to bacterial DNA ligases; although the region of homology is not in the vicinity of the ligase active site, it may be a clue to VDJP biochemical activity. VDJP may b e an interesting accessory protein to RAG1 and RAG2 function in V(D)J recombination. This protein may be most involved in RSS junction formation because of the requirement for RSS in VDJP-mediated joining. Another joining activity has been described that could be relevant to V(D)J recombination and DSB repair. The DNA transfer assay (DTA) measures transfer of DNA from a donor to recipient plasmid substrate, dependent on DNA homology (Jessberger and Berg, 1991). Although there is no evidence that DNA homology is required for either V(D)J recombination or DSB repair, DTA may be useful for identifying important biochemical activities for these processes. A high-molecularweight protein complex (RC-1) has been found that permits DTA i n uitro and consists of several DNA ligase and polymerase components (Jessberger et al., 1993).RC-1 activity is highest in CD4-lCD8- immature wild type or RAG2-/-thymocytes and lowest in CD4+lCD8+or single positive thymocytes ( Jessberger et al., 1994). Nuclear extracts from scid lymphocytes have very little RC-1 activity, and deficient scid extracts can be restored by the addition of fractions from wildtype fetal thymocyte extracts ( Jessberger et al., 1994). Using this procedure, a 72-kDa protein has been purified that complements the in uitro deficiency for DTA. It remains to be seen whether or not the 72-kDa protein (Scid recombination stimulatory protein, SRSP) is encoded by the scid gene, but further descriptions of SRSP functions will be keenly interesting. Because V(D)J recombination from start to finish has yet to be accomplished in uitro,the exact correlation with nonhomologous end-joining remains elusive. However, an understanding of mutations that effect both V(D)J recombination and DNA repair may be the most direct route to understanding how these pathways synergize in eukaryotes.
IV. Genes Involved in DSB Repair and V(D)J Recombination
A. THEScid MUTATION The scid mouse was first reported by Bosma et al. (1983).Research on the scid mutation over the past 10 years has defined the nature of the defect in two main arenas: V(D)J recombination and DNA repair. As such, the scid defect serves as a paradigm for the principle that
46
DAVID T. WEAVER
there is a recruitment of a number of genes for V(D)Jrecombination and double-strand break repair pathways, and that the two processes overlap mechanistically (Table I). The first noted defect in scid mice was an immunodeficiency that was manifested as a lack of mature lymphoid cells and serum Ig (Bosma et al., 1983).The scid immunodeficiency and the many useful functions of scid mice as cell transfer recipients have been reviewed extensively (Schuler, 1990; Bosma and Carroll, 1991; Hendrickson, 1994). I will review the scid V(D)Jrecombination defect and other molecular properties of the mutation. The V(D)Jrecombination defect of scid mice is responsible for the severe immunodeficiency of the animals (Table I). Whereas normal products of the site-specific recombination pathway give rise to Ig and TCR gene products, these products in w i d cells are aberrant, and usually deleted, such that productive rearrangement only occurs at a small level. This conclusion is supported by molecular evidence from endogenous gene rearrangements in vioo, endogenous rearrangements from derived cell lines, continuing endogenous rearrangements in scid lymphoid cell lines, integrated retroviral rearrangement substrates, and the introduction of plasmid recombination substrates. Schuler et a2. (1986) first showed that scid lymphoid cells are defective by noting the absence of rearrangement alleles of Ig p and TCRD in isolated cell lines. Using scid Abelson murine leukemia virus transformed preB cell lines, several groups demonstrated that ongoing V(D)Jrecombination was defective. The scid pre-B cells did not detectably produce plasmid substrate coding junction products relative to normal controls (Lieber et nl., 1988a). Also, integrated retroviral recombination substrates were aberrantly rearranged in scid pre-B cells. Deletions frequently were extensive enough to include flanking mouse genomic DNA (Hendrickson et al., 1988; Malynn et al., 1988). Whereas coding junction products are absent or defective in scid rearrangements, RSS products are relatively normal. RSS junction plasmid substrates form at a slightly reduced efficiency in scid pre-B cells. Of these products, about 50% have small deletions in the signal junctions and N regions added (Lieber et d . ,1988b). These mutant features are ordinarily characteristic of coding junctions. Integrated retroviral substrates that recombine by an inversional path were informative because the two products of the same rearrangement events could be compared. Although inversions in the absence of extensive deletion are rare in scid pre-B cells, the coding junction products are defective relative to the RSS product (Hendrickson et at., 1990).In these experiments, coding junctions showed aberrant deletions, whereas signal junctions were normal and did not contain deletions. Thus, the scid
TABLE I MUTANTSOF V(D)J R E C O M R t N A T l O N
V(D)J Recombination
IR Mutation Group scid scid
v-3
XR-1
XRCC5 xrs5, xrs6 XR-V79B XR-V15B sxi2, sxi3 sxi 1 rag1 KO rag2 KO tdt KO
Fibro
B and T
DSB Repair
S
S
Deficient Deficient Deficient
S
S S
S
Signal
Coding
Gene Identity
Human Chromosome Location
2
2
Deficient Deficient
Deficient Deficient
Deficient
Deficient Deficient
Deficient
Deficient
p82""
2~134-36
Deficient Deficient wt wt wt
Deficient Deficient 0 0 wt
Deficient Deficient 0 0 No N regions
p70"" RAG 1 RAG2 Tdt
22q3 llp13 llp13
8pll-ql2
5
2
S
S S R R
R
Note. S, sensitive; R, resistant; wt, wild type.
48
DAVID T. WEAVER
defect is selectively aberrant for coding junction formation. A likely interpretation of this data is that the scid mutation does not affect the initiation ofV(D)J recombination, but acts at a later stage in the reaction such as processing or product formation. The signal junction deficiencies observed are possibly secondary consequences of slowing both of the joining reactions down, although only one can be completed. N region addition in the “wrong” junction may be a consequence of the phenomenon of a reduced joining rate. Several experiments indicate that the scid coding junction deficiency may be a processing error. First, yGTCR rearrangements in scid T cells have been shown to have very long P nucleotides (Schuler et al., 1991; Kienker, 1991). Because longer than normal P nucleotides can be generated by changing the DNA sequence composition of coding regions of plasmid substrates for V(D)J joining (Meier and Lewis, 1993), the increased length observed for scid rearrangements may occur by a secondary mechanism. The scid coding junction products can be “rescued” by placement of extended DNA homology (approx 70 bp) flanking the two RSS in inversion plasmid substrates (Lieber et al., 1988a). Formation of normal signal joint products indicates that the reaction being measured is initiated by a RAGURAG2-dependent mechanism; coding joints formed are in the region of DNA homology without any base loss or addition in these sequences. Thus, it appears that rescue by homologous recombination has occurred. With templates containing only 10 bp of DNA homology there is no rescue of the scid coding junction defect (N. Boubnov and D. Weaver, unpublished data), which is consistent with the observations that homologydirected recombination in other systems requires a minimal region of >SO bp. Scid thymocytes accumulate hairpins at TCRG coding ends but not at RSS ends (Roth et al., 1992a). These products are not likely to be aberrant by-products of the reaction because they are detectable in normal mouse thymocytes in parallel and because hairpins are estimated to appear as frequently as signal ends in scid (Roth et al., 1992a). More work will be necessary to confirm that hairpin DNA serves as a V(D)J recombination intermediate. Nevertheless, the findings offer intriguing insight into where scid plays a role in the V(D)J recombination pathway; it is possibly required for resolving hairpins at coding ends. Strand breaks distal to the hairpin in scid may create the extended deletions observed in scid rearrangements. It is possible that thymocytes lack this second function that would allow incomplete scid rearrangements to be rescued by an alternate pathway. On the other hand, cells that break hairpins but do not join the chromosome may
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
49
be programmed to die by apoptosis. Recent work with bcl2/scid transgenic mice has shown a difference between the T and B cell population (Strasser et al., 1994). At least partial B cell differentiation can be rescued by expression of Bc12, a protein that inhibits cell death (Vaux et al., 1988; Korsmeyer, 1992).Because these B cells presumably can resolve rearrangement-mediated hairpin DNA to continue proliferation and differentiation, there must be a second pathway for hairpin dissolution in B cells. The scidT cells may not have a second resolution pathway so that their proliferation and differentiation is still blocked. These speculations would be consistent with observations that scid thymocytes, but not B cell populations, have been observed to accumulate hairpins. A second primary defect of scid cells is an inability to adequately repair damage from IR (either X rays of y rays; Fulop and Phillips, 1990; Biedermann et al., 1991; Hendrickson et al., 1991; Disney et al., 1992; van Buul et al., 1994). Scid hematopoietic and germ line stem cells, lymphoid cell lines, and fibroblasts all show differential hypersensitivity to IR. IR sensitivity of scid cells is as profound as has been observed with other IR-sensitive mutants. Thus, the scid mutant phenotype extends beyond V( D)J recombination and immune cell function. IR is both mutagenic and lethal in a dose-dependent manner in all cells, and the IR damage that generates chromosomal doublestrand breaks appears to be responsible for the lethality (Radford, 1986).Paradoxically, scid spermatogonial stem cells are IR hypersensitive, but appear to have a significantly reduced level of IR-induced chromosomal translocations (van Buul et al., 1994). One explanation offered for this phenomenon is that translocation-bearing cells are selectively eliminated and thus not scored in the translocation index. Studies with scid fibroblasts illustrate that DSB repair is defective. This conclusion was reached by monitoring DNA fragmentatiodrepair in PFGE or neutral filter elution assays (Biedermann et al., 1991; Hendrickson et al., 1991).These studies are in good agreement, showing that greater than 50% of the broken DNA in irradiated scid cells is not repaired within a time course that fully repairs wild-type cells. Several additional findings have substantiated this correlation. For example, scid fibroblasts are also hypersensitive to IR-mimetic agents such as bleoniycin and another double-strand break inducing agent, neocarzinostatin (Biedermann et al., 1991; Hendrickson et al., 1991; Tanaka et a1,, 1993).Similarly, restriction enzyme introduction, which creates double-strand breaks in cellular chromatin, is selectively toxic to scid cells (Chang et al., 1993). Calcheamycin, an agent that also mimics IR and restriction enzymes by creating staggered double-
50
DAVID T. WEAVER
strand breaks is also a potent toxic agent for scid fibroblasts (Staunton and Weaver, unpublished data). The effects of DNA damage agents that are linked to other types of DNA repair mechanisms generally are repaired normally in scid cells. Scid cells are only slightly sensitive to uv irradiation, and have normal sensitivity to MMS alkylating agents, and mitomycin C crosslinking (Hendrickson et al., 1991; Biedermann et al., 1991; Tanaka et d.,1993). However, there is some sensitivity to the crosslinking by mechlorethamine (Tanaka et aZ., 1993). Because of the involvement of scid in V(D )J recombination and DSB repair, a role for this gene product in other recombination mechanisms has been explored. In fact, these studies may be useful for determining the extent of similarity between the processes. It may be expected that scid cells will have a decreased ability for nonhomologous recombination. Nonhomologous recombination or end-joining is an abundant activity of mammalian cells that can be measured by the joining of noncohesive restriction enzyme sites of a linear plasmid DNA. Furthermore, repair of IR-induced DSBs is thought to occur via nonhomologous end-joining pathways (see above). The scid cells efficiently recircularize transfected linearized plasmid DNAs (Harrington et al., 1992; Lewis, 1994) and efficiently integrate linearized plasmid DNAs into chromosomal sites (Staunton and Weaver, 1994).These aspects of DNA end-joining and integration are unaffected by the scid mutation. Interestingly, hairpin-ended DNA is also efficiently processed and religated in scid transfection experiments. Lewis (1994) showed that recircularized products of linear hairpin-ended plasmid DNA formed efficiently in scid and wild-type cells. The junctions observed contained P nucleotides of one to five bases consistent with similar structures in V(D)J recombination coding joints. Similarly, hairpin-ended plasmid DNAs integrate efficiently into scid and wild-type cells indicating that the processing of these structures is normal (Staunton and Weaver, 1994). Processing and joining of hairpins bears all the features of linear DNA end-joining in in vitro reactions of Xenopus extracts (Beyert et al., 1994)The scid locus is found on mouse chromosome 16 (Bosma, 1989; Miller et al., 1993). Several laboratories have succeeded in identifying a human chromosome that can complement scid defects when introduced into scid fibroblasts. Microcell-mediated chromosome transfer of individual human chromosomes into scid fibroblasts has shown that human chromosome 8 can restore normal resistance to IR damage (Komatsu et al., 1993a; Kurimasa et al., 1993; Kirchgessner et al., 1993). Since an additional hallmark of the scid mutation is aberrant V(D)J
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
51
recombination, the complementation ofboth of these defects was examined in another study. Transfer of human chromosome 8 complements both scid defects, showing the location of the human SCID gene (Banga et al., 1994).V(D)J recombination coding joints formed in transient transfection assays with RAG1, RAG2, and a plasmid recombination substrate showed a restoration of the wild-type features of coding junctions. Complemented cell lines that have then lost human chromosome 8 by growth in nonselective media were found to be IR sensitive and have the scidV(D)J recombination defective phenotypes. A concordance between IR resistance and retention of human chromosome 8 fragments from radiation hybrid mapping suggests that scid is located in a centromeric region of chromosome 8 ( 8 p l l . l - q l l . 1 ) (Kurimasa et al., 1993). This region is not particularly syntenic with the scid region of mouse chromosome 16; the human Vpre-B and protamine genes that flank scid in the mouse are located on different human chromosomes from scid. Also, this region of human chromosome 8 is not associated with any known immunodeficiency and DNA repair diseases, although Werner’s premature aging syndrome is located on 8p12 (Schellenberg et al., 1992; Goto et al., 1992). Werner’s syndrome fibroblasts are able to execute V(D)J recombination properly in transient transfection assays with RAG1, RAG2, and plasmid rearrangement substrates for coding or signal junction formation (Z. Wills and D. Weaver, unpublished data). The gene for DNA polymerase-@ is located on human chromosome 8pll-12 (Drayna et al., 1993). @-Polymerasehas been implicated in many DNA repair processes and could play a role in V(D)J recombination, as it might be used in joining steps of the reaction. However, P-polymerase maps to another chromosome in the mouse, so @-polymerasecannot be the scid gene. B. THEV-3 MUTATION Chemical mutagenesis of the Chinese hamster ovary cell line AA84 yielded the IR-sensitive mutation, V-3 (Whitmore et al., 1989; Table I). Like scid, this mutant was deficient in repair ofdouble-strand breaks formed by IR. Somatic cell hybrids between V-3 and scid cells remain IR sensitive suggesting that V-3 and scid are in the same complementation group (Taccioli et al., 1994b). Transient transfection of RAG1 and RAG2 into nonlymphoid cells can be used to assess the efficiency of recombination (Oettinger et al., 1990). As exemplified for scid, this strategy has been extremely useful to monitor whether additional cell culture mutants or human DNA repair syndrome disease cell lines may have errors in V(D)J recombination. The V(D)J recombination potential of V-3 cells was fairly similar to scid in that coding joints,
52
DAVID T. WEAVER
but not RSS joints, are most impacted. V-3 coding junctions are generated at very low efficiency and have a preponderance of P nucleotides in the junctions, reminiscent of w i d DJS rearrangements i n vivo (Table I). The V-3 mutation is likely to be different from the scid mutation because V-3 transient transfection assays most frequently give P nucleotides in recovered junctions, whereas scid coding junctions do not. V3 RSS junctions have a similar modest decrease in the frequency of product formation (60%)and a higher incidence of small RSS junctional deletions, like scid pre-B cells and fibroblasts (Taccioli et al., 1994b; Lieber et al., 1988a; Boubnov and Weaver, unpublished data). The combination of each of these V-3 mutant phenotypes is in striking parallel to scid and is strongly supportive of V-3 being another mutant allele of the scid gene.
C . T H E X R - I MUTATION The Chinese hamster ovary cell mutant XR-I was isolated from chemical mutagenesis of CHO-K12 cells in a screen for radiosensitive mutants (Stamato et al., 1983; Table I ) . XR-I cells are also specifically sensitive to double-strand break damage (Giaccia et aZ., 1985),and the effect of IR damage sensitivity can be mimicked by introduction of restriction enzymes as a double-strand break-specific agent (Giaccia et al., 1990).XR-I is a separate complementation group from other IRsensitive mutants (Jones et aZ., 1988). Somatic cell hybrids with scid, V-3, and xrs are all able to complement radiosensitivity. Since the complementing human chromosome for each of these mutants is now known, clearly these mutants are members of unique complementation groups represented by different genes. V(D)J recombination is defective in XR-I cells having reduced RSS and coding junction formation in the transient transfection assay distinguishing this mutant phenotypically from scid in V(D)J recombination (Taccioli et al., 1993). XR-I coding junctions recovered at low efficiency have larger than normal deletions in the products. XR-I RSS junctions also formed at low frequency, and these products show deletion that is not a normal characteristic ofthese junctions. The radiosensitivity of XR-I is complemented by transfer of human chromosome 5 (Giaccia et al., 1990).XR-l:Ch5 cells also revert the V(D)J recombination deficiency for both RSS and coding junction formation (Taccioli et al., 1993).These experiments distinguish XR-I as a separate mutation from scid, but affecting the same pathways (Table I). Recent experiments have elaborated upon the V(D)J joining defect in XR-I cells with an integrated recombination template that undergoes inversional rearrangement (Li and Alt, 1994). The inversional
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
53
configuration is useful for analysis of both rearrangement products from the same recombination event. Transfection of XR-I G12 cells with RAG1 and RAG2 activates rearrangement that is observed to be largely aberrant by a Southern blotting analysis. Limited deletion occurs some of the time and can be selected in culture. Analysis of the RSS and coding junctions from the same recombination event illustrated that XR-I fails to form precise RSS junctions, whereas the corresponding coding junctions are relatively normal. These coding junctions have a very high retention of P nucleotides of 1-5 bp in size; the highly unusual feature of P nucleotides originating from both strands is also found. Therefore, the junctional properties distinguish XR-I from other DSB repair mutants. However, like each of these mutants, single mutant alleles may not be representative of the phenotypes of a null mutant, and more similarities or differences may arise when it becomes possible to compare more mutants in the same complementation groups. Immune cell dysfunction cannot be analyzed in XR-I because the mutation was generated in a somatic cell line. Once the XR-I gene is cloned, it will be possible to assess the level of immunodeficiency generated by creating a mouse mutant in the gene by knockout. Since XR-I RSS junctions are most defective, perhaps this protein normally functions in RSS junctions. Currently, one candidate for the XR-I gene product is VDJP, the nonamer recognition protein that appears to be able to join DNA ends containing RSS elements (Halligan 1994). D. THEXRCC5 MUTATION Six independent isolates of another complementation group,
XRCC5, were isolated from CHO cells following chemical mutagenesis and a screen for radiosensitivity (Jeggo and Kemp, 1983; Table I). The xrs mutants are severely sensitive to IR and IR mimetic agents, and this radiosensitivity is DSB specific (reviewed by Jeggo, 1990). Other members of this group have been more recently derived by chemical mutagenesis of Chinese hamster lung cells, V79 (Zdzienicka et al., 1988), or by spontaneous mutagenesis of V79 (Lee et al., 1994; Boubnov et al., 1994b; Table I ) . These recently derived mutants (sxi2 and s x i 3 ) were demonstrated to be in the same complementation group as xrs by somatic cell hybrid formation and examination of complementation of radiosensitivity (Boubnov et al., 1994b). V(D)J recombination is also defective for XRCC5 group mutants, as assayed b y transfection above (Taccioli et al., 1993b; Pergola et al., 1993; Boubnov et al., 1994b). Similar to X R - I , xrs cells are deficient for both RSS and coding junction formation measured separately with
54
DAVID T. WEAVER
different plasmids. xrs-6 V(D)J recombination RSS junctions formed inefficiently, and most products that could be recovered had RSS junctional deletion. xrs-6 coding junctions were not detectable b y this assay. The V79 mutants, sxi2 and sxi3, have severely diminished RSS and coding junction product formation (Boubnov et al., 1994b). However, infrequent products that were recovered did show a significant frequency of normal rearrangement junctions. Therefore, sxi2 and sxi3 may be less penetrant mutants of the xrs complementation group. xrs complementation group cells that are reverted to IR resistance also revert the V(D)J recombination phenotypes to normal (Taccioli et al., 1993; Boubnov et al., 1994b). xrs cells containing a transfered human chromosome 2 complement both phenotypes: IR resistance and normal V(D)J recombination (Jeggo et al., 1992; Taccioli et al., 1993). The defect in both signal and coding junction formation for xrs distinguishes this mutant group from the scid V(D)J recombination defect. XRCC5 group mutant cells have additional phenotypes that may reveal the function of this gene product in DNA repair and V(D)J recombination. xrs group mutants have diminished proficiency of integration of plasmid DNA into chromosomes (Moore et al., 1986; Hamilton and Thacker, 1987). Because this process is widely believed to primarily occur in mammalian cells by an end-joining or nonhomologous recombination pathway, the xrs group may well be generally deficient in this process. Similarly, xrs-6 and XR-I cells are hypersensitive to D N A topoisomerase I1 inhibitors, such as etoposide V-16 (Jeggo et al., 1989; Caldecott et al., 1990), whereas scid and V-3 cells are not (Jeggo et al., 1989; Staunton and Weaver, unpublished data). Etoposide-V16 traps DNA topoisomerase I1 bound to DNA (cleavable complex) that is presumed to be processed into some form of a DNA DSB. Thus, xrs may be more generally involved in a variety of endjoininglrepair reactions than scid.
E. THES x i l MUTATION Two other mutants, sxil and sxi4, were isolated by spontaneous mutagenesis of V79-4 Chinese hamster lung cells (Lee et al., 1994). sxil constitutes a new complementation group for IR sensitivity and DSB repair (Boubnov, et al., 1994c; Table 1). sxil is as sensitive to IR damage as any of the other DSB repair mutants discussed. The sxil cells are also hypersensitive to the crosslinking agent mitomycin C, but not hypersensitive to UV irradiation or alkylating agents (Lee et al., 1994). sxil also appeared to form a-new complementation group for DSB repair because it was complemented by V-3, mid, XRCC5 andXR-1 cells in somatic cell fusions tested for IR sensitivity (Boubnov et al., 1 9 9 4 ~ ) .
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
55
S x i I was also unable to properly conduct V(D)J recombination analyzed by the same methodology as the above mutants (Boubnov et al., 1 9 9 4 ~ )RSS . junction product formation was reduced by approximately 90-fold in s x i l . Of the low frequency of products, a high percentage are normal junctions. Similarly, coding junction formation is reduced significantly, but a high percentage of the joints are in the normal deletional range. These junctions do not retain any elevated frequency or unusual sizes of P nucleotides. Thus, sxil is phenotypically similar to xrs and X R - I with regard to V(D)J recombination defects and distinctly different from scid. V. The Ku Autoantigen
A. Ku An exciting connection has recently emerged for V( D)J recombination and DNA repair from a surprising direction. Autoimmune patients frequently produce antibodies against proteins from their own cells. Many of these intracellular proteins, identified by the antisera that recognizes them, have yielded valuable insights into cellular processes such as transcription, splicing, and chromatin structure. Antisera against Ku antoantigens were originally described from patients with schleroderma-polymyositis overlap syndrome or systemic lupus erytheniatosus (Mimori et al., 1986).Subsequently, it was shown by immunoprecipitation analysis that two proteins, p70 and p82 kDa, were recognized. These two proteins, p70K"and ~ 8 2 ~form " , a stable heterodimeric complex in mammalian cells. The proteins are nuclear and present in moderately high levels. p70 and p82 coprecipitate as a complex since monoclonal antibodies generated against one or the other subunit will stoichiometrically precipitate the other subunit. Ku has also been purified based on its biochemical properties (see below); the purified protein is a 1:l complex of p70 and p82 kDa subunits. Purified Ku heterodimers have the interesting property of binding to DNA ends irrespective of DNA sequence composition. The doublestranded DNA end-binding property is observed with purified Ku protein or in nuclear extracts (Mimori and Hardin, 1986).Ku does not bind efficiently to single-stranded DNA that is unable to self-anneal or to nicks in DNA. With Ku, addition of circular plasmid DNA in excess does not compete with the KU-DNA complex. Addition of DNA with ends binds to KU and competes for the complex. Purified Ku heterodiniers bind DNA ends with a binding constant of 2.4 x loyM-' (Blier et al., 1993).The 70-kDa subunit has the strongest DNA end-binding capacity (Mimori and Hardin, 1986).Ku binding to DNA
56
DAVID T. WEAVER
ends can also be measured in other assays. An easy detection methodology for protein-DNA complexes has been the gel-shift assay, where radiolabeled DNA fragments are altered in electrophoretic mobility by the binding of protein. Ku-DNA complexes are sufficiently stable that characteristic complexes are observed in gel shifts. Also, using DNasel footprinting of Ku-DNA end complexes, both 5' and 3' ends of double-stranded DNA are protected. This end-binding function of Ku prompted early suggestions that Ku heterodimers might have a DNA repair function. The DNA end-binding property of Ku prompted investigators interested in V(D)J recombination to evaluate whether the Ku proteins may be important to this mechanism. Using the DNA end-binding gel-shift assays, extracts from all of the mutant cell lines of V(D)J recombination discussed above were examined. Several of the XRCC5 complementation group cells are deficient in the major DNA endbinding activity attributable to Ku (Rathmell and Chu, 1994; Getts and Stamato, 1994; Taccioli et al., 1994a; Boubnov et al., 1994b).These mutants include xrs-5, xrs-6, XR-V15B, XR-VSB, sxi2, and sxi3 (Table I). The D N A end-binding activity is competed with linear DNA (DNA with ends), but not with circular DNA, as already demonstrated for purified Ku proteins. Azacytidine-induced revertants of xrs-5, human chromosome 2:xrs-6, or sxi2 spontaneous revertants all restore the IRresistant and V(D)J recombination phenotypes and also restored DNA end-binding activity. Interestingly, the sxil and sxi4 mutants also have reduced end binding (Boubnov et al., 1 9 9 4 ~ )In . contrast, scid, V-3, and XR-1 group cells are not defective for the DNA end-binding property. Mutants that are IR sensitive but not DSB specific, such as EM9 and AT5B1, contain normal end-binding capacity (Rathmell and Chu, 1994; Getts and Stamato, 1994; Boubnov et al., 1994b). Bleomycin-sensitive CHO mutants, BL-10 and BL-14, are also normal for this activity. The protein-DNA complexes that are disrupted in the XRCC5 and sxil complementation group mutants were shown to contain Ku normally. The end-binding Ku-DNA complexes are recognized and supershifted by addition of anti-p70K"or a n t i - ~ 8 2antibodies ~~ in gel-shift assays (Boubnov et al., 1994b). Also, immunodepletion of cross-reacting Ku antisera shows that the DNA end-binding complex contains KU (Taccioli et al., 1994a). Anti-p70K"antibody increases the mobility of the major KLI-DNA complex. Higher-order Ku-DNA complexes show extensive changes in mobility. Some a n t i - ~ 8 2 ~ antibodies " supershift the major end binding complex. Other a n t i - ~ 8 2antibodies ~" do not alter the mobility of the major KU-DNA complex, but d o supershift higher-order complexes. An antibody recognizing a shared epitope
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
57
between p70K" and ~ 8 2 also ~ " shifts the major Ku complex. These criteria show that Ku is responsible for the end-binding activity detected in normal cells. The primary DNA end-binding complex is formed by a Ku heterodimer on DNA. Therefore, an intriguing possibility is that the XRCC5 and sxil complementation groups are mutations in K u subunits. The genes for both subunits of Ku have been cloned (Yaneva et al., 1989; Mimori et uZ., 1990; Reeves and Sthoeger, 1989; Falzon and Kuff, 1992), making it possible to determine whether these DSB repair/ V(D)J recombination-deficient cell lines may be attributable to niutations in Ku. Several experiments argue strongly that the XRCC5 group mutants are defective in ~ 8 2 ~The " . xrs complementation group and p82"" map to the same region of human chromosome 2: 2q33-35 (Ku; Cai et al., 1994) or 2q34-37 (xrs and XR-Vl5B; Jeggo et al., 1993; " expression Hafezparast et al., 1993).Transfection of human ~ 8 2 in~ an plasmid complements the IR sensitivity and V(D)J recombination defects ofsxi2, sxi3, or xrs-6 cells (Taccioli et al., 1994a; Boubnov et al., 19941)). Also, DNA end binding is restored by p82"" in sxi-3 cells. Fui-thermore, radiation hybrids of human chromosome 2 with xrs cells that are IR resistant and V(D)J recombination proficient also have the appropriate region of human chromosome 2 by PCR analysis with primers at particular associated regions. The XRCCS mutations in ~ 8 2 are ~ "not yet fully described, although it is likely that the existing population of mutants contains different types because their repair phenotypes are variable for xrs mutants. Northern blots with a ~ 8 2 ~ " probe indicated that xrs-6 cells produce p82 mRNA indicating that subtle mutations, such as point mutations, are probably the cause (Boubnov and Weaver, unpublished data). Sxi2 and sxi3 d o not have detectable p82"" mRNA (Boubnov et a l . , 199411). p70K"mRNA is also expressed normally in these mutants. There is likely to be some Ku activity in these latter mutants because V( D)J recombination assays on these cells are not identical between xrs-6 and sxi2,sxi3 as discussed above (Boubnov et al., 1994b). N o information is available yet on the human chromosome able to complement the sxil IR sensitivity and V(D)J recombination defects. A likely candidate is human chroinosome 22, where p70"" is located (Cai et al., 1994). sxil may be a mutant in p70"" because it is defective in the DNA end-binding complex associated with KU heterodimers, and because sxil did complement xrs group cells in somatic cell hybrid tests (Boubnov et ul., 1994b,c). Sxil IR', V(D)J recombination, and DNA end-binding is reconstituted by the addition of p70K"(Boubnov et nl., 1 9 9 4 ~ ) .
58
DAVID T. WEAVER
B. How MIGHT Ku STIMULATE V(D)JRECOMBINATION AND DNA REPAIR? The property of DNA end binding of Ku is likely to be highly significant for V(D)Jrecombination. In the joining steps of the reaction, Ku monomers could be associated with each coding and/or RSS ends. This property of Ku may be a means to synapse DNA ends prior to ligation by holding the DNA strands together via protein-protein interactions (Fig. 3). A parallel function may be expected for fragmented or damaged DNA in DSB repair. A.
V(D)J
recornblnatlon
B.
Double strand break repair DNA
J Darnage -~ L--KU
KU
KU KU
+
/ \
end-jolnlng
ceIl cycle arrest
1
end-joining
1
RSS joint
FIG. 3. Similarities between V(D)J recombination product formation and DNA damage-induced double-strand break repair. (A) V(D)J recombination. A putative intermediate structure is shown for V(D)J rearrangement in which a synaptic complex of the four DNA ends in the reaction are sequestered. Coding ends are drawn as hairpins, RSS ends are drawn with terminal RSS (triangles). Protein-protein associations and ~ " ~ 8 2 hetero~ " protein-DNA contacts are shown by shaded boxes. Ku proteins ( ~ 7 2and dimer) are illustrated as joined kiangles associated with double-stranded DNA. Th e property of Ku translocation along DNA and binding to DNA ends and hairpins is discussed in the text. (B) Double-strand break repair. DNA damage, such as IR, creating a DSB in the chromosome is depicted. Ku heterodimers relocated to DNA ends for DNA repair. Two processes are induced: end joining and cell cycle arrest. A DNAdependent protein kinase (DNA-PK) associates with Ku and may b e significant for these processes.
V(D)J RECOMBINATION A N D DOUBLE-STRAND BREAK REPAIR
59
A fascinating biochemical property of Ku is its binding to transitions between double-stranded and single-stranded DNA as effectively as it binds to ends of double-stranded DNA (Falzon et al., 1993). Hairpinended DNA is an efficient substrate and competitor for K u binding (Paillard and Strauss, 1991; Falzon et al., 1993). Hairpins with loop sizes between 4 and 20 bp bound Ku as efficiently as oligonucleotides containing douhle-strand DNA ends (Falzon et al., 1993). Thus, if hairpin coding ends are intermediates for V(D)J recombination, a logical model would be that Ku monomers complex to each hairpin via protein-DNA contacts at the transition between single- and doublestranded DNA at the hairpin base (Fig. 3). Two important functions may be envisioned here. On the one hand, binding at this position may be sufficiently internal to the coding end termini that hairpin resolution and processing by other factors is not interfered with in the presence of KU binding. Second, Ku-Ku associations may b e formed between the two coding ends, allowing continued synapsis and completion of the coding junction rearrangement. Ku may also associate with RSS ends because xrs mutants also affect RSS junction formation. There is an interesting DNA sequence dependence for Ku that has been shown by measurement of DNA end binding in gel-shift assays (Rathmell and Chu, 1994). Similarly, V(D)J recombination is strongly influenced by the DNA sequence composition of coding end DNA (Gerstein and Lieber, 1993; Boubnov et al., 1994a). In particular, stretches of A or T of greater than five nucleotides flanking either one or both RSS inhibitV(D)J recombination by 100-fold or more (Boubnov et al., l994a). A/T-rich DNA is not an efficient competitor for Ku end binding. A/T-rich ends may either be too denatured or contain changes in DNA structure so that KU binding is too far removed from the termini to be effective in facilitating joining. Although these findings can explain the dependence of coding junction formation on DNA sequence composition, they do not explain the reduced efficiency of RSS product formation where there have been no compositional changes. However, if the formation of both products is concerted, then the effects of DNA binding to some of the ends could alter the efficiency of joining of all the products. KU may have a similar ability to recognize and bind to fragmented DNA from IR damage (Fig. 3B). IR-fragmented DNA creates DSBs by two independent ionization events. When these strand breaks occur nearby (<30 bp), broken DNA with overhanging 5' and/or 3' single strands is formed. IR breaks in DNA in oitro frequently contain chemically altered bases, base loss, and other modified DNA structures (Kapp and Smith, 1970; Henner et al., 1983). There is currently no indication that hairpin-ended DNA forms following I R scission of DNA ( J . Staun-
60
DAVID T. WEAVER
ton and D. Weaver, unpublished data). If Ku binds to the doublestranded ends of broken chromosomes then a similar processing region between the site of binding and the single-stranded ends would be expected. Thus, Ku-mediated repair of chromosome damage may yield recombinant joining products by nonhomologous recombination pathways that have small deletions and/or filling-in. More experiments will be required to determine whether the proficiency of Ku binding to hairpin and/or transitions in DNA structure places a limitation on the processing capacity in these V(D)J recombination-directed or damageinduced end-joining steps. Another property of Ku is translocation along DNA. In uitro Ku evidently binds to DNA ends and moves along DS DNA (deVries et aZ., 1989; Paillard and Strauss, 1991; Zhang and Yaneva, 1992). There is also evidence from footprinting analysis that Ku does associate with double-stranded DNA (Gottlieb and Jackson, 1993). An interesting implication of these results would be that Ku can translocate along DNA in uivo to sites of recombination synapsis or DNA damage (Fig. 3). This property could explain how Ku may only be involved in late or joining stages of V(D)J recombination. The rules of Ku involvement for V(D)J recombination product joining may now be better explored with the molecular genetics of the Ku gene products.
C. DNA-DEPENDENT PROTEINKINASE(DNA-PK) Ku also forms a stable complex with a high molecular weight protein kinase [(Gottlieb and Jackson, 1993); reviewed by Anderson, 19931. A novel feature of this serine/threonine protein kinase is that it is activated by binding to DNA, particularly DNA ends (Walker et uZ., 1985). The DNA-PK was purified from HeLa cells and consists of a single polypeptide of approximately 350 kDa (Carter et al., 1990; LeesMiller et al., 1990). The consensus serine/threonine phosphorylation site is simple, SQ or TQ (Less-Miller et al., 1992). DNA-PK is localized to the nucleus, but it is unclear whether its cellular localization is entirely dictated by Ku. The features of DNA-PK thus far observed are consistent with a dual function in cell metabolism: transcription regulation and DNA repair. DNA-PK activates transcription factors by phosphorylation. DNA-PK has been shown to phosphorylate the transcription factors SP1, c-fos, C-Myc,Octl, c-Jun, TFIID, CTF/NFI, and RNA polymerase I1 [see Anderson, 1993 and references within]. Although each of these proteins are phosphorylated in vitro, it is not yet clear what the true substrates of DNA-PK will b e in uiuo. Transitions between DS and
V(D)J RECOMBINATION A N D DOUBLE-STRAND BREAK REPAIR
61
SS DNA binding are presumably found at the region of transcription factor binding in eukaryotic promoters. The model is that DNA conformational changes, possibly caused by transcription factor binding, may be recognized by Ku. The activation of transcription initiation would then be facilitated by localized phosphorylation of transcription factor substrates by DNA-PK. Actually, Ku-DNA-PK has been purified as a stimulatory transcription factor by several groups (Jackson et al., 1990; Falzon et al., 1993; Dvir et al., 1993). Activation of transcription factor function has been clearly documented for S p l (Jackson et al., 1990; Gottlieb and Jackson, 1993)and stimulation of transcription intitiation by RNA polymerase I1 in vitro (Dvir et al., 1993). The tethering of a DNA-dependent protein kinase via Ku heterodimers is likely to have exciting ramifications for V(D)J recombination and DNA repair. Several of the substrates of DNA-PK have been implicated as key players in DNA damage responses and V(D)J recombination. DNA-PK has been shown to phosphorylate SV40 T antigen, p53, Ku subunits, RPA, and topoisoinerases I and I1 (see Anderson, 1993). The tumor suppressor protein, p53, that is part of the G1-S phase DNA damage-induced cell-cycle checkpoint is phosphorylated by DNA-PK at SQ sites (Less-Miller et al., 1990,1992). RPA, which has also been implicated in DNA repair and pathways (Coverley et al., 1991; Liu and Weaver, 1993), is phosphorylated by DNA-PK (Anderson, 1993). Thus, it has been proposed that DNA-PK is an immediate mediator of DNA damage responses by binding to fragmented DNA ends and signaling cell cycle arrest by a p53-dependent pathway (Anderson, 1993). Thus, because of the DNA end-targeting properties of Ku, DNA-PK is likely to be locally available to DNA damage sites. DNA-PK:Ku complexes are anticipated to be immediate responders to damage to DNA because of its availability on the chromosomes. A Ku-associated DNA-PK may be used in V(D)J recombination. A function of Ku-DNA-PK in parallel to DNA damage repair would be in the completion of product formation and end-joining of this pathway. Phosphorylation of Ku may be significant for its V(D)J recombination activity. The DNA-PK is already known to be stoichiometrically associated with a Ku heterodimer (Gottlieb and Jackson, 1993), and p70K" and p82"" are both phosphorylated by DNA-PK in autophosphorylation assays in vitru (Anderson, 1993). DNA-PK is associated with Ku in the DNA end-binding assay because anti-DNA-PK antibodies are able to alter the mobility of some of the Ku:DNA complexes from crude extracts where DNA-PK activity is present (N. Boubnov, V. Liu, and D. Weaver, unpublished data). Investigation is currently under way
62
DAVID T. WEAVER
to evaluate whether phosphorylation of Ku is a requirement for the DNA end-binding activity. An activated DNA-PK may phosphorylate proteins relevant to V(D)J recombination to direct the reaction toward completion of products or to maximize reaction efficiency. Candidate substrates are RAG 1 and RAG2 proteins. RAG2 is phosphorylated at several serine and threonine residues in a cell-cycle-dependent manner (Lin and Desiderio, 1993;Lin and Desiderio, 1994). Ser375 of RAG2 fits a DNA-PK consensus site; however, mutation of this residue has no effect on V(D)J recombination capacity in the transient transfection assay (Lin and Desiderio, 1993). However, phosphorylation of T490 in the COOHterminus of RAG2 regulates its protein stability; a T490A mutation in this phosphorylation site increased RAG2 stability significantly. This phosphorylation site fits the consensus for ~ 3 4 ‘ ~protein ‘~ kinase, as does a related phosphorylation site regulating p53 stabilization (Lin and Desiderio, 1993). Phosphorylation at other residues may also be a means to regulate RAG2 stability, and therefore activity. Likewise, other phosphorylations may activate or inactivate the protein in recombination complexes. If there is a separation between initiation and cleavage steps of the pathway, then Ku binding to hairpin ends may bring DNA-PK into the vicinity of RAG proteins to be inactivated. Other DNA-PK protein substrates could include other proteins in the complex that may regulate the efficiency of recombinational synapses or the completion of products. Finally, it will be interesting to find out whether DNA-PK itself is directly involved in V(D)J recombination. Mutations in DNA-PK may be expected to be defective in gene rearrangement much like Ku mutations if the DNA-PK:Ku complexes are relevant to the pathway. Once the DNA-PK gene is cloned, a reverse genetic analysis will be informative in deciphering the role of this fascinating protein kinase in DSB repair and recombination. VI. Human Immunodeficiency and DNA Repair Syndromes
A. IMMUNODEFICIENCY SYNDROMES WITH V(D)J RECOMBINATIONDEFECTS Severe combined immunodeficiency syndromes in the human population are rare, sometimes exemplified by single patients. Yet, analogous phenotypes with the V(D)J recombination and DNA repair defects found in rodents are anticipated. Severe immunodeficiency diseases in humans are also referred to as “scid” but are not generally synonomous with the murine scid mutant. Approximately one-half of
V(D)J RECOMBINATION A N D DOUBLE-STRAND BREAK REPAIR
63
human scid syndromes are adenosine deaminase deficiencies which are correctable by gene therapy. Only 20% or less of the rare human scid syndromes are classified as T-B- disease (Stephan et nl., 1993). No human scid syndromes have yet been identified that do parallel the scid mouse immunodeficiency phenotypes. T-B- scid could be caused by V(D)J recombination defects because of the common recombinase mechanism between the lineages. Scid diseases that are T’B-, X-linked SCID, or T-Bf are also observed, but most likely are not primarily caused by basal VDJ recombination defects. These diseases more likely reflect differentiation errors that are lineage restricted. Aberrant Ig gene rearrangements have been observed from bone marrow pre-B cells of B- patients, which is consistent with the phenotypic changes for murine scid (Schwartz et al., 1991; Ichikara et al., 1988) (Table 11). Using a PCR assay for Ig DH to JH rearrangement, an assessment of recombination level and product junctions was evaluated in these patients (Schwartz et nl., 1991). A high percentage of the rearrangements observed had aberrantly extended deletions that destroyed coding sequence. Several of these patients were also lacking T cells, in parallel to murine scid, even though TCR rearrangements were not evaluated. Other T-B- patients were examined for IR sensitivity of the granulocyte-macrophage colony-forming unit (GM-CFU)population. In two patients, GM-CFU cells were radiosensitive (Cavazzana-Calvo et al., 1993), another feature of murine scid-type disease. Omenn’s syndrome patients have elevated T cell numbers and hypereosinophilia. Interestingly, T cells from Omenn’s patients are oligoclonal for either cup or y8 TCR rearrangements (Wirt et uZ., 1989; De Saint-Bade et al., 1991). A comparison has been made between this disease and the leaky phenotype of the murine scid mutation (Cavazzana-Calvo et at., 1993).GM-CFU from Omenn’s patients also shows increased radiosensitivity (Cavazzana-Calvo et nZ., 1993). This IR hypersensitivity is comparable to murine scid GM-CFU IR sensitivity (Fulop and Phillips, 1990) and it has been suggested that Omenn’s syndrome behaves as a leaky murine scid-type defect. Because T and B cell rearrangements from Omenn’s can occur as normal, the defect of these cells is not likely to be in the direct mechanism of V(D)J recombination. Cells from Omenn’s syndrome patients have not yet been examined for V(D)J recombination by transient transfection assays as for other mutants. Normal patients show low frequencies ofaberrant Igor TCR recombination detectable by several assays of primary B or T cells (Tycko and
TABLE I1 HUMANDNA REPAIRAND RECOMBINATION SYNDROMES Human Disease Syndrome
Precancer Syndrome
Immunodeficiency
V(D)J Cell Culture
V(D)J Primary BIT wt Ig and TCR transloc. Aberrant Ig D-Jh TCR restricted
Li-Fraumeni Ataxia telangiectasia B-T+
Yes Yes
wt
wt
low Bllow T
wt
?
no B
?
Omenn
?
low Bllow T
Bloom
Yes
low Bllow T
wt
46BR
Yes
low Bllow T
wt
Fanconi's anemia Xeroderma pigmentosa
Yes
wt
wt
wt
Yes
wt
wt
wt
DNA Repair Defect
Mitotic Recombination H yper-rec Hyper-rec
IR' IR'
Gene P53
Gene Location 17~13.1 11~22-23
?
I R' Hyper-rec and elevated SCE H yper-rec (S. cereoisine cdc9)
15
wt
Broad spectrum Broad spectrum MMC'
FACC
uv-induced hyper-rec
uv'
ERCC
DNA Ligase I
19q13.2-3
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
65
Sklar, 1990). A leading theory for the origins of lymphocytic leukemias is that errors in V(D)J recombination may be aberrantly processed into chromosomal translocations that either predispose or directly facilitate malignancy. Chromosomal translocations with V(D)J recombination site breakpoints are frequently found in lymphoid malignancies, where the translocation alters the expression of genes such as c-myc or bcl2 (reviewed extensively by Korsmeyer, 1992). The same Bcl-2; Ig Jh translocations also are detectable from benign tonsilar tissue of normal individuals (Limpens et al., 1991).Thus, errors in V(D)J recombination that occur spontaneously may facilitate entry into tumor progression pathways. The accurate formation of V( D)J products has been examined in transient transfection assays of EBV-immortalized pre-B cell lymphoma lines and fibroblasts (Gauss and Lieber, 1993; Hsieh et al., 1993; Petrini et al., 1994). In one study, evidence was presented for a bias against coding junction product formation (Gauss and Lieber, 1993), although these data are too preliminary to draw any mechanistic conclusions. Perhaps human progenitor lymphoid cells undergoing V(D)J recombination allow more unrepaired DSBs as by-products of the joining reaction. These ends may serve as the precursors for chromosomal translocations without proper cell signaling of the error.
B. BLOOMSYNDROME AND DNA LICASEDEFICIENCY Candidate proteins for DNA repair and V(D)J recombination deficiency may be found from known proteins with well-characterized properties. Bloom syndrome patients are immunodeficient, have numerous chromosome abnormalities, and have accelerated risk to cancer. Molecular phenotypes of Bloom syndrome (BS) cells have indicated that DNA ligase I activity is reduced and thermolabile (Table 11). Also, BS cells have an inordinately high frequency of sister chromatid exchange and broad sensitivity to a variety of DNA damaging agents. As such, it was anticipated that a DNA ligase activity may also be required for completion of V(D)J recombination and DSB repair, and that defects in these processes niay occur when DNA ligase is mutated. Similarly, a patient with characterized D N A ligase mutations and <5% of the normal DNA ligase I activity (46BR) (Webster et al., 1992) was shown to be immunodeficient, have DNA replication and repair defects, and have a cancer prognosis (Barnes et al., 1992). Both BS and 46BR cells are normal for V(D)J recombination as measured with transient transfections of RAG 1, RAG2, and plasmid rearrangement substrates (Petrini et al., 1994). Therefore, abundant DNA ligase I activity is not required for V(D)J recombination. DNA ligase I is an essential gene for DNA metabolism; gene targeted insertion mutagene-
66
DAVID T. WEAVER
sis of the murine DNA ligase I in mouse ES cells can only be made homozygous for the knockout allele by expression of DNA ligase I ecotypically ( J. Petrini and D. Weaver, unpublished). VII. Immunodeficiency/DNA Repair Syndromes Affecting Cell Cycle Checkpoint Mechanisms
Several human immunodeficiency syndromes have reduced B and T cell populations, symptomatic DNA repair, and recombination alterations, but do not specifically lack accurate V(D)J recombination. These syndromes are variable immunodeficiencies in which the penetrance of the syndromes is not severe. Yet, the molecular basis of these deficiencies is expected to shed new light on control mechanisms of DNA repair and recombination processes with regard to cell-cycle controls. Changes in the regulation of these processes may underly the disregulation in the lymphoid populations leading to increased risk of malignancies.
A.
P53-DEPENDENT
PATHWAYS
The growth and division of eukaryotic cells are highly regulated by diverse growth control mechanisms of positive and negative influence throughout the cell cycle. Cell cycle arrests occur in response to ionizing radiation and other forms of DNA damage (reviewed by Hartwell and Weinert, 1989; Hartwell, 1992). A cardinal feature of these adaptive responses is that they are transitory; cells signaled to arrest by DNA damage reenter the cell cycle following an arrest phase. As such, these checkpoint mechanisms are a response-inducible system in which the genome can be surveyed and repaired for damage that would otherwise be catastrophic prior to important cell cycle events such as DNA synthesis and mitosis. The lack of detection of cell cycle progression signals has gained prominence as a factor in promoting tumorigenesis through new findings with a p53 pathway. The tumor suppressor gene, p53, is the most commonly mutated gene in human neoplasia (Hollstein et al., 1991). Patients that inherit a mutant p53 allele from one parent (Li-Fraumeni syndrome) are susceptible to high rates of tumor formation, particularly lymphoreticular cancers (Malkin et al., 1990; Srivasta et al., 1990; Vogelstein, 1990; Lane and Benchimol, 1990).Although Li-Fraumeni patients are not overtly immunodeficient, the wild-type copy of p53 may be sufficient for checkpoint regulation under most conditions. Immune cell metabolism may be notably vulnerable to the absence of p53 because of the high degree of DNA metabolism in these cells:
V(D)J KECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
67
V(D)J recombination, Ig isotype class switching, Ig VDJ somatic mutation, and D N A replication that must be completed accurately for the expansion, differentiation, and function of lymphocytes. The molecular functions of p53 have been a subject of intense scrutiny. p53 is not required for cell division because knockout mutations of p53 in the germline are not cell lethal and do yield homozygous p53-/- animals as normal. p53-/- mice, however, have a high frequency of spontaneous tumor formation, a property in coninion with Li-Fraumeni patients (Li and Fraumeni, 1969; Li e t ul., 1989; Donehower et al., 1992).p53-l- mice are also susceptible to the onset of lymphoreticular tumors. The presence of wild-type p53 is correlated with the ability of cells to induce a G1-S phase arrest (Mercer et al., 1990; Baker et al., 1990; Diller e t al., 1990; Ginsberg e t al., 1991). Wild-type p53 levels increase in response to DNA damage (for review see Hartwell, 1992; Maltznian and Czyzyk, 1984; Kastan et al., 1991,1992; Kuerbitz et al., 1992). Mutated p53 or an inability to accumulate wild-type p53 both override this arrest mechanism (Kern et al., 1992; Kuerbitz et al., 1992; Dulic et al., 1994). Wild-type p53 is an activator of transcription (Kern e t al., 1991; Funk et d., 1992; Farmer e t d., 1992), and several genes that are negative regulators of growth have been identified that are p53responsive ( p21WAF1.C'P, CADD45, MDMB) (Xiong e t al., 1993; ElDeiry et al., 1993; Harper e t al., 1993; Momand et al., 1992; Kastan et aZ., 1992). Mutated p53 is unable to activate the transcription of downstream effector genes that may either complete the cell cycle arrest and/or allow the DNA repair mechanisms to complete the business of repair prior to reentry into the G l / S transition. Thus, p53 is a key player in the signal transduction mechanism of the G1 DNA damage-induced checkpoint pathway. This signaling pathway must be relevant to regulatory events in the cell cycle that may impact DNA damage repair and V( D)J recombination. B. ATAXIATELANGIECTASIA Ataxia telangiectasia (AT) is an immunodeficiency disease transmitted as an autosomal recessive mutation, where patients are variably immunodeficient, contain increased chromosome instability, and are highly susceptible to cancer (reviewed by Gatti et al., 1991; Gatti, 1993).As many as four separate AT complementation groups are found. The immunodeficiency of these patients affects both T and B cell populations. Ig profiles are most frequently deficient in IgA for AT, although other isotypes are also deficient in other A T patients. A T T cells respond poorly to PHA stimulation in culture. In the spectrum of
68
DAVID T. WEAVER
cancers for which AT patients are at great risk, lymphoid malignancies predominate. Several investigators have examined V(D)J recombination products in A T patient primary lymphocytes or in immortalized AT cell lines in culture. The basal V(D)J recombination mechanism is apparently normal, as assessed by transient transfection of AT cell lines with the V(D)J recombination activating genes RAG1, RAG2, and plasmid substrates (Hsieh et al., 1993; Pergola et al., 1993); N. Boubnov and D. Weaver, unpublished data). AT cells have normal DNA end-binding capacity (Rathmell and Chu, 1994; N. Boubnov and D. Weaver, unpublished data) which is the only other biochemical readout associated with appropriate V(D)J recombination that can currently be monitored. However, AT cells have highly elevated levels of illegitimate interlocus TCR rearrangements between TCRyV regions and TCR JP relative to normal individuals even though other Vy-Jy rearrangements are as normal (Lipkowitz et al., 1990). A clue to the connection between the AT defects and the V(D)J recombination pathway is found with AT lymphocytes where a very high frequency of Ig/TCR chromosomal translocations are observed (Hecht and Hecht, 1987; Rabbitts, 1993). I n particular, translocations and inversions of chromosome 7 and 14 at the sites of Ig and TCR gene rearrangement are found very frequently. A T patients that progress to T cell prolymphocytic leukemia and chronic lymphocytic leukemia often have a characteristic chromosome 14 rearrangement or inversion that first appears as a dominant T cell clone that is premalignant (Hollis et al., 1987; Heppell et al., 1988). These translocations exist prior to the malignant phenotype. Molecular mapping and characterization of these translocation and inversion breakpoints has revealed that they are complex and likely involve sequential rearrangements (Baer et al., 1987; Davey et al., 1988; Russo et al., 1988,1989; Stern et al., 1989). At least some of the translocation breakpoints occur at or near RSS (Russo et al., 1989; Davey et al., 1988; Mengle-Gaw et al., 1988). There is no compelling argument that these chromosomal rearrangements are catalyzed by V(D)J recombination defects per se. Another interesting fact is that these same chromosomal rearrangements are observed in normal individuals at 100-fold or lower frequency. The lymphoproliferative features of AT T cells may artificially augment differences between AT and normal patients. Yet, continual appearance of these aberrant rearrangement-associated translocations in A T patients are suggestive that the AT defects may not sense a chromosomal broken end once it occurs. A T cells are sensitive to ionizing radiation (Taylor et al., 1975). The
V(D)J RECOMBINATION A N D DOUBLE-STRAND BREAK REPAIR
69
IR sensitivity of AT cells is due to the DSBs, as is true for the murine scid mutation and other complementation groups (Table I). A T cells are also sensitive to X-ray mimetic agents, such as bleomycin and streptonigrin, and are sensitive to topoisomerase inhibitors such as etoposide V16. However, unlike these other DSB repair mutant complementation groups, AT cells are capable of repairing DSBs in shortterm assays in which scid, xrs, and XR-I are shown to be DSB repair deficient. These experiments led to the conclusion that AT cells may have the appropriate machinery for DSB repair, but that this mechanism is not properly activated or signaled. AT cells do not appear to recognize cell cycle DNA damage-induced checkpoints at the G1-S transition or in S or G2 phases (Painter and Young, 1980; Kastan et al., 1992). The A T lack of recognition is manifested as entry into the next cell-cycle phase before the DNA damage has been adequately repaired, leading to cell death in subsequent cell cycles. G1 phase AT cells go directly into S phase disregarding damage by IR (Dulic et al., 1994). In S phase AT cells treated with IR, DNA replication continues, termed radioresistant DNA synthesis (RRDS), a process that presumably irreversibly fixes DNA damage and/or chromosome instability (Painter and Young, 1972,1980). Thus, A T cells have several cardinal features indicating that AT complementation groups are checkpoint mutants. Patients have also been identified with some, but not all, of the clinical features of AT. Early studies with Nijmegen Breakage Syndrome (NjBS) patients showed similar immune system impairment as AT and a higher incidence of chromosome 7 and 14 translocations possibly at Ig and TCR rearrangement sites (Jaspers et al., 1987).The patient had no evidence of oculocutaneous telangiectasia or cerebellar ataxia, but did have niicrocephaly and growth delay that is not ordinarily characteristic of AT. NjBS fibroblasts are 1R sensitive and show RRDS, both features of AT. NJBS cells are able to complement A T cells for DNA repair defects which shows that NjBS represents distinct complementation groups. Because of the high phenotypic similarities, perhaps NJBS and AT are both involved in the same signaling pathway for DNA damage recognition. The AT checkpoint defect has significant ramifications for the immune system composed of rapidly proliferating cells undergoing DNA rearrangements. This property of several immune deficiency syndromes may also explain the variable nature of the immunodeficiencies in patients, the predelection of these cell populations to malignancy, and an inability to respond as part of the immune defense mechanism.
70
D A V I D T. WEAVER
VIII. Cell Cycle Regulation of V(D)J Recombination and DSB Repair
A. V(D)J RECOMBINATION AND THE CELLCYCLE V(D)J recombination may preferentially occur in G1 phase of the cell cycle. Recent experiments with antibodies against murine RAG2 indicate that RAG2 protein is 20-fold more abundant in G 1 cell cycle phase than in S, G2, or M for either pre-B cells or thymocytes (Lin and Desiderio, 1994). Both cell sources are active for V(D)J recombination. RAG2 protein is actively degraded by a mechanism similar to p53 inactivation, and p53 and RAG2 may be influenced by the same degradation pathway. The implications of these experiments are that V(D)J recombination probably occurs in G1 phase of the cell cycle. Future experiments will have to sort out whether the increased RAG2 protein levels in G1 are consistent with elevated recombinase activity in the cell. Studies with the transient transfection assay with plasmid gene rearrangement substrates in cell culture have illustrated that V(D)J recombination is not dependent on DNA replication. Nonreplicating plasmids, when transfected into RAGl/RAG2+ cells, are as efficient at V(D)J recombination as replicating plasmids (Hsieh, 1991; Petrini et al., 1994). Activation of recombination by heat-shock induction of RAGl and RAG2 expression vectors in murine B cells (Oltz et al., 1993) has also been used to show that plasmid V(D)J recombination occurs prior to DNA replication (N. Boubnov and D. Weaver, unpublished data). These experiments are consistent with a G 1 cell cycle window for the initiation and completion of V(D)J recombination. It seems logical that V(D)J recombination events would be completed in the same cell cycle stage as they were initiated because DNA replication through broken DNA at V(D)J recombination sites may well be mutagenic or lethal (Fig. 4). Broken DNA ends have been implicated as an intermediate in V(D)J recombination based on the correlation oftheir appearance with RAGl and RAG2 activation (Schlissel et al., 1993; Roth et al., 1993). Interestingly, Ig Jh RSS ends are observed in cells that are in GO/Gl of the cell cycle, and not S or G2 (Schlissel et al., 1993), which is consistent with RAG2 protein abundance. Also, Jh RSS ends are observed in cells from scid bone marrow at wild-type levels, which is consistent with the notion that scid V(D)J recombination events initiate properly but cannot form coding junction products. Coding ends are not detectable by this assay from wild-type cells (Schlissel et al., 1993).
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
S
G1
w t
--
71
J
V
arrest
--x scid adaplatlon
deletlons and translocations
FIG.4. Cell-cyle checkpoint mechanism and cell mutant errors in V(D)J recomhination. Th e appearance of V(D)J recombination intermediates in G1 phase of the cell cycle is diagrammed. Wt, wild-type cells that produce broken DNA at low levels in the V(D)J rearrangement pathway. Errors of this type presumably cause a cell cycle arrest (X) in parallel to IR chromosome damage. Scid,the murine scid mutation may accumulate hairpin intermediates at V(D)J recombination coding ends. Hairpins either generate a cell cycle arrest or by adaptation, progress to the next cell cycle phase, S ( D N A synthesis). DNA replication forks in the vicinity of hairpin-ended DNA are shown. xrs, AT, mutations in the xrs complementation group or in ataxia telangiectasia (AT) may be unable to recognize broken DNA resulting from V(D)Jrecombination. Either mutant allows passage to S phase.
B. V(D)J RECOMBINATION/DSB REPAIRMUTANTSAND CELLCYCLEARREST Scid cells are highly sensitive to IR damage, but these cells appear to recognize cell cycle IR-induced checkpoints as normal. In S phase scid fibroblasts arrest DNA synthesis as do wild-type cells (Komatsu et al., 1993). V-3 cells, in the same complementation group as scid, have been examined for the cell cycle position of their radiosensitivity (Whitmore et al., 1989). V-3 cells are sensitive to IR in GI but not in S/G2. In contrast, rrs cells appear to vary in the level of sensitivity to IR damage with regard to checkpoint control in S phase. rrs-1,2,4,6, and -7 mutants have a prolonged inhibition of DNA synthesis following IR damage in S phase (Jeggo, 1985). The rrs-5 mutant is indistinguishable from the parental CHOKl cells with regard to RRDS. xrs-5 and other xrs mutants are similar in other DNA repair and recombination
72
DAVID T. WEAVER
phenotypes. A prolonged inhibition of DNA synthesis is the opposite phenotype to that which is observed in cells from AT and NjBS patients. Athough cell cycle arrest points have not specifically been examined for the XR-I mutation, XR-I cells are extremely sensitive to IR damage in the G1 cell cycle phase (Giaccia et d., 1990).G1 phase of the cell cycle has greater than a 10-fold hypersensitivity to IR as opposed to late S phase. It is not yet clear whether or not XR-I cells will bypass a DNA damage checkpoint. Synchronized cells at these two stages also differ significantly in ability to repair y-ray-induced DSBs as measured by a short-term neutral filter elution assay (Giaccia et d.,1990). Late S phase cells, that may be indistinguishable from G2 by these assays, have the same kinetics of DSB repair as the parental cell controls. xrs mutants also examined for DSB repair in short-term assays are indistinguishable from the controls (Kemp et al., 1984).Thus, there may be a distinction between the machinery for DSB repair at different cell cycle times. In S and G2, a likely mechanism would be recombinational repair (from sister chromatids). In G1, a sister chromatid is not present, and the efficiency of utilization of the chromosome homolog may not be high enough to allow efficient recombinational repair. Under G1 “conditions” DSB repair by a nonhomologous recombination or end-joining process may be prominent. The G1-radiosensitive phenotype of XR-I and scid may be indicative of the enzymology required for this process. Two of the xrs mutants that show prolonged S phase arrest also have been examined for other checkpoints by FACS analysis of asynchronous populations. xrs-2 and xrs-4 show a pronounced G2 arrest that may be irreversible under the conditions of the assay (Weibezahn et al., 1985). The G2 arrest of xrs mutants may point to defects in the recognition properties of the DNA damage checkpoint. The absence of ~ 8 2 would ~ ” not be expected to allow DNA-PK to associate with DNA ends. Barring tethering of DNA-PK association, phosphorylation of yet unidentified DNA-PK substrates in G2 may prevent processing of the DNA damage signaI to arrest cell-cycle progression. The G2 checkpoint may not be significant for V(D)J recombination. C. How MIGHTV(D)J RECOMBINATION/DSBR MUTANTSLEADTO CHROMOSOME ERRORS? Cell cycle checkpoint errors could broadly explain the origin of defects resulting from V(D)J recombination for several of the V(D)J recombination/DSB repair mutants identified in mice, cell culture, or human syndromes (Fig. 4). Recognition of broken DNA as a stage in
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
73
the V(D)J recombination mechanism may be a means to signal the cell to arrest the cell cycle for a sufficient time to allow DSBs to be repaired. If this process was interrupted b y mutation, then chromosomal breakage initiated by the correct initiation of V(D)J recombination may lead to errors eventually resulting in translocations. In this model, DNA breaks associated with V(D)J recombination intermediates and/or errors would occur in G1 phase of the cell cycle (Fig. 4, wt). The presence of broken molecules would lead to cell cycIe arrest until repair can be completed. This process would be expected to be mediated by Ku complexes. Three mutant outcomes can be considered. In the scid case, an enzymatic step of V( D)J recombination is modified or lost, whereas the signaling mechanism is normal (Fig. 4). Scid rearrangement events may generate, but not resolve, hairpins as discussed above. Consequently, hairpin ends may or may not be recognized by a DNA damage checkpoint mechanism. This issue is yet to be answered by experimentation. If hairpins do arrest the cell cycle, then the scid cells will be irreversibly blocked unless hairpin DNA is resolved by another means. Extensive deletion may result by default utilization of a secondary and less-favored pathway that leads to chromosome deletion. Usage of a secondary pathway to overcome a cellcycle checkpoint (adaptation) is a standard feature of checkpoint pathways. In the specialized case of precursor lymphocytes undergoing gene rearrangement, an excessive loss of DNA in Ig or TCR loci is not deleterious since no essential genes are localized in these regions, and the deletion can be tolerated. For repair of IR damage, extensive deletion of chromosomal material may not be tolerated. Alternatively, chromosomal hairpin ends may be unrecognizable as a DNA damage arrest signal. Thus, unresolved hairpins will pass into S phase; DNA replication through these structures would presumably be accompanied by excessive deletion. In the A T case, the enzymology of V(D)J recombination is intact, but the means of signaling mistakes might be mutated (Fig. 4). In this scenario, no unusual DNA products are involved. Instead, broken DNA ends that ordinarily arise in a low level in the normal pathway become recombinogenic for translocations by being unable to signal cell-cycle arrest in a p53-dependent manner. In the xrs case, DNA ends may not be properly held together (Fig. 4). The xrs defect would potentially be compounded by also losing the signaling pathway of a cell cycle arrest checkpoint from G1-S. Checkpoint mutants, such as xrs, do lead to faulty processing of double-strand breaks of coding and signal ends. Because the same protein is involved in both the regular
74
DAVID T. WEAVER
joining of these ends and the cell cycle arrest at DNA damage checkpoints, a dual error would be invoked. Ku binds to hairpins in uitro as efficiently as to DNA ends (Paillard and Straws, 1991; Falzon et ul., 1993), but no experiments have yet examined whether there is a DNA-PK activation that may actually serve as the signal transducer for DNA chromosomal breaks.
ACKNOWLEDGMENTS I thank menihers of the laboratory for many fruitful discussions and ideas. Many thanks to colleagues in the field who have shared results and manuscripts prior to publication and a special thanks to John Petrini for his critical reading and helpful comments.
REFERENCES Aguilar, L., and Belmont, J. W. (1991).Vyp T cell receptor rearrangement and expression in the adult thymus. I . Immunol. 146, 1348-1352. Akira, S., Okazaki, K., and Sakano, H. (1987). Two pairs of recombination signals are sufficient to cause immunoglobulin V-(D)-J joining. Science 238, 1134-1 138. Allison, J., and Havran, W. L. (1991). T h e immunobiology of T cells with invariant gd antigen receptors. Annu. Rev. Immunol. 9, 679-705. Alt, F. W., Oltz, E. M., Young, F., Gorman, J., Taccioli, G., and Chen, J . (1992).V(D)J recombination. Zmrnunol. Today 13,306-314. Anderson, C. W. (1993).DNA damage and the DNA-activated protein kinase. TIBS 18, 433-437. Asarnow, D., Goodman, T., LeFrancois, L., and Allison, J. (1989). Distinct antigen receptor repertoires of two classes of murine epithelium-associated T cells. Nature 341,60-62. Asarnow, D. M., Cado, D., and Haulet, D. H. (1993).Selection is not required to produce invariant T-cell receptor y-gene junctional sequences. Nature 362. 158-160. Baer, R., Forster, A,, and Habhitts, T. H. (1987). T h e mechanism of chromosome 14 inversion in a human T cell lymphoma. Cell 50,97-105. Baer, H., Heppell, A., Taylor, A. M. R., Hahbitts, P. H., Boullier, B., and Rabhitts, T. H. (1987).Th e breakpoint of an inversion of chromosome 14 in a T-cell leukemia: Sequences downstream of the immunoglobulin heavy chain locus are implicated in tumorigenesis. Proc. Natl. Acad. Sci. USA 84, 9069-9073. Baker, S. J., Markowitz, S., Fearon, E. H., Willson, J. K., and Vogelstein, B. (1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249,912-915. Banga, S., Hall, K., Sandhu, A., Weaver, D., and Athwal, H. (1994). Complementation of V(D)J recombination defect and x-ray sensitivity of scid mouse cells by human chromosome 8. Mutat. Res., in press. Barnes, D. E., Tomkinson, A. E., Lehmann, A. R., Wehster, A. D.. and Lindahl, T. (1992). Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents. Cell 69(3), 495-503. Beyert, N., Reichenberger, S., Peters, M., Hartung, M., Vielmetter, W., Goedecke, W., and Pfeiffer, P. (1994). Nonhomologous DNA en d joining of synthetic hairpin substrates in Xenopus laevis egg extracts. Nocl. Acids Res., 22, 1643-1650. Biedermann, K. A., Sun, J., Giaccia, A. J., Tosto, L. M., and Brown, J. M. (1991). scid
V(D)J RECOMBINATION A N D DOUBLE-STRAND BREAK REPAIR
75
mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc. Nutl. Acad. Sc i. USA 88, 1394-1397. Blier, P. R., Griffith, A. J., Craft, J., and Hardin, J. A. (1993). Binding of Ku protein to DNA-Measurement of affinity for ends and demonstration of binding to nicks. J . B i d . Ch em. 268, 7594-7601. Bosnia, G., Davisson, ha., Ruetsch, N., Seweet, H., Shultz, L., and Bosnia, M . (1989). T h e inurine mutation severe combined immune deficiency (scid) is on chromosome 16, Znimtcnogerietics 29, 54-57. Bosnia, G. C., Custer, R. P., and Bosnia, M. J. (1983).A severe combined ininiunodeficieticy mutation in the mouse. Nature 301, 527-530. Bosnia, M . , and Carroll, A. (1991).The Scid tnoitse mutant: Definition, characterization, and potential uses. Annrc. Recj. Itnniunol. 9, 323-350. Boubnov, N . V., Wills, Z. P., and Weaver, D. T . (1993). V(D)J recombination coding junction forniation without DNA homology: Processing of coding termini. Mol. Cell. B i d . 13, 6957-6968. Boubnov, N . V., Wills, Z. P., and Weaver, D. T. (1994a).Coding sequence composition Hanking either signal element alters V(D)J recombination efficiency. Submitted for publication. Boubnov, N. V., Hall, K. T., Wills, Z. P., Lee, S. E., He, D. M., Benjamin, D . M., Pulaski, C . R., Band, H., Reeves, W., Hendrickson, E. A., and Weaver, D. T. (1994b). Cotnplementation of the ionizing radiation DNA end binding, and V(D)J recombination defects of double-strand break repair mutants by the p86"' autoantigen, in press. Boubnov, N. V., Wills, Z. P., Hall, K. T., Lee, S . E., Hendrickson, E. A., and Weaver, D. T. (1994~). Restoration of DNA end-binding, ionizing radiation, and V(D)J recombination defects of the sxil mutant by the p70'" autoantigen. (in preparation). Cai, 0. Q., Plet, A,, Imbert, J., Lafagepochitaloff, M., Cerdan, C., and Blanchard, J. M. (1994).Chromosomal location and expression of the genes coding for Ku p70 and p80 in hunian cell lines and normal tissues. Cytogen. Cell Genet. 65, 221-227. Caldecott, K.,Banks, G., and Jeggo, P. (1990).DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase 11. Cancer Res. 50, 5778-5783. Carter, T. H., Vancurova, I. S., Lou, I. W., and DeLeon, S . P. (1990).A DNA-activated protein kinase from HeLa cell nuclei. Mol. Cell. B i d . 10, 6460-6471. Cavazzana-Calvo, hl., L e Deist, F., D e Saint Basile, G . , Papadopoulo, D., D e Villartay, J. P., and Fischer, A. (1993). Increased radiosensitivity of granulocyte macrophage colony-fornming units and skin fibroblasts in human autosonial recessive severe combined intmunodeficiency. J . Clin. Inuest. 19, 1214-1218. Chang, C., Biederman, K., Mezzina, M., and Brown, J. M . (1993). Characterization of the DNA double strand break repair defect in scid mice. Caticer Res. 53, 1244-1248. Chen, J . , Lansford, R., Stewart, V., Young, F., arid Alt, F. W. (1993). Rag-2-deficient blastocyst complementation: An assay of gene function in lymphocyte development. Proc. Not!. A w d . Sci. USA 90, 4528-4532. Chen, J , , Young, F., Bottaro, A,, Stewart, V., Smith, R . K., and Alt, F. W. (1993).Mutations of the intronic IgH enhancer and its Hanking sequences differentially affect accessibility of the J H locus. E M B O J. 12, 4635-4645. Chien, Y., Iwashirna, M., Wettstein, D., Kaplan, K., Elliott, J., Born, W., and Davis, M. (1987).T-cell receptor 6 gene rearrangements in early thymocytes. Nature 330, 722-727. Coverley, D., Kenny, M. K., Miinn, M., Rupp, W. D., Lane, D. P., and Wood, R. D . (1991).Requirement for the replication protein SSB in human DNA excision repair. Nutitre 349, 538-541.
76
DAVID T. WEAVER
Davey, M., Bertness, V., Nakahara, K., Johnson, J . P., McBride, W., Waldmann, T. A., and Kirsch, I. R. (1988).Juxtaposition of the T-cell receptor a-chain locus (14qll) and a region (14q32) of potential importance in leukemogenesis by a 14; 14 translocation in a patient with T-cell chronic Iyniphocytic leukemia and ataxia-telangiectasia. Proc. Nutl. Acud. Sci. USA 85,9287-9291. De Saint-Basile, G., Le Deist, F., De Villartay, J. P., Cerf-Bensussan, N., Journet, O., Brousse, N., Griscelli, C., and Fischer, A. (1991). Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn’s Syndrome). J. Clin. Inuest. 87, 1352-1359. deVries, E., van Driel, W., Bergsma, W. G., Arnberg, A. C., and van der Vliet, P. C. (1989). HeLa nuclear protein recognizing DNA termini and translocating on DNA forming a regular DNA-multimeric protein complex. J. Biol. Chem. 208, 65-78. Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., Vogelstein, B., and Friend, S. H. (1990). p53 functions as a cell cycle control protein in osteocarcomas. Mol. Cell. Biol. 10, 5772-5781. Disney, J., Barth, A. L., and Schultz, L. D. (1992). Defective repair of radiation-induced chromosomal damage in scid/scid mice. Cytogen. Cell Genet. 59,39-44. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A. J., Butel, J. S., and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaenous tumours. Nature (London) 356, 215-211. Drayna, D., Leach, R., and Wood, S. (1993). Workshop on human chromosome 8 mapping 1993. Dulic, V., Kaufinann, W. K., Wilson, S . J., Tlsty, T. D., Lees, E., Harper, J. W., Elledge, S. J., and Reed, S. I. (1994). p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G I arrest. Cell 76,1013-1023. Dvir, A., Stein, L. Y., Calore, B. L.,and Dynan, W. S. (1993).Purification and characterization of a template-associated protein kinase that phosphorylates RNA polymerase 11. J. Biol. Chern. 268, 10440-10447. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825. Fairman, M. P., Johnson, A. P., and Thacker, J. (1992).Multiple components are involved in the efficient joining of double stranded DNA breaks in human cell extracts. Nucl. Acids Res. 20(16), 4145-4152. Falzon, M., Fewell, J. W., and Kuff, E. L. (1993). EBP-80, a transcription factor closely resembling the human autoantigen Ku, recognizes single- to double-strand transitions in DNA. J . Biol. Chem. 268, 10546-10552. Falzon, M., and Kuff, E. (1992). Nucleotide sequence o f a mouse cDNA encoding the 80 kDa subunit of the Ku (p70/p80) autoantigen. Nucl. Acids Res. 20, 3784. Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., and Prives, C. (1992). Wild-type p53 activates transcription in vitro. Nature 358, 83-86. Feeney, A. (1990). Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences. J. E x p . Med. 172, 1377-1390. Feeney, A. (1991). Predominance of the prototypic T15 anti-phosphorylcholine junctional sequence in neonatal pre-B cells. J. Irnrnunol. 147,4343-4350. Feeney, A. J. (1992). Predominance of VH-D-JH junctions occurring at sites of short sequence homology results in limited junctional diversity in neonatal antibodies. J . Immunol. 149,222-229. Fulop, G. M., and Phillips, R. A. (1990). The scid mutation in mice causes a general defect in DNA repair. Nature 347, 479-482.
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
77
Funk, W. D., Pak, D. T., Karas, R. H., Wright,W. E., and Shay, J. W. (1992).Atranscriptionally active DNA-binding site for human p53 protein complexes. M o l . Cell. B i d . 12, 2866-287 1. Gatti, R. (1993).Ataxia-telangiectasia: Genetic studies. I n “New Concepts in Immunodeficiency Diseases” (S. Gupta and C . Griscelli, Eds.), pp. 203-229. Wiley, New York. Gatti, R., Boder, E., Vinters, H. V., Sparkes, R. S . , Norman, A,, and Lange, K. (1991). Ataxia-telangiectasia: An interdisciplinary approach to pathogenesis. Medicine 70, 99- 117. Gauss, C., and Lieber, M. (1993). Unequal signal and coding joint formation in human V(D)J recombination. Mol. Cell. B i d . 13, 3900-3906. Gellert, M. (19924. Molecular analysis of V(D)J recombination. Annu. Reo. Genet. 22, 425-446. Gellert, M . (1992b). V(D)J recombination gets a break. TIC 8, 408-412. Gerstein, H. M., and Lieber, M. R. (1993a). Coding end sequence can markedly affect the initiation of V(D)J recombination. Genes Deo. 7, 1459-1469. Gerstein, R. M., and Lieber, M. R. (1993b). Extent to which homology can constrain coding exon junctional diversity in V(D)J recombination. Nature 363, 625-627. Getts, R. C., and Stamato, T. D. (1994).Absence ofa Ku-like DNA end-binding activity in the xrs double-strand DNA repair-deficient mutant. J. B i d . Chem. 269, 15981-15984. Giaccia, A., Weinstein, R., Hu, J., and Stamato, T. D. (1985). Cell cycle-dependent repair of double-strand DNA breaks in a gamma-ray-sensitive Chinese hamster cell. Somat. Cell Mol. Genet. 11(5), 485-491. Giaccia, A., MacLaren, R. A,, Denko, N., Nicolaou, D., and Stamato, T. D. (l990a). Increased sensitivity to killing by restriction enzymes in the XR-1 DNA double-strand break repair-deficient mutant. Mutat. Res. 236, 67-76. Giaccia, A. J., Denko, N., MacLaren, R . , Mirman, D., Waldren, C., Hart, I., and Stamato, T. D. (l990b). Human chromosome 5 complements the DNA double-strand breakrepair deficiency and gamma-ray sensitivity of the XR-1 hamster variant. Am. J. Hum. Genet. 47, 459-469. Gilfillan, S . , Dierich, A., Lenieur, M., Benoist, C., and Mathis, D. (1993).Mice lacking TdT: Mature animals with an immature lymphocyte repertoire. Science 261, 1175-1 178. Cinsberg, D., Michael-Michalovitz, D., Ginsberg, D., and Oren, M. (1991). Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Mol. Cell. Biol. 11,582-585. Goto, M., Rubenstein, M., Weber, J. Woods, K., and Drayna, D. (1992). Genetic linkage of Werner’s syndrome to five markers on chromosome 8. Nature 355, 735-738. Gottlieb, T. M., and Jackson, S. P. (1993).The DNA-dependent protein kinase: Requirement for DNA ends and association with KU antigen. Cell 72, 131-142. Gu, H . , Foster, I., and Rajewsky, K. (1990). Sequence homologies, N sequence insertion and Jrrgene utilization in VHDJH joining: Implications for the joining mechanism and the ontogenetic timing of Lyl B cell and B-CLL progenitor generation. E M B O J. 9, 2 133-2 140. Hafezparast, M., Kaur, G. P., Zdzienicka, M., Athwal, R. S., Lehmann, A. R., and Jeggo, P. A. (1993).Subchromosomal localization of a gene (XRCC5) involved in doublestrand break repair to the region 2q34p36. Somat. Cell Genet. 19, 413-421. Halligan, B. D. (1993). A new protein motif found in DNA joining and DNA binding proteins. Nucl. Acids Res. 21, 5520-5521. Halligan, B. D., Teng, M., Guilliams, T. G., and Halligan, N. L. N. (1994). A protein related to niurine replication factor C has site specific DNA joining. in press.
78
DAVID T. WEAVER
Hamilton, A. A., and Thacker, J. (1987).Gene recombination in X-ray-sensitive hamster cells. Mol. Cell. Biol. 7(4), 1409-1414. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. (1993).Th e p21 Cdk-interacting protein C i p l is a potent inhibitor of G 1 cyclin-dependent kinases. Cell 75, 805-816. Harrington, J., Hsieh, C.-L., Gerton, J., Bosma, G., and Lieber, M. R. (1992). Analysis of the defect in DNA end joining in the murine scid mutation. Mol. Cell. B i d . 12. 4758-4768. Hartwell, L. (1992). Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71, 543-546. Hartwell, L. H., and Weinert, T. A. (1989). Checkpoints: Controls that ensure the order of cell cycle events. Science 246, 629-634. Hecht, F., and Hecht, B. K. M. (1987).Chromosome changes connect immunodeficiency and cancer in ataxia-telangiectasia. Am. J . Pediatr. Hemutol. Oncol. 9, 185-188. Hendrickson, E. A. (1994).T h e scid mouse-Relevance as an animal model system for studying human disease. Am. J . Pathol. 143, 1511-1522. Hendrickson, E. A., Qin, X.-Q., Bump, E. A., Schatz, D. G., Oettinger, M . , and Weaver, D. T. (1991).A link between double-strand break-related repair and V(D)J recombination: T h e scid mutation. Proc. Natl. Acad. Sci. USA 88,4061-4065. Hendrickson, E. A., Schatz, D. G., and Weaver, D. T. (1988). The scid gene encodes a trans-acting factor that mediates the rejoining event of Ig gene rearrangement. Genes Deu. 2,817-829. Hendrickson, E. A., Schlissel, M. S., and Weaver, D. T . (1990).Wild-type V(D)J recombination in scid pre-B cells. Mol. Cell. Biol. 10(10), 5397-5407. Henner, W. D., Grunberg, S . M., and Haseltine, W. A. (1983). Enzyme action at 3' termini of ionizing radiation-induced DNA strand breaks. J . Biol. Chem. 258(24), 15198- 15205. Heppell, A., Butterworth, S. V., Hollis, R. J., Kennaugh, A. A., Betty, D. W., and Taylor, A. M. R. (1988). Breakage of the T cell receptor achain locus in moon malignant clones from patients with ataxia telangiectasia. Hum. Genet. 79, 360-364. Hesse, J. E., Lieber, M . R., Mizuuchi, K., and Gellert, M. (1989).V(D)J recombination: A functional definition of the joining signals. Genes Deu. 3, 1053-1061. Hollis, R. J,, Kennaugh, A. A., Butterworth, S. V., and Taylor, A. M. R. (1987). Growth of large chromosomally abnormal T cell clones in ataxia telangiectasia patients is associated with translocation at 14ql1. Hum. Genet. 76, 389-395. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. (1991). p53 mutations in human cancers. Science 253, 49-53. Hsieh, C., McCloskey, R., Radany, E., and Lieber, M. (1991). V(D)J recombination: Evidence that a replicative mechanism is not required. Mol. Cell. Biol. 11,3972-3977. Hsieh, C. L., Arlett, C., and Lieber, M . R. (1993).V(D)J recombination in ataxia telangiectasia, Bloom's syndrome, and a DNA Ligase I-associated immunodeficiency disorder. J . B i d . Chem. 268,20105-20109. Ichara, Y., Hayashida, H., Miyazawa, S., and Kurosawa, Y. (1989). Only DFL16, DSP2, and DO52 gene families exist in mouse immunoglobulin heavy chain diversity gene loci, of which DFL16 and DSP2 originate from the same primordial D H gene. Eur. 1. Zmmunol. 19, 1849-1854. Ichikara, Y., Matsuoka, H., Tsuge, T., Okada, J., Torii, S., Yasui, H., and Kurosawa, Y. (1988). Abnormalities in DNA rearrangements of immunoglobulin gene loci in precursor B cells derived from a X-linked agammaglobulinemia patient and a severe combined immunodeficiency patient. Inmunogenetics 27,330. Itohara, S., Mombaerts, P., Lafaille, J., Iacomini, J., Nelson, A., Clarke, A. R., Hooper, M.
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
79
L., Farr, A., and Tonegawa, S. (1993).T cell receptor gene mutant mice: Independent generation of ap T cells and progranuned rearrangements of78 TCR genes. Cell 72, 337-348. Jackson, S. P., MacDonald, J. J., Lees-Miller, S . , and Tjian, R. (1990). G C box binding induces phosphorylation of S p l by a DNA-dependent protein kinase. Cell 63, 155- 165. Jaspers, N. G. J., Roza, L., Vermeulen, W., Eker, A., Taalnian, R. D. F. M., Hoeijniakers, J. H. H., and Bootsma D. (1987). I n vitro correction ofcells from patients with mutagen hypersensitivity. I n “DNA Damage and Repair” (A. Castellani, Ed.). Plenum Press, New York. Jeggo, P., Hafezparast, M., Thompson, A. F., Broughton, B. C., Kaur, G. P., Zdzienicka, M. Z., and Athwal, R. S.(1992).Localization o f a DNA repair gene (XRCC5) involved in double-strand-break rejoining to human chromosome 2. Proc. Natl. Acad. Sci. USA 89,6423-6427. Jeggo, P., Hafezparast, M., Thompson, A. F., Kaur, G . P., Sandhu, A. K., and Athwal, R. S. (1993).A hamster-human subchromosomal hybrid cell panel for chromosome 2. Somut. Cell Mid. Genet. 19,39-49. Jeggo, P. (1990). Studies on mammalian mutants defective in rejoining double-strand breaks in DNA. Mutat. Res. 239, 1-16. Jeggo, P. A. (1985).X-ray sensitive mutants of Chinese hamster ovary cell line: Radiosensitivity of DNA synthesis. Mutat. Res. 145, 171-176. Jeggo, P. A,, Caldecott, K., Pidsley, S., and Banks, G. (1989). Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase I1 inhibitors. Cancer Res. 49, 7057-7063. Jeggo, P. A., and Kemp, L. M. (1983).X-ray-sensitive mutants ofChinese hamster ovary cell line. Isolation and cross-sensitivity to other DNA-damaging agents. Mutat. Res. 112,313-327. Jessberger, R., and Berg, P. (1991). Repair of deletions and double-strand gaps by homologous recombination in a mammalian in vitro system. Mol. Cell. Biol. 11, 445-457. Jessberger, R., Podust, V., Hubscher. U., and Berg, P. (1993). A mammalian protein coniplex that repairs double-strand breaks and deletions by recombination. J . Biol. Chem. 268, 15070-15079. Jessberger, R., Riwar, B., Rolink, A., and Rodewald, H.-R. (1994). A protein which rescues a recombination deficiency in SCID lymphocyte extracts. Proc. Natl. Acad. Sci. USA submitted for publication. Jones, N. J., and Thacker, J. (1988).Six complementation groups for ionising-radiation senstivity in Chinese hamster cells. Mutat. Res. 193, 139-144. Kapp, D., and Smith, K. (1970).Chemical nature of chain breaks produced in DNA by X-irradiation in vitro. Rudiut. Res. 42, 34-49. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, J. A. J. (1992).A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia. Cell 71, 587-597. Kenip. L. M., Sedgwick, S. G., and Jeggo, P. A. (1984).X-ray senstivie mutants ofChinese hamster ovary cells defective in double-strand break rejoining. M u t o t . Res. 132, 189- 196. Kern, S. E., Kinzler, D. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C, and Vo-
80
DAVID T. WEAVER
gelstein, B. (1991).Identification of p53 as a sequence-specific DNA-binding protein. Science 252, 1708-1711. Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinzler, K. W., and Vogelstein, B. (1992). Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256,827-830. Kienker, L., Kuziel, W., and Tucker, P. (1991). T cell receptor y and 6 gene junctional sequences in SCID mice: Excessive P nucleotide insertion.]. E x p . Med. 174,769-773. Kirchgessner, C. U., Tosto, L. M., Biederman, K. A,, Kovacs, M., Araujo, D., Stanbridge, E. J,, and Brown, J. M. (1993).Complementation of the radiosensitive phenotype in severe combined immunodeficient mice by human chromosome 8. Cancer Res. 53, 6011-6016. Kitamura, D., Roes, J., Kuhn, R., and Rajewsky, K. (1991). A B cell-deficient mouse by targeted disruption of the membrane exon of immunoglobulin p chain gene. Nature 350,423-4426. Komatsu, K., Ohta, T., Jinno, Y., Niikawa, N., and Okumura, Y. (1993a). Functional complementation in mouse-human radiation hybrids assigns the putative murine scid gene to the pericentric region of human chromosome 8. Hum. Mol. Genet. 2, 1031-1034. Koniatsu, K., Yoshida, M., and Okumura, Y. (1993b). Murine scid cells complement ataxia-telangiectasia cells and show a normal post-irradiation response of DNA synthesis. Znt. ]. Radiat. Biol. 63, 725-730. Komori, T., Okada, A,, Stewart, V., and Alt, F. W. (1993).Lack of N regions in antigen receptor variable region genes ofTdT-deficient lymphocytes. Science261,1171-1175. Korsmeyer, S. J. (1992). Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu. Reo. Zmmunol. 10, 785-807. Kuerbitz, S., Plunkett, B., Walsh, W., and Kastan, M. (1992). Wildtype p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89, 7491-7495. Kurimasa, A., Nagata, Y., Shimizu, M., Emi, M., Nakamura, Y., and Oshimura, M. (1993). A human gene that restores the DNA-repair defect in scid mice is located on 8 p l l . l qll.1. Hum. Genet. 93,21-26. Lafaille, J. J., DeCloux, A., Bonneville, M., Takagaki, Y., and Tonegawa, S. (1989). Junctional sequences of T cell receptor y6 genes: Implications for y6 T cell lineages and for a novel intermediate of V-(D)-J joining. Cell 59, 859-870. Lane, D. P., and Benchimol, S. (1990). p53: Oncogene or anti-oncogene. Genes Deo. 4, 1-8. Lee, S. E., Pulaski, C. R., Voss, M. J., Um, J., He, D. M., Karpinski, E. R., Rhew, E. Y. M., and Hendrickson, E. A. (1994). Isolation and characterization of four mammalian cell mutants generated by insertional niutagenesiss that are x-ray sensitive and defective in DNA double-strand break repair. Submitted for publication. Lees-Miller, S. P., Chen, Y., and Anderson, C. W. (199O).Human cells contain a DNAactivated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol. Cell. Biol. 10, 6472-6481. Lees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E., and Anderson, C. W. (1992). Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. B i d . 12, 50415049. Lewis, S., and Gellert, M. (1989). The mechanism of antigen receptor gene assembly. Cell 59,585-588. Lewis, S. M. (1994). P Nucleotide insertions, and the resolution of hairpin DNA structures in mammalian cells. Proc. Natl. Acad. Sci. USA 91, 1332-1336.
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
81
Li, F. P., and Fraunieni, J. F. (1969). Rhabdomyosarcoma in children: Epidemiology study and identification of a familial cancer syndrome. J . N a t l . Cancer Znst. 43, 1365-1373. Li, F. P., Fraumeni, J. F., Mulnihill, J. J., Blattner, W. A., Dreyfus, M. G., Tucker, M. A., and Miller, R. W. (1988). A cancer family syndrome in twenty-four kindreds. Cancer Hes. 48, 5358-5362. Li, Z., and Alt, F. W. (1994). Recombination of chromosomal substrates in the C H O double-strand break repair mutant, XR-I. Submitted for publication. Lieber, M. R. (1991). Site-specific recombination in the immune system. FASEB J . 5, 2934-2944. Lieber, M. R., Messe, J. E., Lewis, S . , Bosma, G . C, Hosenberg, N., Mizuuchi, K., Bosnia, M. J., and Gellert, M. (1988a). The defect in niurine severe combined immune deficiency: Joining of signal sequences but not coding segments in V(D)J reconibination. Cell 55, 7-16. Lieber, M. R., Hesse, J. E., Mizuuchi, K., and Gellert, M. (1988b). Lymphoid V(D)J recombination: Nucleotide insertion at signal joints as well as coding joints. Proc. Natl. Acad. Sci. USA 85,8588-8592. Linipens, J., d e Jong, D., van Krieken, J., Price, C., Young, B., van Omnien, G., and Kluin, P. (1991). Bcl-2/JH rearrangenients in benign lymphoid tissues with follicular hyperplasia. Oncogene 6, 2271-2276. Lin, W.-C., and Desiderio, S. (1993). Regulation ofV(D)Jrecombination activator protein RAG-2 by phosphorylation. Science 260, 953-959. Lin, W.-C., and Desiderio, S. (1994). Cell cycle regulation of V(D)J recombination activating protein RAG-2. Proc. Natl. Acad. Sci. CJSA,91, 2733-2737. Lipkowitz, S., Stern, M. H., and Kirsch, 1. R. (1990). Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasia lymphocytes. J . E x p . bled. 172, 409-418. Liu, V., and Weaver, D. (1993). The ionizing radiation-induced replication protein A phosphorylation response differs between ataxis telangiectasia and normal human cells. M o l . Cell. Biol. 13, 7222-7231. Lu, Y., Zeft, A. S., and Reigel, A. T. (1993). Cloning and expression of a novel human DNA binding protein, PO-GA. Biochern. Bi0)Jhy.s. Res. Comtnun. 193, 779-786. Luckow, B., Bum, F., Stillman, B., Lichter, P., and Schutz, G. (1994). Cloning, expression, and chromosomal localization of'the 140-kilodalton subunit of replication factor C from mice and humans. Mol. Cell. Biol. 14, 16262-1634. Malkin, D., Li, F. P., Strong, L. C., Fraunieni, J. F., Nelson, C. E., Kim, D. H., Kassel, J.. Gryka, M. A , , Bischoff, F. Z., Tainsky, hl. A., and Friend, S. H . (1990). Gerniline p53 mutations in a faniilial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233-1238. Maltzman, W., and Czyzyk, L. (1984). UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. B i d . 4, 1689-1694. Malynn, B. A,, Blackwell, T. K., Fulop, G . M., Rathbun, G. A., Furley, A. J. Mi., Ferrier, P., Heinke, L. B., Phillips, R. A,, Yancopoulos, G . D., and Alt, F. W. (1988). The scid defect affects the final step of the imniunoglobulin VDJ reconibinase mechanism. Cell 54, 453-460. McCormack, W. T., Tjoelker, L. W., Carlson, L. M., Petryniak, B., Barth, C . F., Huniphries, E. H., and Thompson, C . B. (1989). Chicken Ig, gene rearrangement involves deletion of a circular episome and addition of single nonrandom nucleotides to both coding segments. Cell 56, 785-791. Meier, J . T., and Lewis, S. M. (1993). P Nucleotides in V(D)J recombination: A finestructure analysis. Mol. Cell. B i d . 13, 1078-1092.
82
DAVID T. WEAVER
Mengle-Caw, L., Albertson, D. G., Sherrington, P. D., and Rabbitts, T. H . (1988). Analysis of a T-cell tumor specific breakpoint cluster at human chromosome 14~132. Proc. Natl. Acad. Sci. USA 85, 9171-9176. Mercer, W. E., Shields, M. T., Amin, M., Sauve, G. I., Appel, E., Romano, J. W., and Ullrich, S. J. (1990). Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. Natl. Acad. Sci. USA 87, 6166-6170. Miller, R., Ozaki, J. H., and Riblet, R. (1993). T h e mouse severe combined immune deficiency (scid) mutation is closely linked to the B-cell-specific developmental genes VpreB and lambda 5. Genoinics 16, 740-744. Miinori, T., and Hardin, J . A. (1986). Mechanism of interaction between Ku protein and DNA. J. Biol. Chern. 261, 10375-10379 Mimori, T., Hardin, J. A., and Steitz, J . A. (1986). Characterization o f t h e DNA-binding protein antigen Kit recognized by autoantibodies from patients with rheumatic disorders. J. Riol. Chem. 261,2264-2278. Mimori, T., Ohosone, Y., Hama, N., Suwa, A., Akizuki, M., Homma, M., Griffith, A. J., and Hardin, J. A. (1990). Isolation and characterization of cDNA encoding the 80kDa subunit protein of the human autoantigen Ku (p70/p80) recognized by autoantibodies from patients with scleroderma-polymyositis overlap syndrome. Proc. N a t l . Acad. Sci. USA 87, 1777-1781. Mizuuchi, K. (1992).Polynucleotidyl transfer reactions in transpositional DNA reconibination. J. Biol. Chem. 267, 21273-21276. Mizuuchi, K., and Adzuma, K. (1991). Inversion of the phosphate chirality at the target site of mu DNA strand transfer: Evidence for a one-step transesterification mechanism. Cell 66, 129-140. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J . (1992).Th e mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53mediated transactivation. Cell 69, 1237-1245. Mombaerts, P., Iacomini, J., Johnson, R. S.,Herrup, K., and Tonegawa, S. (1992).RAG1-deficient mice have no mature B and T lymphocytes. Cell 68, 869-877. Moore, P. D., Song, K.-Y., Chekuri, L., Wallace, L., and Kucherlapati, R. S. (1986). Homologous recombination in a Chinese hamster X-ray-sensitive mutant. Mutut. Res. 160, 149-155. Oettinger, M. A. (1992).Activation of V(D)J recombination by RAG1 and RAC2. TIGS 8,413-416. Oettinger, M. A., Schatz, D. G., Gorka, C., and Baltimore, D. (1990).RAG-1 and RAG2, adjacent genes that synergistically activate V(D)J recombination. Science 248, 1517- 1523. OItz, E. M., Alt, F. W., Lin, W.-C., Chen, J., Taccioli, G., Desiderio, S., and Rathbun, G. (1993).A V(D)J recombinase-inducible B-cell line: Role of transcriptional enhancer elements in directing V(D)J recombination. Mol. Cell. B i d . 13, 6223-6230. Paillard, S., and Straws, F. (1991). Analysis of the mechanism of interaction of simian Ku protein with DNA. Nucl. Acids Res. 19, 5619-5624. Painter, R. B., and Young, B. R. (1972). Repair replication in mammalian cells after X-irradiation. Mutut. Res. 14, 225-235. Painter, R. B., and Young, B. R. (1980). Radiosensitivity in ataxia-telangiectasia: A new explanation. Proc. Natl. Acad. Sci. USA 77, 7315-7317. Pergola, F., Zdzienicka, M. Z., and Lieber, M. R. (1993).V(D)J recombination in mammalian cell mutants defective in DNA double-strand break repair. M o l . Cell. Biol. 13, 3464-3471.
VCU)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
83
Petrini, J. H. J., Donovan, J. W., DiMare, C., and Weaver, D. T. (1994).Normal V(D)J coding junction fommation in DNA ligase I deficiency syndromes. J. [nimunol. 152, 176- 183. Pfeiffer, P., Thode, S., Hancke,J., Keohavong, P, and Thilly, W. G. (l994a). Resolution and conservation of mismatches in nonhomologous DNA end joining. Mutagenesis i n press. Pfeiffer, P., Thode, S., Hancek, J., and Vielmetter, W. (1994b). Mechanisms of overlap formation in nonhomologous DNA end joining. Mol. Cell. Biol. 14, 888-895. Pfeiffer, P., and Vielmetter, W. (1988). Joining of non-homologoits DNA double strand breaks in vitro. Nucl. Acids Res. 16, 907-924. Rabbitts, T. (199Q).Chromosoinal abnornialities in cancer cells-Identification ofmolecules important for tumor development. Biochern. Soc. Truns. 21, 809-815. Radford, I . R. (1986). Evidence for a general relationship between the induced level of DNA double-strand breakage and cell-killing after X-irradiation ofmammilian cells. l i l t . J. Rurliut. Biol. 49(4), 611-620. Ranisden, D., Baetz, K., and Wu, G. (1994). Conservation of sequence in recombination signal sequence spacers. Niicl. Acids Res. i n press. Rathmell, W. K., and Chu, G. (1994). A DNA end-binding factor involved in doublestrand break repair and V(D)J rccombination. M o l . Cell. B i d . 14, 4741-4748. Reeves, W. H., and Sthoeger, Z. M. (1989). Molecular cloning of cDNA encoding the p70 (Ku)lupus autoantigen. J. B i d . CAem. 264, 5047-5052. Roth, D., and Wilson, J. (1988). Illegitimate recombination in mammalian cells. In “Genetic Recombination” (R. Kucherlapati and G. Smith, Eds.), pp. 621-653. American Society for Microbiology, Washington, DC. Roth, D. B.. Chang, X.-B.,and Wilson, J. H. (1989).Comparison of filler DNA at immune, no t i i in ti1 11II e , and oti cogen i c rearrange in e 11t s sit gge st s in i t I tip1e niech an i s ins of forniation. Mol. Cell. Biol. 9, 3049-0057. Hoth, D. B . , Merietski, J. P., Nakajima, P. B., Bosnia, M. J., and Gellert, M. (1992a). V(D)Jrecombination: hroken DNA molecules with covalently sealed (hairpin) coding ends in scid mouse thymocytes. Ceif 70, 983-991. Hoth, D. B., Nakajima, P. B., Menetski, J. P., Bosma, hl. J., and Gellert, M. (199213). V(D)J recombination in mouse thymocytes: Double-strand breaks near T cell receptor S rearrangement signals. Cell 69, 41-53. Roth, D. B., Porter, T. B., and Wilson, J. H. (1985). Mechanisms of non-homologous recombination in mammalian cells. M o l . Cell. Biol. 5, 2599-2607. Roth, D. B., and Wilson, J. H. (1986). Nonhomologous recombination in mammalian cells: Role for short sequence homologies in the joining reaction. Mol . Cell. Biol. 6 , 4295-4304. Hoth, D. B., Zhu, C., and Gellert, hl. (1993). Characterization of broken DNA molecules associated with V(D)J recombination. Proc. N n t l . Accid. Sci. USA 90, 10788-10792. Husso, G . , Isobe, M . , Gatti, R., Finan, J., Batuman, O., Huebner, K., Nowell, P. C., and Croce, C. M.(1989). Molecular analysis of a t( 14;14) translocation in leukemic T-cell clones of an ataxia telangiectasiii patient. Proc. N u t / . Acad. Sci. USA 86, 602-606. Husso, G., Isobe, hl., Pegoraro, L., Finan, J., Nowell, P. C., and Croce, C. M . (1988). Molecular analysis of a t(7; 14;q35:(132)chromosome tramlocation in a T cell leukemia of a patient with ataxia telangietasia. Cell 53, 137-144. Schatz, D., and Baltimore, D. (1988).Stable expression of immunoglobulin gene V(D)J recombinase activity by gene transfer into 3T3 fibroblasts. Cell 53, 107-115. Schatz, D., Oettinger, h l . , and Schlissel, M. (1992). V(D)J recombination: Molecular biology and regulation. Atinti. Rec. Z r n i i i u t i o l . 10,
84
DAVID T. WEAVEH
Schatz, D., Oettinger, M. A., and Baltimore, D. (1989).The V(D)J recombination activating gene RAG-1. Cell 59, 1035-1048. Schellenberg, G. D., Martin, G. M., Wijsman, E. M., Nakura, J . , Miki, T., and Ogihara, T. (1992). Homozygosity mapping and Werner’s syndrome. Lancet 339, 1002. Schlissel, M., Constantinescu, A., Morrow, T., Baxter, M., and Peng, A. (1993). Doublestrand signal sequence breaks in V(D)J reconibination are blunt, 5’-phosphorylated, RAG-dependent, and cell cycle regulated. Genes D e v . 7,2520-2532. Schuler, W. (1990).The scid monse mutant: Biology and nature ofthe defect. In “Molecular Biology of B Cell Developments,” pp. 132- 173. Karger, Basel, Switzerland. Schuler, W., Ruetsch, N. R., Amsler, M . , and Bosnia, M. J. (1991).Codingjoint formation of endogenous T cell receptor genes in lymphoid cells from scid mice: Unusual Pnucleotide additions in VJ-coding joints. Eur. J . Zminunol. 21, 589-596. Schuler, W., Weiler, I. J., Schuler, A., Phillips, R. A,, Rosenberg, N., Mak,T. W., Kearney, J. F., Perry, R. P., and Bosma, M. J. (1986). Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 46, 963-972. Schwartz, K., Hansen-Hagge, T. E., Knobloch, C., Friedrich, W., Kleihauer, E., and Bartram, C. R. (1991). Severe combined immunodeficiency (SCID) in man: B cell negative (B-) SCID patients exhibit an irregular recombination pattern at the Jh locus. I . E x p . Med. 174, 1039-1048. Shinkai, Y., Rathbun, G., Lam, K., Oltz, E., Stewart, V., Mendelsohn, M., Charon, J., Datta, M., Young, F., Stall, A., and Alt, F. (1992). RAG-2 deficient mice lack mature lymphcoytes due to an inability to initiate V(D)J recombination. Cell 68, 855-867. Srivasta, S., Zou, Z., Pirollo, K., Blattner, W., and Chang, E. H. (1990). Germ line transmission of a mutated p53 gene in a cancer-prone family. Nature 348, 747-749. Stamato, T. D., Weinstein, R., Giaccia, A,, and Mackenzie, L. (1984). Isolation of cell cycle-dependent gamma-ray-sensitive Chinese hamster ovary cell. Sotnat. Cell Genet. 9, 165-173. Stark, W. M., Boocock, M. R., and Sherratt, D. J. (1992). Catalysis by site-specific recombinases. TZGS 8,432-439. Staunton, J., and Weaver, D. (1994). Hairpin-ended DNA integrates efficiently in w i d fibroblasts. Mol. Cell. Biol. 14, 3876-3883. Stephan, J. L., Vlekova, V., LeDeist, F., BIanche, S., Donadieu, J., DeSaint-Basille, G., Durandy, A., Griscell, C., and Fischer, A. (1993). Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients. J . Pediatr. 123, 564-572. Stern, M., Lipkowitz, S., Aurias, A., Griscelli, C., Thomas, G., and Kirsch, I. R. (1989). Inversion of chromosonie 7 in ataxia telangie ia is generated by a rearrangement between T-cell receptor @ and T-cell receptor y genes. Blood 74,2076-2080. Strasser, A., Harris, A. W., Corcoran, L. M., and Cory, S. (1994). Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature 368, 457-460. Taccioli, G, Blunt, T., Gottlieb, T. M., Priestly, A., Demengeot, J., Mizuta, R., Lehmann, A. R., Alt, F. W., Jeggo, P., and Jackson, S . P. (1994a). Ku80 is the product of the XRCC5 gene: A link between DNA repair and V(D)J recombination. Science 265, 1442-1445. Taccioli, G . E., Cheng, H.-L., Varghese, A. J., Whitmore, G., and Alt, F. W. (19941~).A DNA repair defect in Chinese hamster ovary cells affects V(D)J recombination similarly to the niurine scid mutation. /. Biol. Chem., 269, 7439-7442. Taccioli, G. E., Rathbun, G., Oltz, E., Stamato, T., Jeggo, P. A,, and Alt, F. W. (1993). Inipairnient of V(D)J recombination in double-strand break repair mutants. Science 260.207-210.
V(D)J RECOMBINATION AND DOUBLE-STRAND BREAK REPAIR
85
Takeda, S., Zou, Y. R., Bluethmann, H., Kitamura, D., Muller, U., and Rajewsky, K. (1993).Deletion ofthe immunoglobulin kappa-chain intron enhancer abolishes kappachain gene rearrangement in cis but not lambda-chain rearrangement on trans. E M 3 0 J . 12,2329-2336. Tanaka, T., Yamagami, T., Oka, Y., Nomura, T., and Sugiyama, H. (1993). Th e scid mutation in mice causes defects in the repair system for both double-strand DNA breaks and DNA cross-links. Mutat. Res. 288, 277-280. Taylor, A. M. R., Harnden, D., Arlett, C . F., Harcourt, S. A,, Lehmann, A. R., Stevens, S., and Bridges, B. A. (1975).Ataxia-telangiectasia: A human mutation with abnormal radiation sensitivity. Nature 258,427-429. Thode, S., Schafer, A., Pfeiffer, P., and Vielmetter, W. (1990). A novel pathway of DNA end-to-end joining. Cell 60, 921-928. Tonegawa, S. (1983). Somatic generation of antibody diversity. Nature 302, 575-581. Tycko, B., and Sklar, J . (1990). Chromosomal translocations in lymphoid neoplasia: A reappraisal of the recombinase model. Cancer Cells 2, 1-8. van B LI U~ P., P. W., d e Rooij, D. G., Zandman, I. M., and van Duyn-Goedhart, A. (1994). X-ray induced chroinosmal aberrations and cell killing in somatic and germ cells of scid mice. Submitted for publication. Vaux, D. L., Cory, S., and Adams, J. M. (1988). Bcl-2 gene promotes a haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335,440-442. Vogelstein, B. (1990).A deadly inheritance. Nature 348, 681-682. Walker, A. I., Hunt. T., Jackson, R. J., and Anderson, C. W. (1985). Double-stranded D N A induces the phosphorylation of several proteins including the 90,000 Mr heatshock protein in animal cell extracts. E M B O J . 4, 139-145. Webster, A. D. B., Barnes, D. E., Arlett, C. F., Lehmann, A. R., and Lindahl, T. (1992). Growth retardation and immunodeficiency in a patient with mutations in the DNA ligase I gene. Lancet 339, 1508-1509. Weibezahn, K. F., Lohrer, H., and Herrlich, P. (1985).Double-strand break repair and G2 block in Chinese hamster ovary cells and their radiosensitive mutants. Mutat. R ~ s 145, . 177-183. Whitmore, G. F., Varghese, A. J . , and Gulyas, S. (1989). Cell cycle responses of two Xray sensitive mutants defective in DNA repair. I n t . I . Radiat. Biol. 56(5), 657-665. Wirt, D. P., Brooks, E. G., Vaidya, S., ef (11. (1989).Novel T-lymphocyte population in combined immunodeficiency with features of graft versus host disease. N . Engl. J . Med. 321, 370-374. Xiong, Y., Hannoii, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704. Yaneva, M., Wen, J., Ayala, A., and Cook, R. (1989).cDNA-derived amino acid sequence of the 86-kDa subunit of the Ku antigen. J . B i d . Chem. 264, 13407-13411. Zdzienicka, M. Z., Tran, Q., van der Schans, G . P., and Simons, J. W. I. M. (1988). Characterization of an X-ray-hypersensitive mutant of V79 Chinese hamster cells. Mutat. Res. 194, 239-249. Zhang, W.-W., and Yaneva, M. (1992). On the mechanisms of Ku protein binding to DNA. Biochem. B i o p h y s . Res. Conintun. 186, 574-579.
ADVANCES I N IMMUNOLOGY. VOL 58
Development and Selection of T Cells: Facts and Puzzles PA WE^ KISIELOW~AND HARALDVON BOEHMERZ Basel Institute for Immunology, CH-4005 Basel, Switzerland
I. Introduction 11. Thymus-Derived Lineages of‘T Cells 111. Extrathymically Derived Lineages of T Cells
87 102 110
and Communication with the Antigen-Presenting Cells V. Intrathyinic Development and Selection of T Cells VI. Coiicluding Remarks References
112 139 174 175
IV. T Cell Surface Molecules Involved in an Antigen Recognition
1. Introduction
Mature T cells are essential components of the immune system. They represent phenotypically and functionally heterogenous populations of lymphocytes that are equipped with unique, clonally distributed, heterodimeric (a@ or yS) T cell receptors (TCR), which unlike antigen-specific immunoglobulin (Ig) receptors on B cells, are designed to recognize exclusively cell-bound antigens and cannot be blocked by free antigen. To cope with various kinds of subversive agents exhibiting different biological properties, several lineages of T cells evolved which are programmed to respond differently to different types of antigens. For example, virus-specific antigens on the surface of infected cells recognized by “killer” T cells will stimulate them to release molecules lysing the infected target cells, whereas viral or bacterial antigens recognized by “helper” T cells will stimulate them to release growth factors that regulate the activity of other cells of the immune system, including antibody production by B cells. Recent years have witnessed an enormous progress i n elucidating mechanisms b y which self and foreign proteins (antigens) are pro-
’ ’
On leave of absence from the Institute of Immunology and Experimental Therapy, Polish Academy of Science, 53-114Wroclaw, Poland. Affiliated with the Faculte d e Medicine Necker Enfants Malades, Paris, France. 87 Cupyrigllt 0 1995 bv Academic Press, Inr. ( 1 1 rr~prrrductioni n d n ) form rewrred.
hll riglit,
88
PAWEL KISIELOW A N D HARALD VON BOEHMER
cessed and made “visible” to T cells, especially to those that express ap TCRs and “see” antigen in the context of the major histocompatibility complex (MHC) encoded molecules. The main discovery was that during their intracellular assembly, MHC molecules bind peptides and transport them to the cell surface for T cell recognition (reviewed by Yewdell and Bennink, 1992; Germain, 1994). As a rule, class I MHC molecules bind peptides derived from intracellular proteins and class I1 MHC molecules bind peptides derived from extracellular, ingested proteins. The development and programming of the majority of T cells to recognize foreign antigens, and to perform their different functions, occurs predominantly in the thymus. T lymphocytes learn during development to disregard peptides derived from the body’s own or selfproteins at their physiological concentrations with the exception of those that are not present in the thymus. In that sense the T cell immune system can distinguish between self and nonself. Understanding how functionally different lineages of T cells develop from multipotential hemopoietic stem cells has been a great challenge. The goal is very ambitious and to reach it, it will be necessary to identify all different T cell lineages, to trace back their origin to hemopoietic stem cells, and to elucidate molecular mechanisms of cellular communication and signaling which are responsible for divergence, selection, differentiation, and migration of various cellular stages with progressively restricted developmental potential. For many years the paucity ofavailable markers distinguishing different T cell subsets and/or their developmental stages, combined with the unknown molecular nature of the antigen-specific TCR molecules and their ligands, was preventing any significant progress in this field. The stage for the present era in the study of T cell development, which began about 10 years ago with the discovery of TCR molecules and genes encoding them (reviewed by Allison and Lanier, 1987), was set b y a number of methodological breakthroughs. First, monoclonal antibodies helped to discover TCR molecules and equipped investigators with reagents of great specificity and potential to identify and purify protein molecules. Second, the advances in solubilizing and crystallizing cell membrane proteins coupled with the progress in peptide chemistry permitted the description of the structure of TCR ligands. Third, the polymerase chain reaction technique, which allows the amplification of a single copy of any nucleotide sequence, enriched the armamentarium of gene cloners by a powerful tool. Finally, the
DEVELOPMENT AND SELECTION OF T CELLS: FACTS AND PUZZLES
89
generation of transgenic and gene deficient (“knockout”) mice created new possibilities to unravel the physiological role of individual genes and their products during development of a whole animal and/or of a particular cell lineage. The widespread application of these new technologies generated data that have been advancing our knowledge and their impact on understanding the development of T cells was periodically reviewed (Adkins et al., 1987; von Boehmer, 1988; Raulet, 1989; Fowlkes and Pardoll, 1989; von Boehmer, 1990; Allison and Havran, 1991; Rothenberg, 1992; Haas et al., 1993). Despite this recent progress, however, the extent of phenotypic and functional heterogeneity of T cells is not yet fully appreciated. Along with the identification of new surface markers and the methodological refinement of multiparameter analysis of cell populations in normal and mutant mice, minor subsets of T cells with unexpected phenotypes and unknown ftinctions continue to be discovered. In the present review, we will focus mainly on the important results of recent years of research that was dominated by the analysis of T cell development in transgenic and gene-deficient mice. Genes and proteins, whose role in T cell development has already been analyzed in knockout mice, are listed in Table I, which also summarizes the obtained results. In our review we will discuss the mechanisms of positive and negative selection of T cells within the framework of the concept of programmed cell death (Glucksmann, 1951; Lockhin and Williams, 1965), which strongly influenced the thinking about T cell development in recent years. Programmed cell death could be viewed as a ticking time bomb, which kills developing cells at a predetermined hour unless its clock is set back by signals that positively select “wanted” cells or, if needed, is set forward by apoptosis-inducing signals that precipitate negative selection of “unwanted” cells. It is now well established that during the intrathyinic development TCRs play a central role in transmitting signals that induce proliferation, maturation, or cell death. Understanding the cellular and molecular mechanisms of these events has been a major goal of the ongoing research. We will begin our review by a survey of the heterogeneity of mature T cells, which will be followed by the description of our still sketchy knowledge concerning the mechanisms of T cell development from hemopoietic stem cells.
TABLE I EFFECTSOF NATURALAND ARTIFICIALMUTATIONSOF SOMESELECTED GENESON T CELLDEVELOPMENT Gene
scid
RAG-1 or RAG-2
TdT ip
c
TCRp
TCRa
Phenotype and Conclusions Complete block of development at the CD4-8-44-25' stage. N o mature T and B cells. TCR gene rearrangement is observed but signal sequences are not required. Conclusion: Appropriate rearrangement of TCR and Ig genes is essential for lymphocyte development. Complete block of development at CD4-8-44-25' stage. N o mature T and B cells. No V(D)J recombination. Conclusion: Both RAG genes and their products are indispensable for V(D)J recombination and development of lymphocytes. Cellularity and T cell subset composition in the thymus and peripheral lymphoid organs is not affected. T and B cells are capable of mounting normal responses to complex antigens. Lymphocytes have no o r few N nucleotides in their variable region genes which show extensive evidence of homology-directed recombination (a characteristic of Ig and TCR genes of newborn mice, limiting junctional diversity of rearranged genes). Conclusion: TdT is responsible for N region additions to rearranging antigenreceptor genes. Reduced numbers of CD4'8' cells. N o mature CD4+8- and CD4-8+ cells. Some TCRa rearrangement. Apparently normal development of y6 T cells. The origin and nature of a few CD4'8- and CD4-8' cells present i n these mice is unknown. Conclusions: (1) TCRp gene rearrangement and expression is not essential for CD4/8 expression but important for the expansion of CD4'8' cells. (2) TCRp rearrangement is not needed for generation of y6 T cells. Normal development up to the CD4'8' stage. The numbers and phenotypes of CD4-8- thymocytes appear normal. No effect on rearrangements of TCRP, -6, and -y loci. Apparently normal development of y6 T cells. Small numbers of CD4'8-TCRa-p' cells whose nature and function is unknown are present in the periphery of older mice
Reference Bosina and Carroll, 1991; Rothenberg et ul., 1993
Mombaerts et ul., 1992; Shinkai et al., 1992 Komori et ul., 1993; Gilfillan et ul.. 1993
Mombaerts et ul., 1992
Mombaerts et ul., 1992; Phillpot et ul., 1992
TCRa and TCRp TCRG
5
TCRp and TCHG
CD3c
Conclusions: (1) TCRa chain is not required for the progression of thyniocytes from the CD4-8- to CD4'8' stage and the expansion of CD4'8' cells but is required for further differentiation to CD4'8- and CD4-8' cells. ( 2 ) TCRa expression is not needed for the generation of y6 cells. The phenotype of these mice is identical as that of TCRP mutant mice. Conclusion: Development of yti cells is independent of rearrangement and expression of the TCR genes encoding a p TCR. Complete lack of T cells bearing TCR yG chains while development of ~$3 T cells is unaffected. N o difference in the pattern of y and 6 gene rearrangements and i n generation of restricted junctional sequences between TCRG mutant mice ( i n which only the CG gene segment was disrupted) and wild-type animals. Mice are unable to resist liver infection with Plosmodium yoelli. Conclusions: (1) Development of ap T cells is independent of yG T cells. (2) Rearrangement of TCRy and TCRG genes is developmentally programmed. ( 3 )y6 cells can provide immunity to infectious disease. The phenotype of these inice represents a combination of phenotypes of TCRp and TCHG mutants. Development of a@ T cells is arrested at (7134-8-44-25' stage and i n contrast to TCRp mutants, virtually no CD4'8' cells are generated. yG cells are also absent i n these mice. I n contrast to single mutants (TCRaP- or TCRyG-) the TCRp x TCRG double mutants are sensitive to disease caused b y Listet-iu nronocytogenes. Conclusions: ( 1 ) The yG cells can provide immunity to infectious disease. (2) In TCRp single mutant mice the small numbers of cells expressing CD4 and/or CD8 molecules represent cells of y6 lineage and/or yG cells can induce CD4/ CD8 expression i n cells of other lineages. Complete block of development at CD4-8-44-25' stage. N o mature T cells. Normal rearrangement of TCRp locus. N o TCRa rearrangement. Conclusion: CD3.s is not required either for TCRp rearrangement or for generation of CD44-25' thyniocytes but is required for further development of these cells, resulting i n immature and mature ap T cells.
hloinbaerts et a / . , 1992 Itohara et u l . , 1993; Tsuji d., 1994
Pt
Mombaerts et al., 1992,1993
B. hlalissen, personal communication
(continued )
TABLE I-Continued Gene CD36
5
Phenotype and Conclusions Normal development up to the CD4-8' stage. CD4+8- and CD4-8' cells are virtually absent in the thymus and considerably reduced in the spleen and lymph nodes. Apparently normal development of y8 cells. Conclusions: (1) CD36 is not required for the progression of thyniocytes from the CD4-8- to CD.1-8' stage and the expansion of CD4'8' cells but is required for further differentiation to CD4'8- and CD4-8' cells. (2) CD36 is not required for the generation of y6 cells. The HSA'CD44-25- subset of immature CD4-8- thymocytes is missing in these mice. The numbers of CD4+8+(which differentiate directlv from CD44-25' cells), CD4+8-, and CD4-8ap' thymocytes and peripheral ap T cells are greatly reduced as well as the expression levels nf u1p TCR. y6 [ELs are not affected. The crPTCR complexes arc associated prudomiiiaiit,ly with r ) homodimers. Only vory small amounts of FcyR transcripts are detected. Proliferative responses to TCR stimulation are impaired. Conclusions: (1)<-chain is required for the normal level of assembly and surface expression of the TCR complex in immature thymocytes and this function cannot be fully compensated by r ) or FcyR. (2) 6 chain has a critical role in thymocyte development and signal transduction of T celIs in ciao: the absence of {-chain does not abrogate the differentiation of CD4-8- to CD4+8+cells but inhibits their proliferation and downmodulation of CD25. The generation of CD4'8- and CD4-8ap' cells is also not completely abrogated. Cellularity and T cell suhset composition in the thymus and peripheral lymphoid organs is not affected. hlloprolifcrative and CTL responses are rlonriaj. Positive arid negative selection of transgenic ;inti-HI' TCli is not chaiiged. Conclusion: The product of q gene is not necessary for T cell development and selrctiurl.
Reference D. Kappes, personal communication
Ohno et al., 1993; Love et al., 1993; Crompton et ul., 1994
Koyasu et ul., 1994; Ohno et ol., 1994
FcRy chain
CD4
CD8a
CD8B
The phenotype is very similar to (-only mutants. Rearrangement of TCRa and TCRp genes is unaffected. Numbers of IELs are normal but surface levels of TCRs on both ap and y6 cells are reduced. TCRs on y6 and ap IELs that express CD8a homodinier are associated with homodimers of the FceRIy chain. CD4+8- and CD4-8ap' IELs are CD3-. Conclusions: (1) 5 gene product is essential for efficient generation and/or survival of CD4'8+ thymocytes. (2) TCRs associated with FceRIy chain appear able to sustain the maturation of gut IELs. Thymic and peripheral populations of ap T cells appear normal. up and y6 IELs were not investigated in these mice. Conclusion: FcRy chain is not essential for the development of thymus-derived ap T cells. No atrophy of lymphoid organs. T/B cell ratio is normal. The production of IL-2 in response to class I1 MHC differences and T cell-dependent antibody responses are greatly reduced but not all class I1 MHC restricted responses are affected. Antiviral class I MHC restricted cytotoxic responses are not significantly affected in these mice. The defect in helper T cell responses can be corrected by expression of CD4 transgene. Conclusions: (1)CD4 is needed for efficient development of some but not all T helper cell functions. (2) Development of cytotoxic CD4-8' T cells is independent of CD4 expression. No atrophy of lymphoid organs. T/B cell ratio is normal. Not only CD8a' but also CD8p' cells are missing in these mice. Cytotoxic T cell responses are dramatically decreased but helper functions appear unaffected. Conclusions; (1) CD8 (either CD8a or CD8p or both) is needed for development of cytotoxic T cells but not for helper T cells. (2) CD8a is limiting the surface expression of CD8ap heterodimers. Development of CD4+8+and CD4'8- thymocytes as well as CD4'8- T cells is nomial. The numbers of CD4-8' thymocytes and T cells are strongly reduced. The number of CD4-8+ T cells was restored by transfer of an exogenous CD8p gene into CD8p-deficient T cells. No functional studies reported.
Malissen et al., 1993
Takai et ul., 1994
Rahemtulla et al., 1991; Locksley et al., 1994
Fung-Leung et al., 1991
Nakayama et al., 1994
(continued )
TABLE I-Continued ~
Gene
CD4 and CD8
CD45-exon6
CD28
CD2
Phenotype and Conclusions Conclusion: CD8p is required for efficient positive selection of some CD4-8' T cells. Cellularity of the thymus is normal but the numbers of mature apTCRh1gh, HSA- cells (also in the periphery) are greatly reduced. Alloreactive but not antiviral cytotoxic responses can be generated. Conclusion: CD4 and CD8 are essential for maturation of immature (aPTCR'"" HSAhlgh)thymocytes. More than 90% of T cells lack expression of CD45 but some (about 9%) remain CD45 positive. The development of T cells is impaired as manifested by ) reduced numbers of increased numbers of CD4-8- thymocytes ( 2 ~and CD4'8' (1/3), CD4+8-, and CD4-8+ (1110) thymocytes as well as peripheral T cells: CD4'8- (1/3)and CD4-8' (1/5). Proliferative responses to TCR stimulation of both CD45- and CD45+ cells are strongly reduced and cytotoxic T cell responses to LCM virus are absent. CD4'8' but not CD4'8and CD4-8' thymocytes express elevated levels of CD4 and CD8 molecules. Clonal deletion of superantigen-reactive T cell is not impaired. Conclusions: (1) CD45 is required for efficient transition of CD4+8+to mature CD4'8- and CD4-8' T cells and possibly (to some extent) for transition of CD4-8- cells to CD4+8+thymocytes. (2) Negative selection of superantigen reactive T cells does not require CD45 expression. Development of T and B cells appeared normal. Impaired responses to lectins: decreased IL-2R (CD25) expression and IL-2 production. Reduced helper activity. Apparently normal CTL and DTH responses. No defect in the clonal deletion of self-reactive T cells specific for Mls-1 and I-E. Conclusion: CD28 is not essential for T cell development and repertoire selection and it is dispensable for the development of some effector cells. Development of crp and yti T cells in CD2 mutant mice and their investigated functions are indistinguishable from those of wild-type mice.
Reference
Schilham et al., 1993
Kishihara et ol., 1993
Shahinian et al., 1993
Killeen et al., 1992b
~
IL-2Ry chain
IFNyR
TNFRp55
W
cn
p56Ick
p59fun
Conclusion: CD2 is dispensable for the development and function of T cells I n humans mutations of the IL-2R-y gene result in X-linked severe combined immunodeficiency (XSCID) that is characterized by absence or markedly reduced numbers of thymocytes and T cells. Conclusion: IL-2Ry chain plays a vital role in intrathymic development of T cells in humans. All major subsets of thymocytes and peripheral T cells are normal as revealed by cell count and staining with CD3, CD4 and CD8 antibodies. CTL and T helper cell dependent antibody responses against vaccinia, LCMV and VSV viruses were normal. Conclusion: Lack of IFNyR seems to interfere neither with normal development of T cells nor with their function. Thymic and peripheral populations of T lymphocytes appear normal and clonal deletion of T cells reactive to endogenous viral superantigens is not impaired. Also, the CTL responses against vaccinia and LCMV viruses are normal. Conclusions: 55-kDa receptor for tumor necrosis factor does not play a role in the development of thymus-derived (YP T cells and is not essential for clonal deletion of potentially self-reactive T cells or for CTL responses. Drastic reduction of CD4'8' as well as CD4'8- and CD4-8' cells but not CD4-8-44-25+ cells in the thymus. Few peripheral CD4'8- and CD4-8' cells express strongly reduced levels of CD4 and CD8, respectively. T h e expression of (YP TCR on thymocytes is elevated. O n e percent of the lymph node population is y6 T cells. Proliferative responses of peripheral T cells to TCR crosslinking and to IL-2 alone are almost normal. Conclusions: (1) p56Ickplays a critical role in early stages of intrathyniic T cell development, which cannot b e compensated for by other tyrosine kinases. (2) p56ICkis dispensable for some of the TCR-CD3 and for the IL-2 signaling pathways. The development of all T cell subsets is normal both in terms of the numbers and cell surface phenotypes. Phenotypically mature thymocytes but not
Noguchi et ol., 1993
Huang et al., 1993
Pfeffer et ol., 1993; Rothe et al., 1993
Molina et al., 1992
Appleby et al., 1992 (continued)
TABLE I-Continued Gene
ZAP-70
(D 0)
IRF-1 (Interferon regulatory factor-1)
IRF-2 B2m
Phenotype and Conclusions
Reference
peripheral T cells are compromised in their ability to mobilize intracellular calcium and to proliferate in response to TCR-mediated stimulation. The ability of CD4+8+thymocytes from p59fY" deficient mice to mobilize intracellular calcium in response to TCR stimulation is unaffected. Conclusion; p59fYn plays a pivotal role in TCR signal transduction but loss of p5@' signaling leaves T cell development intact. Arpaia et al., 1994 Thymi of human patients carrying mutation of zap-70 resulting in loss of activity of ZAP-70 kinase have CD4+8+and CD4'8- thymocytes but no or few CD4-8+ thymocytes or T cells. CD4'8- T cells do not respond to TCR stimulation by mitogens or anti-TCR antibody. Conclusion: ZAP-70 kinase appears to be indispensable for the development of CD4-8' T cells as well as for signal transduction in CD4'8- T cells. The phenotype is similar to that of p2m, TAP-1, and ZAP-70 mutants. Thymi of Matsuyama et al., 1993 IFR-1 mutant mice contain normal total numbers of thymocytes but are specifically (10-fold) deficient in CD4-8' thymocytes and peripheral T cells. The proportion of CD4'8- T cells was elevated but yti T cells were not affected. MHC class I expression was not changed. Antiviral cytotoxic responses of residual CD4-8' T cells are normal. CD4'8- helper activities are not affected. Conclusions: (1)IRF-I is involved in the development of CD4-8' but not CD4+8- T cells. (2) Reduced expression of MHC class I molecules does not appear to be responsible for the effect of IFR-1 mutation. Matsuyama et al., 1993 T cell development and function is not affected. Zijstra et al., 1990; Koller et Cells in these mice are severely deficient in the surface expression of most if ol., 1990 not all class I MHC molecules but a low level of class I molecules on the cell surface can be detected with serological and/or functional tests (reviewed by Raulet, 1994b). Thymi of mutant mice contain normal total numbers of thymocytes but are specifically deficient in CD4-8' cells. The residual
I-AP (MHC class 11)
I-i (MHC-I1 associated invariant chain)
p2m and I-A/3
CD4-8' cells in the thymus and periphery constitute only 1-5% of the normal pool of TCRaP'CD4-8' T cells. Cytotoxic responses are drastically reduced but not totally absent. The development and function of CD4'8cells appears not affected. y6 T cells are normal. Conclusions: (1) MHC class I molecules are crucial for positive selection of most TCRaP+CD4-8+ T cells. (2) Development of most y8 T cells does not require class I MHC molecules, at least at their normal expression levels. Complete absence of class I1 MHC molecules on the cell surface. Thymi of mutant mice contain normal total numbers of thymocytes but are specifically deficient in CD4'8- cells. A sizeable proportion of immature cortical thymocytes express CD4'8''" phenotype. CD4'8' thymocytes display elevated levels of CD4 and af3 TCR. The residual CD4'8- cells in the thymus and periphery constitute about 5% of the normal pool of TCRaP'CD4'8- T cells and many of them are larger, express CD4 and ab TCR at reduced levels, and are found at distinct anatomical sites. The mice are unable to mount T cell-dependent antibody responses. Conclusion: Class I1 MHC molecules are required for positive selection and functional maturation of most CD4'8- T cells. The absence of the I-i chain results in a reduction of cytoplasmic and cell surface expression of I-Ab and in surface reduction of I-A' and I-Ek molecules which have an aberrant conformation. T cell development in these mice is affected similarly as in I-AP mutants but reduction of CD4+8- cells is less pronounced. In contrast to the wild-type animals the CD4'8- cells contain significantly higher proportion of I-E reactive VPll' cells. Primary but not secondary antibody responses to protein antigens are impaired. Conclusion: Lack of I-i chain results in deficient expression of class I1 and deficient positive and negative selection of CD4% cells. The phenotype of these double mutants is a combination of the phenotypes of single mutants. Thymi contain normal total numbers of thymocytes but are strongly deficient in CD4+8- and CD4-8' cells both in the thymus and in the periphery. The CD4'8' thymocytes express equivalent levels of CD4 and
Cosgrove et ul., 1991; Grusby et ul., 1991
Viville et d., 1993; Bikoff et ul., 1993
Grusby et al., 1993
(continued )
TABLE I-Continued Gene
Phenotype and Conclusions CD8 molecules: cells with CD4'""8' and CD4'8'"" phenotypes are practically absent. y8 cells appear to develop normally. Cells from these mice exhibit very poor cellular immune responses in uitro but can reject imcompatible skin grafts efficiently. Whether in uiuo responses are due to the activity of residual ap T cells or to non-ap T cell-mediated mechanisms is unknown. Conclusions: (1) Development of most up T cells is dependent on the presence of MHC molecules. (2) Development of most y8 T cells does not require MHC molecules, at least at their normal expression levels. The effect TAP-1 mutation on T cell development and function is similar to that of the mutated p2m gene.
TAP-1 (peptide transporter gene 1) LMP-7 (proteasome Despite clear reduction (10-40%) in cell surface expression of the MHC class I subunit) molecules no obvious effect on T cell development and function was noticed. Antigen presentation is less efficient. ICAM-1 All major subsets of thymocytes and peripheral T cells are normal. Infammatory responses are impaired. Mutant cells provide negligible stimulation in mixed lymphocyte reaction but proliferate normally as responders. Conclusion: Lack of ICAM-1 does not seem to impair T cell development. The development of major subsets of thymocytes and peripheral T cells is IL-2 unperturbed in these mice but they have altered serum levels of immunoglobulin isotypes and in uitro T cell responses are dysregulated. In oiuo, however, the ability to mount antiviral cytotoxic responses is preserved. Conclusion: IL-2 is dispensable for T cell development and (at least for some) functions. IL-4 There is no deficiency in absolute cell numbers or in the proportion of major T cell subsets in the thymus and in the periphery. The serum levels of IgGl and IgE are strongly reduced and Th2 cytokine responses (IL-5 and IL-10) are significantly impaired.
Reference
van Kaer et al., 1992 Fehling et al., 1994 Sligh et al., 1993
Schorle et al., 1991; Kundig et al., 1993
Kuhn et al., 1991; Kopf et al., 1993
IL-4 and 1L-2. IFNy
IL-6
IL-10
Perforin
Conclusion: IL-4 is not essential for development of major T cell subsets but is required for the generation of the The-derived cytokines. All major T cell subsets are normal. Conclusion: IL-2 and IL-4 are not essential for development of T cells. All major subsets of thymocytes and peripheral T cells are normal as revealed by cell count and staining with CD3, CD4, and CD8 antibodies. Splenic T cells respond by uncontrolled proliferation to mitogens and allaontigens. In oitro-generated CTL responses against alloantigens are enhanced. Conclusion: IFNy is not essential for the development of T cells but is essential as a regulator of T cell function. Numbers of thymocytes and peripheral T cells are reduced by 20-40% compared to controls but no difference in the representation and distribution of major subsets defined by TCRa, -p, -y, and -6 chains, CD4, CD8, CD44, and HSA is observed. CTL function against some (vaccinia) but not other (LCMV) viruses is strongly reduced and T cell-dependent antibody response against VSV virus is impaired. Conclusion: T cell development is not significantly affected by the absence of IL-6 but IL-6 is important as regulator of T cell functions. T lymphocytes appear to develop normally. T cell-dependent antibody responses are normal. Following infection with nematode N . brasiliensis develomient of a The remonse is not affected but in contrast to normal mice development of T h l response is not supressed. The mice develop chronic enterocolitis. Conclusion: IL-10 is not required for development of T cells but is needed to inhibit T h l cell responses. T lymphocytes appear to develop normally. No significant differences in the number and distribution of thymocyte and T cell subsets were observed. CD4-8+ T cells do not lyse virus-infected or allogeneic fibroblasts and the mice fail to clear LCMV virus. Conclusion: Perforin is a key molecule for T cell-mediated cytolysis.
Sadlack et ul,, 1994 Dalton e t al., 1993
Kopf et al., 1994
1993 Kuhn et d.,
Kagi et ul., 1994
(continued )
TABLE I-Continued
O
Gene
Phenotype and Conclusions
L I F (Leukemia inhibitory factor)
Thymocyte numbers are slightly reduced compared to control animals but no differences in major thymocyte and T cell subsets are observed. The Con Ainduced proliferative response of thymocytes but not peripheral T cells is reduced both in homo (LIF-’-)- and heterozygous (LIF+’-)mice. Conclusion; LIF plays no major role in T cell development but has some poorly defined effect on thymocyte proliferation. T cell development is unaffected. Like in normal mice, CD4+8+thymocytes are susceptible to apoptosis induced by TCR engagement or by glucocorticoids but unlike in normal mice are resistant to apoptosis induced by ionizing radiation and etoposide. Conclusion: p53 is dispensable for T cell development but is required for apoptosis induced by agents that cause DNA strand breakage. The development of T cells is initially normal. Until 3 weeks of age thymus and peripheral T cells show normal subset composition but later undergo massive apoptotic involution. Peripheral T cells have short life span and increased sensitivity to glucocorticoids and ionizing radiation. Stimulation with anti-CD3 antibody inhibits death of these cells.
P53
bcl-2
Reference Escary et al., 1993
Donehower et al., 1992; Lowe et al., 1993; Clarke et al., 1993
Veis et al., 1993b; Nakayama et al., 1993
c-jun
c-fos
Conclusions: (1)Bcl-2 is dispensable for T cell development but is required for the resistance of mature T cells to glucocorticoid and y-irradiation-induced apoptosis. ( 2 ) Rescue from programmed cell death of developing thymocytes may involve Bcl-2-independent signaling mechanism. Thymus and peripheral T cells show normal subset composition as assessed by staining with C D ~ ECD4, , CD8, aP TCR, y6 TCR, Thy-1, IL-2Ra, CD5, and CD45R but thymocyte numbers are small (10% of normal), mostly due to depletion of CD4'8' as well as CD4'8- andCD4-8' cells. In contrast, the number of peripheral T cells which show normal activation responses (expression of IL-2R, IL-2 secretion, and proliferation) is significantly increased in some mice. Conclusion: c-jun expression is dispensable for T cell development in oioo but its absence causes some unexplained quantitative perturbations of the process. T cell development and function is unaffected.
Chen et al., 1994
Jain et al., 1994
102
PAWEX: KISIELOW A N D HARALD VON BOEHMER
II. Thymus-Derived lineages of T Cells
The thymus is a major site of T lymphocyte production that starts during the late phase of embryonic life and continues until puberty. Thereafter, the role of the thymus as a source of newly generated T cells subsides and it can be removed without major consequences for the functioning of the immune system. Genes encoding TCR chains are formed in immature thymocytes by rearrangement of V (variable), D (diversity), J boining), and C (constant) gene segments, similarly to immunoglobulin genes (Tonegawa, 1983; see Section 1V.A.la). The majority of T cells produced in the mature thymus expresses ap TCRs, while a minority bears y6 TCRs. During ontogeny cells with y6 TCRs appear earlier than ap T cells (Bluestone et al., 1987; Havran and Allison, 1988; Pardoll et al., 1987a) and until Day 17 of gestation y6 cells comprise the major population of TCR positive cells in the murine thymus (reviewed by Fowlkes and Pardoll, 1989). A. THYMUS-DERIVED y6 T CELLS Detailed discussions of the heterogeneity, specificity, and function of thymus-derived as well as nonthymus-derived y6 T cells (Section II1,A) have been recently published (Allison and Havran, 1991; Haas et al., 1993) and we will only briefly summarize the most important points.
1 . Heterogeneity Subsets of the thymus-derived y6 T cells can be distinguished according to the TCR-V gene segment usage, anatomical location, and time of appearance in ontogeny. Although thymus-derived yi3 T cells were reported to express CD4 (Itohara et al., 1989; Morita et al., 1991; Spits et al., 1991) or CD8 molecules (Bucy et al., 1989; Groh et al., 1989; Itohara et al., 1989), which on two major subsets of thymusderived ap T cells function as coreceptors during antigen recognition (see Section IV.B.l), the overwhelming majority of y6 cells are CD4-CD8-. The function of CD4 and CD8 molecules on y6 cells is unknown. The yi3 cells which appear in the first two waves that colonize the fetal thymus have monomorphic TCRs. They express TCRy chains encoded by rearranged V5JlC1 or V6JlC1 gene segments, respectively, paired with TCRG chains encoded b y rearranged VlD2J 1C-8 gene segments (for explanation of nomenclature and genomic organization of TCR loci, see Fig. 1). These receptors exhibit essentially no junctional diversity (Section IV,A,lb) (Elliott et al., 1988; Laffaille et
DEVELOPMENT AND SELECTION OF T CELLS: FACTS AND PUZZLES
t
___L
Wl
V B k m m x 25)
TCRp
103
itlittk
JBll-17
W2
CB2
CB2
JP21-27
*
VP14
+
c a pom 7Ovb+lOV6
&DSlM2&1
J62
M
v65 qJa
J o (approx 801
Ca
TCRo-6
t-
C v 4 Jy4
TCRv
Vvl Vy2
-e
Jv2 Cv2
CV3
Jv3
Vv3
+fB&k4
Cvl
Jvl
et Vy5 Vv6
tt
Vv4 Vy7
+Et+-tt---
FIG.1 . Genornic organization ofthe murine TCRP, TCRdG, and TCRy loci. Arrows indicate transcriptional orientation; * indicate pseudogenes. VG segments are distinguished by open squares. 8 rec and $ Jo are elements mediating deletion of the TCRG locus. A11 of the C genes are composed of multiple exons (not shown). Drawings are not to scale. Nomenclature of TCR-Vy gene segments is according to Heilig and Tonegawa (1986).
ul., 1990).Vy5-expressing cells migrate to the skin and Vy6-expressing cells to the epithelia of the tongue and the female reproductive tract (uterus, vagina). The next waves of y6 cells consist of cells expressing TCRs with extensive junctional diversity. Cells with TCRs encoded by V1J4C4y and V6fV4fVS or V7-6 are abundant in newborn thymus and spleen and can be found in the skin and in the gut. y6 cells expressing Vy2 are infrequent and can be found in different locations. The predominant population of y6 cells in the thymus, spleen, and lymphnodes of adult mouse expresses a highly diverse repertoire of TCRs encoded by V4JlC1-y and V5-6fV4-6fV6-6 or V7-6. The origin (thymic versus extrathymic) of y6 cells residing in the liver, lung, and mammary gland is unclear. The predilection of y6 cells with different TCRs for particular anatomical sites suggested the possibility that the specificity of y8 TCRs determines the homing pattern. This, however, is not the case because in y6 TCR transgenic mice the correlation between anatomical site and y6 TCR broke down (Bonneville et al., 1990).
2 . Speci5city Murine and human y6 T cells (clones, lines, and hybridomas) recognizing classical class I and class I1 MHC proteins, nonclassical MHC class I-like (TL region encoded) proteins, mycobacteria, and heat shock proteins have been described (reviewed by Haas et al., 1993) but the
104
PAWEE KISIELOW AND HARALD VON BOEHMER
nature of the natural target antigens (ligands) of y6 T cells remains elusive and the general rules of antigen recognition by these cells and antigen presentation have yet to be established. Two lines of evidence suggest that the molecular nature of y6 T cell recognition may be fundamentally different from that of a/3 T cells (reviewed by Raulet, 1994a). First, it was found that most y6 T cells develop normally in mice lacking MHC class I and class I1 molecules (Bigby et al., 1993; Correa et al., 1992; Grusby et al., 1993) which questions the involvement of these MHC molecules in the normal function of y6 T cells. Second, analyses of y6 T cell hybridomas specific for classical MHC class I1 molecule (IE) and for TL class I molecules were interpreted to indicate that the topology of the y6 T cell receptor’s interaction with the MHC is distinct from that of a/3 T cells and that MHC bound peptides do not influence TCR binding (Schild et al., 1994). These results could suggest that some yS TCRs bind to MHC molecules not from the top but from the side, away from the peptide-binding groove. Comparative measurements of the length of the third complementarity determining regions (CDR3) of 6, y, a,and /3 TCR chains and immunoglobulin heavy and light chains suggested the possibility that y6 TCRs may be more immunoglobulin like in their antigen-recognition properties and therefore recognize native antigens without a requirement for degradation and presentation by professional antigen-presenting cells (Rock et al., 1994; Schild et al., 1994). The monospecific Vy5 expressing cells residing in skin epithelium were shown to react specifically to cultured keratinocytes and/or to living or fixed fibroblasts treated with tryptic digests of cultured keratinocytes (Havran et al., 1991)suggesting that the Vy5 subset is specific for a stress-induced, keratinocyte-specific self-peptide (Allison and Havran, 1991). Since the third complementarity determining regions of the canonical TCR of the Vy6 and Vy5 subset are identical it was proposed that the two TCRs recognize the same endogenous peptide in the context of different tissue-specific peptide-presenting molecules (Haas et al., 1993).
3. Function The great diversity ofy6 TCRs, achieved mainly by junctional diversification, strongly suggests that the majority of y6 T cells is concerned with protection against microbial infections. Recent experiments in mice deficient for a/3 T cells provide direct evidence that y6 T cells can provide immunity to infectious diseases (Mombaerts et al., 1993; Tsuji et al., 1994): mice deficient for both a/3 and y6 T cells were found to be extremely sensitive to disease caused by the intracellular
DEVELOPMENT AND SELECTION OF T CELLS: FACTS AND PUZZLES
105
bacterium Listeria monocytogenes, whereas mice deficient for either a@ or y6 T cells were found to be similarly resistant to primary infections (Mombaerts et al., 1993). In another study (Tsuji et al., 1994) yS T cell-deficient mice, unlike a@ T cell-deficient mice, were shown to be unable to resist liver infection with Plasmodium yoelli. The role of the monospecific subsets of y6 cells is more puzzling. It is suspected that some of them may recognize self-antigens such as stress-induced proteins (Allison and Havran, 1991; Asarnow et al., 1988). The ability of stimulated yS cells to secrete various lymphokines and to lyse target cells has been amply documented (reviewed by Haas et al., 1993). Interestingly, analysis of rare CD4' yS T cell clones indicated that they produce lymphokines at high levels but have little or no cytolytic activity (Spits et al., 1991), suggesting the existence of similar correlation between function and expression of CD4 and CD8 molecules among y8 T cells as observed among a@ T cells (see Section II.B.l and 2). B. THYMUS-DERIVED a@ T CELLS On the basis of cell surface expression of CD4 and CD8 molecules (see Section IV, B, 1) one can distinguish at least three different lineages of T cells with a@TCRs, namely the CD4+8-, the CD4-8', and the CD4-8- cells that are exported from the thymus with these phenotypes (Kelly and Scollay, 1990). Recently, the export of CD4'8cells that do not bear TCR (neither a@ nory6) was described in neonatal mice (Kelly and Scollay, 1992). The fate of these cells is, however, not known and therefore they will not be discussed further here. Small numbers of CD4+8+cells, apparently representing recent thymic emigrants, can also be found in peripheral organs (Bonomo et al., 1994; Hosseinzadeh and Goldschneider, 1993) where they may undergo post-thymic maturation. This population is especially prominent in lymph nodes of 3 day old mice (Bonomo et al., 1994). Some experiments suggest that in the absence ofa thymus these cells can differentiate into autoimmune effector cells that may be responsible for organspecific autoimmune disease observed in neonatally thymectomized mice (Nishizuka and Sakakura, 1969). 1 . CD4'8- a@ T Cells a . Heterogeneity and Function. The CD4+8- T cells, originally characterized as possessing helper activity in humoral and cellmediated immune responses (Cantor and Boyse, 1975; Kisielow et al., 1975; Dialynas, et al., 1984; Rheinherz and Schlossman, 1980), do
106
PAWEY, KISIELOW A N D HAHALD VON BOEHMER
not represent a homogenous population of cells. The analysis of the spectrum of lymphokines produced by long-term clones of CD4+8- T cells led to the distinction of functionally different subsets of T helper (Th) cells (Mosmann et al., 1986; Street et al., 1990; for reviews, see Mosmann and Coffman, 1989; Swain et aZ., 1991; Paul and Seder, 1994). Cells producing IL-2, IFNy, and tumor necrosis factor beta (TNFp) have been designated as T h l ; cells producing IL-4, IL-5, IL6, IL-10, and IL-13 as Th2; and cells producing IL-2, IFNy, and IL4 as Tho. It is believed that T h l and Th2 cells arise via an intermediate Tho stage (Kamogawa et al., 1993) as a result of antigenic stimulation of naive CD4+8- precursors (pTh),which can produce IL-2 but neither IL-4 nor IFNy (reviewed by Paul and Seder, 1994). T h l and Th2 cells are involved in regulation of cellular immunity and antibody production, respectively, as well as in the mutual regulation of their activities, which appears important not only for mounting the appropriate response to different pathogens but possibly also for regulating autoimmune responses. With regard to the latter possibility it was found that lymphokines produced by Th2 cells can regulate the activity of T h l cells (Liew et al., 1989), which in some cases of prolonged activation may b e responsible for local inflammation and tissue damage. Consistent with the observations of inhibitory influences of Th2 cells on T h l cells was the finding that IL-10-deficient mice develop chronic enterocolitis (Kuhn et al., 1993) which could result from uncontrolled response of Thl cells to normal antigenic stimulation. It was also found that IL-12 is able to promote the differentiation of T h l cells while inhibiting Th2 formation (Hsieh et al., 1993). Hayakawa and Hardy defined four distinct subsets of CD4'8- T cells on the basis of expression of cell surface markers called 6C10 and 3 G l l (Hayakawa and Hardy, 1988), which can be further subdivided by different levels of CD45, L-selectin (Mel-14), and CD44 molecules on the cell surface (Kariv et al., 1994). Analysis ofanti-TCRinduced production of lymphokines by individual cells in each subset from normal, healthy, unmanipulated mice revealed that the surface phenotype defined by the above markers largely overlaps with clusters ofcells showing uniform and distinct cytokine profiles. In these studies only cells corresponding to pTh and Tho subsets were detected. As discussed by the authors the absence of typical T h l , i.e., IL2+IIFNy+/ IL4-, cells and typical Th2, i.e., IL-2-/IFNy-/IL4+, cells in healthy nonimmunized animals may indicate that potent antigenic stimulation as it occurs in infected or intentionally immunized animals may be required to generate cells exhibiting a more extreme bias in cytokine production. In fact, the avidity ofTCR for their ligands may also contribute to development into T h l or Th2 subsets.
DEVELOPMENT A N D SELECTION OF T CELLS: FACTS A N D PUZZLES
107
Recently, two additional distinct minor subpopulations of CD4'8cells exhibiting restricted TCR V gene utilization were described. One was designated Thy0 (Hayakawa et al., 1992) and was of the CD4'8-HSA (heat-stable antigen)'""'- 6C10-3G11- phenotype. This cell type is found predominantly in the thymus and consists of autoreactive class I1 MHC-specific or restricted cells (Kariv et al., 1992). Another one, identified by expression of NK1.l marker, has the HSA~OW/-Ly6Ct3G11'"" phenotype (Arase et al., 1992,1993; Bendelac et al., 1994). The CD4'8-NKl.1' cells are found in the thymus as well as in the periphery and are particularly potent producers of IL4 (Bendelac et at., 1992; Yoshimoto and Paul, 1994). Their function is unclear but it was speculated that they may enhance differentiation of CD4+8- cells into Th2 cells (Paul and Seder, 1994). As a rule CD4'8- ap T cells are not directly cytotoxic but in some instances direct cytotoxicity of these cells can be demonstrated (Barnaba et al., 1990; Macphail and Stutnian, 1987; Muller et al., 1992).The mechanism of direct killing by CD4+8- cells is, however, unknown.
b. S p e c i j k i t y . Most CD4'8- T cells (pTh, Tho, T h l , Th2, and cytolytic CD4 cells) respond to peptides presented by self or foreign class I1 MHC molecules that also ligate CD4 molecules (Doyle and Stroniinger, 1987; Konig et al., 1992; see Section IV,B,l). Coengagenient of the ap TCR and the CD4 coreceptor by the same ligand is required for most efficient activation of CD4+8- cells (reviewed by Miceli and Parnes, 1993),which may give the illusion that the ap TCR of these cells can only bind to class I1 MHC molecules. Since binding assays of soluble TCRs are not readily available the possibility remains that ap TCRs of CD4'8- T cells can in fact bind to a much larger variety of antigens but that this is not revealed in T cell activation because ligands other than class I1 MHC molecules cannot coligate the CD4 coreceptor. Experiments in TCR transgenic mice expressing receptors specific for peptides presented by class I (Pircher et al., 1989; Sha et al., 1988; Teh et al., 1988)or class I1 (Berg et al., 1989; Kaye et al., 1989) MHC molecules as well as in mice deficient in class I (Koller et al., 1990; Zijlstra et al., 1990) or class I1 (Cosgrove et al., 1991; Grusby et al., 1991)MHC molecules demonstrated that the development ofthe majority of CD4'8- ap T cells required interaction with class I1 MHC molecules, whereas the development of the majority of CD4-8' ap T cells required interaction with class I MHC molecules (see Section V,C,2). However, CD4+8- ap T cells with specificity for class I MHC antigens have been described (De Bueger et al., 1992; Macphail and Stutman, 1987; McKisic et al., 1991). They could represent cells se-
108
PAWEE KISIELOW AND HARALD VON EOEHMER
lected by class I1 MHC molecules that cross-react with class I MHC molecules or alternatively could be selected by class I MHC molecules in the thymus. Recently, it was found that some CD4'8- ap T cells can develop in class II-deficient mice (Bendelac et al., 1994; Cosgrove et al., 1991) but not in class I1 as well as class I-deficient mice (Chan e t al., 1993a). It was also proposed that CD4+8- cells expressing the NK1.l marker are selected by interaction with class I MHC molecules on hematopoietic cells (Bendelac et al., 1994).
2 . CD4-8' ap T Cells a. Heterogeneity and Fzirtction. Thymus-derived CD4-8+ a@T cells express CD8 molecules as heterodimers consisting of a and p chains (Parnes, 1989). Like CD4+8- T cells, CD4-8' T cells consist of heterogenous subsets. The predominant function of the majority of CD4-8' ap T cells is commonly believed to be the generation of cytolytic effector cells after antigenic stimulation but CD4-8+ cells with helper activity were also described (Horvat et al., 1991; Swain, 1981)(see review by Kemeny e t al., 1994). Cytolytic activity may result either from the release of perforin molecules together with granzyme molecules (Griffith and Muller, 1991) or from the recently discovered interaction of Fas protein with the Fas-ligand (Rouvier et al., 1993; Vignaux and Golstein, 1994; see Section IV.B.6). The importance of perforin-mediated cytotoxicity was documented in perforin-deficient mice that were severely compromised in their ability to cope with viral infections (Kagi et al., 1994). However, as mentioned above, cytotoxicity is not the only effector function of CD4-8+ T cells. These cells can, at least for some time, grow in an autocrine fashion resulting from the production of small amounts of IL-2 (von Boehmer et al., 1984)and when antigenically stimulated can also secrete IFNy, TNFa, and TNFp (reviewed by Rothenberg, 1992). In one particular line of TCR transgenic mice, CD4-8+ cells with a receptor for an HY peptide presented by class I MHC molecules could be induced to proliferation and lymphokine secretion but only to poor cytolytic activity (von Boehmer et al., 1991). These cells failed to reject skin grafts but could reject hemopoietic grafts from male mice (unpublished results). It is possible that the type of effector function of CD4-8' cells is, at least in part, determined by the avidity of the TCRs for their ligand. Recently, it was reported that CDw6O antigen on human CD4-8+ T cells allows discrimination between helper T cells and T cells with cytotoxic and suppressor activity (Rieber and Rank, 1994). The alloantigen-specific cytotoxic activity and B cell differentiation sup-
DEVELOPMENT AND SELECTION OF T CELLS: FACTS A N D PUZZLES
109
pressing activity resided entirely in the CDw60-population, whereas the CDw60' population provided substantial help to B lymphocytes.
b. Specijicicity. As mentioned above, CD4-8+ T cells are, as a rule, selected in the thymus by interaction with class I MHC molecules (Teh et al., 1988; Kisielow et al., 1988a; Zijlstra et al., 1990) (see Section V.C.2) and exhibit specificity for peptides presented by class I MHC molecules, which represent specific ligands for CD8 molecules (Rosenstein et al., 1989; Salter et al., 1990). Again, it is not clear whether the observed specificity of CD4-8+ T cells for class I MHCassociated peptides is due to the fact that their ap TCRs do not bind to peptides presented by class I1 MHC molecules or to the fact that in order to induce CD4-8+ cells efficiently, the TCR must be coligated with CD8 molecules (Emmerich et al., 1986). Some CD4-8+ T cells or T cell clones can be activated either by allogeneic class I1 MHC molecules or by peptides presented by self-class I1 MHC molecules (Schilham et al., 1986). In most cases it is not known whether this simply reflects cross-reactivity of class I MHC-restricted T cells selected by thymic class I MHC molecules or whether some of these cells were in fact selected by class I1 MHC molecules. Recently, CD4-8+ T cells that expressed exclusively a transgenic, class I1 MHCrestricted TCR, have been shown to be selected by thymic class I1 MHC molecules (Kirberg et al., 1994; see Section V.C.2). This may occur regularly with cells that express TCRs of relatively high affinity for self-MHC ligands and that can be selected without the coengagement of TCRs and CD4/CD8 coreceptors by the same MHC ligand (see Section V.C.2). 3 . CD4-8- ap T Cells CD4-8- a@ T cells are found in the thymus and in peripheral lymphoid organs where they account for less than 1% of all a@ T cells. The characteristic feature of this population is the predominant expression of Vp8 TCR chains (Fowlkes et al., 1987) which is present on approximately 60% of CD4-8- ap T cells. The identity of progenitor cells of ap CD4-8- cells is mysterious as well as is their selection, function, and specificity. Studies of the methylation patterns of the CD8 gene in these cells may suggest that at least some of them passed through CD8+ stage (Takahama et al., 1991; Wu et al., 1990). CD4-8aP T cells can be stimulated by engagement oftheir TCRs to proliferate and secrete various lymphokines (Fowlkes et al., 1987; Zlotnik et al., 1992). A fraction of these cells expresses the NK1.l marker (Levitsky et al., 1991),and recent studies were interpreted to indicate that some
110
PAWEY. KISIELOW AND HARALD VON BOEHMER
Vp8